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1 Chapter 1: Introduction and goals 
Chapter 1: Introduction and goals  
1.1. Introduction 
Quinones constitute a valuable class of organic compounds that are non-aromatic but fully conjugated 
cyclic diketones. Each of these compounds is named after its aromatic analogue. For instance, benzene 
gives rise to benzoquinone, naphthalene to naphthoquinone, anthracene to anthraquinone, etc... 
However, the term quinone stems etymologically from the native South-America Quechua word kina-
kina, which can be translated through the Spanish word quina meaning Cinchona bark.  
Despite the discovery of 1,4-benzoquinone 2 by the Polish chemist Alexandre Wosrerenski in 1838, 
quinones rose up in the literature around the mid-nineteenth century with the oxidation of quinic acid 1 
(Figure 1-1), which was isolated from Cinchona species (Rubiaceae), a genus of medicinal plants native 
to tropical South-America, to 1,4-benzoquinone 2 (Figure 1-1).1  
O
O
3 1,2-benzoquinone
OH
HO OH
COOHHO
1 quinic acid
O
O
2 1,4-benzoquinone  
O
O
O
O
 4 1,4-naphthoquinone  5 9,10-anthraquinone  
Figure 1-1. Structure of quinic acid 1 and some simple quinones 
 
The simplest and prototypical examples of the class of quinones are 1,4-benzoquinone 2 and 1,2-
benzoquinone 3. Other relevant members are 1,4-naphthoquinone 4 and 9,10-anthraquinone 5, which 
constitute the basic core of many naturally occurring quinones. 
The chemistry of this class of compounds is dominated by the reversible conversion between 
hydroquinones 6 and quinones 7 (Scheme 1-1), which is of paramount importance to different biological 
systems, much as the respiratory chain.2 
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O
O
OH
OH
76
Oxidation
Reduction
 
Scheme 1-1. para-Quinone redox equilibrium 
The electron-donating groups present on aromatic compounds 6 increase the electron-density of the 
aromatic system and contribute to reach the necessary redox potential to break the aromaticity by an 
oxidation process giving rise to quinones 7. The latter compounds 7 are electrophilic Michael acceptors, 
which are stabilized by conjugation and across which addition reactions occur. These addition reactions 
often result in the formation of the corresponding hydroquinones due to aromatization. In addition, 
quinones are excellent dienophiles for Diels-Alder reactions.3 
O
O
O
N
O
O
8 1H-pyranonaphthoquinone
(pentalongin)
9 2-azaanthraquinone
                                    
Figure 1-2. Examples of heterocyclic quinones 
The class of quinones also includes heterocyclic compounds such as pyranonaphthoquinone 8 and 2-
azaanthraquinone 9 (Figure 1-2). The heterocyclic moiety may be constructed selectively starting from 
either quinone derivatives or their reduced analogues which may be reoxidized in a subsequent step.4 In 
case of hydroquinones 6, this oxidation can be achieved spontanously in the presence of air oxygen.5 
Several other reactions such as rearrangement reactions,6 the phthalide annulation,5,7 Friedel-Crafts 
acylation,8 palladium catalyzed coupling reactions,9 Knorr cyclization,10 ortho-lithiation11 and the 
dominating hetero Diels-Alder addition2a,5b are described in literature to synthesize heterocyclic 
quinones. The syntheses of 2-azaanthraquinone derivatives as potential new antibiotics against 
Mycobacterium strains are integral parts of the present thesis. Heterocyclic quinones encompass 
several types of potent biologically active compounds and antibiotics.12 As a result, they are used as 
templates in drug discovery and development.  
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1.2. Goals of the research 
The goals for the present reseach were set forth in the three following areas:  
(1) Azaanthraquinones 10 and naphthonaphthyridines 12 represent two important related classes of 
bioactive compounds (Figure 1-3). For instance, cleistopholine 10a and sampangine 12a are two 
strongly related alkaloids which are renowned for their antibiotic activity and which have been initially 
isolated from the African tropical Annonaceae species Cleistopholis patens13 and the Asian 
Annonaceae species Cananga odorata,14 respectively. Due to their interesting biological activities, the 
syntheses of cleistopholine 10a, sampangine 12a and their derivatives represent an attractive target for 
organic chemists.15 However, their 2-aza analogues, 2-azacleistopholine 10b and 2-azasampangine 
12b have never been isolated from a natural source nor been synthesized hithertho. In the published 
synthetic methods of cleistopholine 10a and sampangine 12a,15 the synthesis of cleistopholine 10a 
derivatives led to the efficient synthesis of sampangine 12a derivatives via 4-(2-
dimethylaminovinyl)benzo[g]quinoline-5,10-dione 11a as the key intermediate, which has been found to 
exert potent biological activities.15d Furthermore, the synthesis of sampangine 12a can even be 
accomplished starting from cleistopholine 10a in a one-pot process without the isolation and purification 
of the corresponding intermediate 11a.15a Since it is known that 2-azaanthraquinones are more active 
than the corresponding 1-azaanthraquinones,15d the first objective of the present work was to unfold an 
efficient total synthesis of the hitherto unknown 2-azacleistopholine 10b, 4-(2-dimethylaminovinyl)-2-
azacleistopholine 11b and 2-azasampangine 12b. 
Y
X
MeO
O
Y
X
N
O
Y
X
O
O
NMe Me10a cleistopholine
 X = N, Y = CH
10b 2-azacleistopholine
 X = CH, Y = N
11a X = N, Y = CH
11b X = CH, Y = N
12a sampangine
 X = N, Y = CH
12b 2-azasampangine
 X = CH, Y =  N  
Figure 1-3. Structures of 1- and 2-azaanthraquinone lead and target molecules 
  
Two synthetic methodologies will be investigated towards the targeted 2-azacleistopholine 10b. The 
Heck reaction of a suitable naphthoquinone 13 and the Pomeranz-Fritsch reaction of 2-formyl-1,4-
dimethoxynaphthalene 14 and 2-aminomethyl-2-methyl-1,3-dioxolane 15 will be explored. Once the 
synthesis of the 2-azacleistopholine 12b is completed, the synthesis of 2-aza-4-[2-(dimethylamino)vinyl] 
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cleistopholine 11b and 2-azasampangine 12b is envisaged by treatment of 2-azacleistopholine 10b with 
DMF-DMA and subsequent reaction with ammonia, respectively (Scheme 1-2). 
N
Br
PG
O
O
13 PG = protecting group
Heck N
Me
O
O
OMe
OMe
CHO
H2N Me
OO+
(1) Pomeranz-
Fritsch
(2) Oxidation
N
N MeMe
O
O
N
N
O
NH3
10b 14 15
11b 12b
DMF-DMA
 
Scheme 1-2. Synthetic strategies towards the targeted 2-azacleistopholine 10b and 2-azasampangine 
12b 
 
(2) 2-Azaanthraquinones continue to draw much attention among medicinal chemists since they display 
a wide spectrum of biological activities. SAR studies established the relevance of the substitution 
pattern of the peri-carbonyl position in increasing biological activities of these molecules.16 For instance, 
the presence of a hydroxyl group at the C-1 peri-carbonyl position was found to enhance the antibiotic 
activity.16 Alternatively, the antifungal activity of naphthoquinonoids also requires the presence of a 
hydroxyl group at the C-1 peri-carbonyl position.16b Since the basic chemical structure of 
azaanthraquinones is a tricyclic aromatic anthracene, another important feature which determines the 
biological activity is the presence of a covalent bond between two aromatic rings called the biaryl 
axis.2a,17 Therefore, the synthesis of 2-azaanthraquinones 16, 17 and 18, substituted at the C-1 peri-
carbonyl position and linked to phenyl groups through a biaryl axis, was devised in order to make a 
good library of potential pharmaceuticals. More specifically, 3-aryl-2-aza-1-hydroxyanthraquinones 16, 
3-aryl-2-aza-1-methylanthraquinones 17 and 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylanthraquinones 
18 will be targeted (Figure 1-4). In addition, the plan was devised to synthesize 3-aryl-2-aza-1-(2-
dimethylaminovinyl)anthraquinones 21. Finally, subsequent ammonia addition would lead to the 
corresponding sampangine analogues 22 (Scheme 1-3). 
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Figure 1-4. Structures of targeted substituted 2-azaanthraquinones 16-18 
 
First, the reaction of different pyridinium salts 20 with activated quinones 19 will be investigated under 
Kröhnke conditions, which refers to the use of ammonium acetate in methanol or acetic acid. Having the 
2-aza-1-methyl-3-arylanthraquinones 17 in hand, the synthesis of 2-aza-1-(2-dimethylaminovinyl)-3-
arylanthraquinones 21 will be attempted by using DMF-DMA. Finally, subsequent addition of ammonia 
would lead to the formation of sampangine analogues 22. 
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Scheme 1-3. Synthetic strategy towards substituted 2-azaanthraquinones 16, 17 and their sampangine 
analogues 22 
 
Secondly, the reaction of enaminoesters 23 with the activated naphthoquinone 19a should give 2-aza-1-
hydroxyanthraquinone derivatives 18 upon nucleophilic addition of the enaminoesters 23 and 
subsequent aza-ring closure, aromatization and oxidation by air oxygen (Scheme 1-4). 
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Scheme 1-4. Synthetic strategy towards 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylanthraquinones 18 
 
(3) Isocoumarins are secondary metabolites structurally related to the coumarins, but with an inverted 
lactone ring. These compounds have a wide range of biological activities, including antitumor, 
antileucemic, antiviral and antimicrobial activities.18 
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Figure 1-5. Structure of paepalantine 24 
 
Paepalantine 24 (Figure 1-5) is the first isocoumarin isolated from Paepalanthus bromelioides 
(Eriocaulaceae),19 a species widespread and used in traditional medicine in some Brazilian regions. The 
inhibitory effect on the respiratory burst was reported20 and it also showed an antimicrobial effect similar 
to chloramphenicol,21 and mutagenic and cytotoxic properties.22 In spite of its biological activity, 
paepalantine 24 has not been synthesized to date. Therefore, the first synthesis of paepalantine 24 is 
planned by a phthalide annulation reaction of 3-cyanophthalide 25 and pyran-2-one 26 (Scheme 1-5) for 
which the synthesis of the unprotected form has been reported in the literature.23 Acidic workup should 
give rise to hydroquinone 27 which can be converted to the natural product anhydrofusarubin lactone 
2824 upon a photochemical oxidation. Alternatively, selective methylation of compound 27 will be 
investigated and subsequent treatment with boron(III) bromide should give paepalantine 24. 
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Scheme 1-5. Synthetic strategy towards paepalantine 24 
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2.1. Modes of actions of quinone biological activities 
The detailed mechanism of bioactive quinones in biological systems is not yet fully explored. However, 
the interaction with biological systems may result from three processes: 
(1) A radical-based mechanism generating highly toxic reactive oxygen species (ROS), which 
trigger oxidative stress, upon interaction with the cellular electron transport system. 
(2) An intercalation-based mechanism resulting from quinone insertion between two DNA base 
pairs causing disturbance of DNA transcription and replication by inhibition of DNA 
topoisomerases. 
(3) A bioreductive alkylation-based mechanism involving reactions of quinone methides or other 
electrophilic side chains with vital cell compounds such as DNA, RNA and proteins.  
These modes of action are not specific to types of quinones. They may act in synergy for a type of 
molecule. Thus, the biological activities of benzoquinones, naphthoquinones and 
pyranonaphthoquinones are generally accepted to be related to a radical-based mechanism and/or 
bioreductive alkylation while these of anthraquinones are predicted to be an intercalation based 
mechanism.25 The biological activities of azaanthraquinones seem to be mediated by DNA intercalation 
and radical-based mechanisms.26 In these latter cases, the biological activities are improved by the 
basic and electron-withdrawing properties of the N-heterocyclic ring.27  
2.1.1. Quinone interaction with the electron transport system. A radical-based mechanism  
 
At the core of many important energy conversion processes in biology are oxidation-reduction reactions 
in which electrons are transferred through the electron transport system. Famous examples are the 
photosynthesis and the respiration in green plants, in which carbon dioxide and water combine into 
glucose and oxygen with energy release (∆G° = -675 kcal). The electron transport system appears to 
be particularly stable in some mitochondria where low-content of proteolytic enzymes and a minimum 
number of respiratory chain-linked dehydrogenases, are present to allow NADH oxidation to NAD+ by 
oxygen. Such electron transport system is used by chemotropic and phototropic organisms to allow 
oxidative phosphorylation of ADP to ATP. The key biological functions of these phenomena are 
quinone-based couples as electron transfer agents.28 With regard to these functions, quinones or 
quinoïd compounds are provided with redox cycling properties, which result in their toxic and therapeutic 
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activities. The redox cycling of quinones may be initiated by either a one- or two-electron reduction 
(Figure 2-1). The one electron reduction of quinones has been suggested to result from the interaction 
of cellular electron transport systems (containing cytochromes and ferredoxines) to release reactive 
oxygen species.29 This process is catalyzed by cellular oxidoreductases (NADH dehydrogenase, 
NADPH cytochrome P450 reductase and xanthine oxidase)-flavoenzymes which induce one-electron 
reduction of quinones 7 leading to the formation of semi-quinone anion radicals 30. These latter 
compounds react with molecular oxygen to form superoxide, which can be converted to hydrogen 
peroxide via a superoxide dismutase (SOD)-catalyzed reaction, followed by the formation of a hydroxyl 
radical by the iron-catalyzed reduction of hydrogen peroxide via the Fenton-type reaction. The formation 
of a cascade of reactive oxidative species (superoxide, hydrogen peroxide and hydroxy radicals) 
triggers the oxidative stress responsible for irresversible cell damage leading to apoptosis or cell death. 
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Scheme 2-1. Quinone interation with the biological electron transport system 
 
Alternatively, the flavoenzyme DT-diaphorase-mediated two electron reduction of quinones 7 leads to 
the formation of stable hydroquinones 6, which are activated in vivo to reactive quinone methide species 
(vide infra). These latter compounds are rapidly removed by conjugation with nucleophilic biomolecules 
such as glutathione, UDP-glucoronic acid, etc. This two electron reduction prossess is catalyzed by the 
DT-diaphorase that reduces toxic, reactive and unstable quinones shunting the creation of the 
semiquinone radicals, thus sparing the cell from ROS formation. This process is known to be promoted 
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by the redox cycling of 2-hydroxy-1,4-naphthoquinones 31 (Figure 2-1) and is considered as a 
detoxification route for toxic quinones.30 
O
O
OH
R
31 R = Alkyl  
Figure 2-1. Structure of 2-alkyl-3-hydroxy-1,4-naphthoquinones 31 
2.1.2. Quinone intercalation between two DNA-base pairs. Intercalation-based mechanism 
 
DNA intercalation was discovered in 1961 by the American scientist Leonard Lerman who ascribed the 
mutagenic activity of several compounds to this process.31 Compounds known to possess biological 
activities by DNA intercalation have bi- and tricyclic planar aromatic rings that can fit in between 
adjacent base pairs of uncoiled DNA structure.32 The presence of cationic and/or electrophilic 
functionalities on the intercalating molecules plays a necessary role for the genotoxicity.32c-e Such 
intercalating agents may then form hydrogen, covalent or ionic bonds, which increase the residence 
time inside DNA and thereby inducing sufficient DNA structural modifications that prevent the DNA from 
regaining its normal helical structure. In this way, such intercalators inhibit DNA topoisomerases I and II 
efficiently, which rule over DNA replication, transcription and recombination. For instance, derivatives of 
anthracenediones (mitoxantrone 32a and ametantrone 32b) belong to a promising class of new 
chemotherapeutic agents. Other examples include anthra[2,3-b]furan-5,10-diones 33,32b 2-
azaanthraquinone 34,33 acridones (acronycine 35 and rhodesiacridone 36),34 oxoisoaporphines 3735 
and phenanthrines (fagaronine 38 and ethoxidine 39).36 These compounds are not only able to insert 
between two DNA base pairs but are also able to form chemical bonds leading to irreversible DNA 
structural modification which causes cell mutagenesis and/or death.  
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Figure 2-2a. Structures of some DNA intercalating quinones 
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In this perspective of forming chemical bonds with and inserting in DNA, Moore and co-workers have 
predicted that quinones having a nitrogen-heterocyclic ring will intercalate more easily due to the 
formation of additional hydrogen bonds.37 Diazaquinomycin A 40 (Figure 2-3), for instance, has been 
made an attractive lead compound in cancer chemotherapy research.38  
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Figure 2-3. Sctructure of diazaquinomycin A 40 
2.1.3. Quinone methide nucleophilic reaction. Bioalkylation mechanism 
 
Quinone bioalkylating agents represent a class of drugs in extensive investigation. They are really pro-
drugs which generate in vivo simple ortho-quinomethides or vinylogous methides.39 Since these types of 
quinones generate conjugated unsaturated ketones, which are highly susceptible towards nucleophilic 
attack, they can alkylate nucleophilic centers in biomolecules such as in DNA, RNA and proteins. The 
key element of this mechanism implies the formation of a Michael-type acceptor, which may result from 
a keto-enol tautomerism process or a two-electron reduction of quinones (vide supra). The formation of 
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the covalent bond between the activated drug and the DNA can have a variety of damages including 
irreparable DNA damage and prevention of DNA replication due to strand cross linking.40  
Duroquinone 41 for instance (Scheme 2-2), can tautomerize in vivo to ortho-quinomethide 42.41 The 
latter compound can react with a nucleophilic center in one of the DNA strands. This bioactivated 
alkylation reaction can be repeated with another nucleophilic center in the same or the other DNA strand 
and thus prevent DNA replication by cross linking causing cell death.   
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Scheme 2-2. Duroquinone ortho-quinomethide reaction with DNA 
 
On the other hand, it is believed that the anticancer drug E09 (apaziquinone) 4542 generates its active 
principle by DT-diaphorase-assisted two-electron reduction to form the hydroquinone 46 (Scheme 2-3), 
which is activated in vivo by forming a vinylogous quinone methide 47. A subsequent DNA base is then 
alkylated by this electrophile 43, resulting in a potent and an effective antitumour drug. The aziridinyl 
group, present in this molecule, may also be an electrophilic center susceptible to a DNA nucleophilic 
attack, which would result in ring opening of the aziridinyl substituent. The two possible electrophilic 
sites may act to create an interstand crosslink between DNA strands, thus preventing DNA replication 
entailing cell death. The anticancer drug E09 (apaziquinone) 45 was developed as an analogue of 
mitomycin C 51 (Figure 2-4), with which it shares the same mode of action,42 and is more active and 
less toxic than mitomycin C 51 under both oxic and hypoxic conditions. However, the apaziquinone 45 
unfortunately failed to pass the complete clinical trials due to unrevealed reasons.42a,b 
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Figure 2-4. Structure of mitomycin C 
2.2. Biosynthesis of pyranonaphthoquinones and 2-azaanthraquinones 
Naturally occurring quinones are synthesized mainly through two biosynthetic pathways from different 
precursors. They may be formed from phenolic systems generated by either the acetate or shikimate 
pathway. 
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Pyranonaphthoquinones are suggested to be biosynthetic precursors of 2-azaanthraquinones. The 2-
aza analogues of pyranonaphthoquinones are formed by ammonia insertion into the 
pyranonaphthoquinone peripheral carbon chain after reductive amination of the terminal chain carbonyl 
function.42 These 2-aza analogues very often aromatize to afford ultimately the corresponding 2-
azaanthraquinones. The first 2-azaanthraquinone was isolated in 1953 from Fusarium bostrycoides as a 
red pigment with antibiotic properties and was named bostrycoidin 52.43 Like naturally occurring 
anthraquinones and pyranonaphthoquinones, 2-azaanthraquinones constitute a class of polyketide-
derived metabolites, which have been isolated from fungi, lichens and from plants such as Mitrocarpus 
scaber (Rubiaceae).43 2-Azaanthraquinones are generally produced in vivo as part of a detoxifying 
process for high ammonia concentrations.43b In this way, in vivo ammonia incorporation into 
dihydrofusarubin 53 and fusarubin 54, is reported to give rise to the naturally occurring 2-
azaanthraquinone bostrycoidin 52.43b,44  
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Figure 2-5. Structures of bostrycoidin 52, dihydrofusarubin 53 and fusarubin 54 
 
Alternatively, the biosynthesis of 2-azaanthraquinones polyketide 55 is reported to be involved in this 
process.43,45 The incorporation of the nitrogen atom in these metabolites could derive from either an 
inorganic nitrogen source or nitrogen-containing organic metabolites. The alternative insertion of the 
nitrogen atom may be mediated by an amino-transferase from an amino acid.43 Therefore, a plausible 
biosynthetic pathway of scorpinone 58 was reported44 starting from the intermediate 56, which leads to 
aminoketone 57 through the action of an aminotransferase or reductive amination. Then, cyclization 
(dehydration or/and enolization), oxidation and methylation processes give rise to scorpinone 58 
(Scheme 2-4).45 On the other hand, the same intermediate 56 may lead to the pyranonaphthoquinone 
herbarin 59, which dehydrates to dehydroherbarin 60. Subsequently, amination or transamination of 
dehydroherbarin 60 may occur to produce scorpinone 58.6,45 
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Scheme 2-4. Biosynthesis of scorpinone 58, herbarin 59 and dehydroherbarin 60 
2.3. Naturally occurring quinones from African plants and their biological activities 
Africa is famous for the biodiversity of its tropical forests. In such a competitive environment, plant 
species will protect themselves by producing a vast array of bioactive compounds. African plants have 
for long been the source of important products with nutritional and therapeutical values. In certain 
countries, more than 90% of the population still relies on plants as a source of medicines.46 A variety of 
quinoid compounds have been among the bioactive compounds isolated from diverse extracts of these 
plants. They range from simple monomeric quinones to complex oligomeric compounds. Given the 
richness of the African flora, still a lot of active principles remain to be isolated and identified from 
medicinal plants. To present an exhaustive list of naturally occurring quinones isolated from African 
plants in this literature overview will go beyond the scope of the present dissertation. Therefore, this 
overview will highlight some recently studied naturally occurring quinones and their biological activities. 
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2.3.1. Monomeric quinones 
2.3.1.1. Benzoquinones 
Simple dimethoxybenzoquinones 61 (Figure 2-6) are often present in trunk extracts of higher plants 
since they are considered to be the ultimate products of biodegradation of lignin and other phenolic 
compounds of plant trunks. 2,5-Dimethoxybenzoquinone 61a has been isolated from several African 
plants such as Maesa lanceolata (Myrsinaceae)47 and Cassia obtusifolia (Caesalpiniaceae).48 It has 
been recognized to possess defence stimulant activity47 and antimicrobial activity against 
Staphylococcus aureus and Escherichia coli.48 2,6-Dimethoxybenzoquinone 61b, which can cause 
dermitis and effects on the central nervous system, has been isolated from Milletia laurentii 
(Fabaceae).49 Finally, 2,3-dimethoxybenzoquinone 61c was isolated from Newbouldia laevis 
(Bignoniaceae).50  
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Figure 2-6. Structures of some naturally occurring benzoquinones 
 
In 1988, plants of four genera of the Myrsinaceae family, i.e Maesa, Myrsine, Rapanea and Embelia 
from Kenya, were investigated for their distribution of benzoquinones.51 The study revealed that the 
benzoquinones 62 (Figure 2-6) with longer side chains (R = C15 - C19) were clearly restricted to Maesa, 
while those with shorter side chains (R = C11 - C13) were found in Myrsine, Rapanea, and Embelia. Five 
years earlier, the isolation and efficient synthesis of maesanin 63 (Figure 2-7), a host defense stimulant 
and 5-lipoxygenase blocker, isolated from the African medicinal plant Maesa lanceolata, was 
reported.47,52 More recently, maesamin 63 has been found to possess antiasthmatic activity.52a In 
Central Africa, M. lanceolata is used against Entamoeba histolyca infections.52b In 1999, a 
reinvestigation of M. lanceolata (Myrisinaceae)53 has revealed the presence of 5-alkylated 2-
methylbenzoquinones 64 with different oxygenated substituents (Figure 2-8). 
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Figure 2-7. Structure of maesanin 63 
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Figure 2-8. Structures of some 5-alkylated 2-methylbenzoquinones 
  
Recently, two simple prenylated 1,4-benzoquinones 65 (Figure 2-9) have been isolated from the 
dichloromethane extract of the leaves and stem of the South African Gunnera perpensa (Haloragaceae) 
and were examined for their antimicrobial activities.54 2-Methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone 
65a showed significant antimicrobial activity at microgram scale against Staphylococcus epidermidis, 
while 3-hydroxy-5-methyl-2-(3-methyl-2-butenyl)-1,4-benzoquinone 65b showed no bioactivity.  
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Figure 2-9. Prenylated 1,4-benzoquinones isolated from Gunnera perpensa (Haloragaceae) 
2.3.1.2. Naphthoquinones  
Naphthoquinones are considered as privileged quinones in medicinal chemistry because of their wide 
occurrence in nature, their biological activities and their structural properties.55 They serve vitally as 
links in the electron transport chain in many metabolic pathways. They appear in various families of 
African plants. Thus, 7-methyljuglone 66a and plumbagin 66b (Figure 2-10) are the most representative 
naphthoquinones isolated from African plants. In 1989, they were found to be ubiquitously present in all 
the plant organs of the South-African Drosera species (Droseracea). D. capensis was considered as an 
interesting natural source of 7-methyljuglone 66a, while D. binata and D. binata dichotoma represented 
good natural sources of plumbagin 66b.56 These two naphthoquinones 66a and 66b have been found to 
be active against tuberculosis57 and trypanosomiasis.58 Lapachol 67 (Figure 2-10), a prenylated 
naphthoquinone, which was isolated from African Kigelia africana (Bignoniaceae), is widely distributed 
in the South, Central and West-Africa.59 A wide spectrum of therapeutic activities has been attributed to 
lapachol 67 including antileishmanial, antiedemic, anti-inflammatory, antimalarial, antiseptic, antitumor, 
antiviral, bactericidal, fungicidal, insecticidal, protisticidal, respiradepressant, schistosomicidal, 
termiticidal and viricidal activities.6a,60 
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Figure 2-10. Structures of 7-methyljuglone 66a, plumbagin 66b and lapachol 67 
 
Swertia calycina (Gentianaceae) from Rwanda surprisingly revealed the presence of 2-methoxy-1,4-
naphthoquinone 68 (Figure 2-11), which is responsible for the antifungal activity of the plant’s 
dichloromethane extract.61 In 1990, two Araliorhamnus species which are endemic to Madagascar, i.e, 
A. vaginata and A. punctata (Rhamnaceae), revealed the existence of 6-acetylnaphthoquinone 69 and 
2-methoxycarbonylnaphthoquinone 70 with two other interesting heterocyclic quinones 71 (Figure 2-
11).62  
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Figure 2-11. Structures of African naturally occurring naphthoquinones and pyranonaphthoquinones 
 
Heterocycles, fused with naphthoquinones, are well represented among heterocyclic quinones isolated 
from African plants. The two lead compounds of the present research work cleistopholine 10a and 
sampangine 12a (Figure 1-3) have been isolated from Cleistopholis patens (Annonaceae), a large tree 
which occurs in the rain forests of Africa, from Sierra Leone eastward to the Democratic Republic of 
Congo and Uganda.63 This plant is used in traditional medicine in Central Africa to fight lung disorders. 
In addition, its stem bark extract is claimed to be active for infective hepatitis and stomach disorders 
while its root is used as a vermifuge and its leaves for the treatment of fever.64 These two compounds 
10a and 12a are reported to display strong antimycobacterial activity resembling the activity of 
rifampicine, an important drug in the treatment of tuberculosis.65  
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Plants of the Asphodelaceae family (Bulbine capitata, B. frutescens, B. abyssinica), the extracts of 
which are used as antibiotics in some countries of eastern, central and southern Africa were 
investigated.66 Extract of the aerial parts and roots of these plants revealed the abundance of 
furanonaphthoquinones 72 and isofuranonaphthoquinones 73 (Figure 2-12).67   Isofuranonaphthoquino-
nes 73 have been found to have antioxidant and also mild antiplasmodial properties.68 A particular 
Newbouldia laevis species from Guinea-Conakry was found to present various furan derivatives of 
lapachone 74b-f (Figure 2-13) with interesting antifungal activities.69  
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Figure 2-12. Structures of furanonaphthoquinones and isofuranonaphthoquinones 
 
The isolation of pentalongin 8 (Figure 1-2) and isagarin 75 (Figure 2-13) from Pentas longiflora 
(Rubiaceae) has been a landmark to our department.5a,70 Special attention was attracted in the early 
nineties to this very promising plant species used in Burundi, Rwanda and Kenya for its medicinal 
propreties. Synthesis of different pentalongin derivatives has been accomplished in our research group. 
This applies as well as for their corresponding aza analogues. Pentalongin derivatives and their aza 
analogues, assorted with their biological activities are extensively described in literature.5a 
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Figure 2-13. Structures of isagarin 75, cyclocanaliculatin 76 and crassiflorone 77 
 
Cameroonian medicinal plants have been studied for the relevance of quinone metabolites present in 
them. In this way, pentacyclic quinones such as cyclocanaliculatin 76 and crassiflorone 77 (Figure 2-13) 
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have been isolated from Diospyros crassiflora (Ebenaceae).71 Crassiflorone 77 has been recognized to 
possess antimicrobial activity.72  
2.3.1.3. Anthraquinones 
Simple anthraquinones such as chrysophanol 78a and aloe-emodin 78b (Figure 2-14) have been 
isolated from species of the genus Bulbine. They have been recognized as DNA-intercalating73 and 
antileukemic74 agents. The anthraquinone emodin 78c and geranyloxy-6-methyl-1,8-
dihydroxyanthraquinone 79 (Figure 2-14) from the ethanolic stem bark extract of the Tanzanian 
medicinal plant Vismia orientalis (Clusiaceae) showed strong antiprotozoal activities against 
Trypanosoma rhodesiense, T. cruzi, Leishmania donovani and Plasmodium falciparum. Aloe-emodin 
78b, isolated from the African medicinal shrub Stephania dinklagei (Menispermaceae), showed 
moderate activity against T. rhodesiense.75 Other simple anthraquinones such as 2-methyl-9,10-
anthraquinone 80, 2-hydroxy-3-methoxy-9,10-anthraquinone-1-carbaldehyde 81 (Figure 2-14), have 
been isolated from N. laevis (Bignoniaceae).76 
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Figure 2-14. Structures of some anthraquinones isolated from African medicinal plants 
 
The genus Bulbine (Fabaceae) produces a great diversity of 4-arylanthraquinones 82 (Figure 2-15), 
which have been identified as a class of antiplasmodial substances comparable to the commercial drug 
chloroquine.77 Although the first phenylanthraquinone, knipholone 82, was reported to be isolated from 
Kniphofia foliosa,78 it has also been isolated from other Kniphofia, Bulbinella,79 Bulbine,80 and Senna 
species (Fabaceae).81 These arylanthraquinones 82b are constitutionally asymmetrical, 
stereochemically stable and optically active biaryl compounds. Their pronounced antiplasmodial activity 
is intrinsically associated with the stereogenic axis of their rings.77 The substitution patterns on the 
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combined anthraquinone and benzene rings increase difference of atropoisomer chemical and physical 
properties.  
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82b knipholone R1 = R2 = H, R3 = R4 = Me
 
Figure 2-15. Structures of 4-arylanthraquinones 82  
 
Rhamnaceae species, Araliorhamnus vaginata and A. punctata, endemic to Madagascar also revealed 
several other interesting anthraquinones, such as methyl 1-methylanthraquinone-2-carboxylate 83 and 
anthraquinone lactones 84 (Figure 2-16).62  
O
O
O
O
OH
CH2OH
R1
R2
R3
R1 = OH, OMe
R2 = H, OMe
R3
 
= H, OH
84
O
O R4
R1
R2
Me
OMe
O
R3
83
R1 = OH, OMe
R2 = H, OH, OMe
R3 = H, OH
R4 = OH, OMe
 
Figure 2-16. Anthraquinones isolated from Rhamnaceae species 
2.3.2. Dimeric quinones 
 
The family Myrsinaceae is characterized by the presence of 2,5-dihydroxy-3-alkylbenzoquinones. In 
search for further related chemical constituents of these plants, the isolation and the structure 
determination of the dimeric quinones methylvilangin 85, methylanhydrovilangin 86, in addition to the 
bisbenzoquinone, lanciaquinone 87 have been reported for the first time from M. lanceolata and M. 
africana (Figure 2-17).82 
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Figure 2-17. Dimeric benzoquinones isolated from African plants of the Myrsinaceae family 
 
Dimeric naphthoquinones from South African plants were the topic of extensive research in 2006. 
Bisnaphthoquinones, diospyrin 88a, neodiospyrin 88b and isodiospyrin 88c (Figure 2-18) were isolated 
in different concentrations from Euclea species (Ebenaceae) and have been found to be active against 
tuberculosis48 and trypanosomiasis.49 Diospyrin 88a and neodiospyrin 88b have been shown to posses 
a good tumor inhibitory effect against different cancer cell lines.83 Isodiospyrin 88c has been reported as 
a novel human DNA topoisomerase I inhibitor.83 Since then, quinonoid compounds have been claimed 
to constitute a large and an important class of anticancer drugs in treating cancer as well as potential 
‘‘lead molecules’’ for novel anticancer drugs.49a 
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Figure 2-18. Bisnaphthoquinones isolated from Euclea species (Ebenaceae) 
 
Two dimeric phenylanthraquinones, namely joziknipholones A 89a and B 89b (Figure 2-19), possessing 
axial and centrochirality, were isolated from the roots of the African plant Bulbine frutescens 
(Asphodelaceae).84 Joziknipholones A 89a and B 89b are the first members of a structurally unique 
novel class of dimeric phenylanthraquinones. These novel type of metabolites possess good 
antimalarial activities and are thus potential lead compounds for antimalarial drug discovery.67c 
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Figure 2-19. Structures of joziknipholones 89 
 
The genus Newbouldia (Bignoniaceae) comprises only one species distributed throughout the tropical 
and sub-tropical zones of Africa. It has been used in African folk medicine as an astringent in diarrhea, 
dysentery ailments and in the treatment of various diseases such as worms, malaria, sexual transmitted 
diseases, and in the reduction of dental caries.84 From this species, a special type of dimeric quinone, 
namely newbouldiaquinone 90 was isolated (Figure 2-20). The newbouldiaquinone 90 merits focus 
because it is an unusual quinone with mixed naphthoquinone-anthraquinone coupling monomers, a 
feature uncommon to naturally occurring dimeric quinones. The presence of this type of quinones in a 
plant contrasts with the most widespread groups of quinone dimers found in nature85 which are often 
bis-benzoquinones, bis-naphthoquinones and bis-anthraquinones. A preliminary study76c on biological 
activities showed that newbouldiaquinone 90 is moderately active against Bacillus megaterium. 
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Figure 2-20. Structure of newbouldiaquinone 90 
 
Rhamnaceae species, Araliorhamnus vaginata and A. punctata showed the presence of dimeric 
heterocyclic quinones 91 (Figure 2-21).62  
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Figure 2-21. Dimeric heterocyclic quinones from African Rhamnaceae species 
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Chapter 3: Results and discussion 
3.1. Effort towards a short and efficient synthesis of 2-azacleistopholine 10b and 2-
azasampangine 12b 
Cleistopholine 10a and sampangine 12a are two strongly related polycyclic aromatic alkaloids isolated 
from different plants belonging to the Annonaceae family with a wide range of interesting biological 
activities.86 Cleistopholine 10a is a tricyclic azaanthraquinone alkaloid isolated from the root bark of 
Cleistopholis patens13 and sampangine 12a is a tetratracyclic naphthyridine alkaloid isolated from the 
stem back of Cananga odoranta.87 Cleistopholine 10a showed fungitoxic potential against Candida 
albicans, Cryptococcus neoformans and Mycobaterium intracellulare, which are opportunistic fungi 
occurring in AIDS patients.86e In addition of exhibiting a powerful activity against Mycobaterium 
tuberculosis with a minimum inhibitory concentration (MIC = 0.78 µg/ml) which is lower than the MIC for 
current anti-TB drugs as rifampicin (MIC = 0.5-0.9 µg/ml) and streptomycin (MIC = 2-8 µg/ml),65 
sampangine 12a is known to possess strong antifungal activity.86e In the literature, a convenient 
synthesis of sampangine 12a was reported starting from cleistopholine 10a (Scheme 3-1).15a  
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30 min
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30 min.
(84%)
1) 1.3 equiv. TPM, 125°C, 2 h
2) 16.7 equiv. NH4Cl, 100°C, 1 h
AcOH (62%)
Ref. 15a
Scheme 3-1. Synthesis of sampangine 12a starting from cleistopholine 10a 
 
Since it is known that 2-azaanthraquinones are more bioactive than their corresponding 1-aza 
analogues,16a a short and efficient synthesis of 2-azacleistopholine 10b and 2-azasampangine 12b was 
envisaged. This synthesis is based on the above presented literature reports of the synthesis of 
cleistopholine 10a and sampangine 12a. The strategy, which will be followed, is depicted 
retrosynthetically in the following scheme (Scheme 3-2).  
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Scheme 3-2. Retrosynthetic analysis of 2-azasampangine 12b 
 
2-Azacleistopholine 10b may be obtained by either an intramolecular palladium-catalyzed coupling 
reaction (Heck reaction, route A) or an acid-promoted intramolecular condensation (Pomeranz-Fritsch 
reaction, route B) as described in scheme 3-3. In the first reaction route, the key step consists of an 
intramolecular coupling reaction of the N-protected 1-bromo-2-(allylaminomethyl)-1,4-naphthoquinone 
13, which could be obtained upon reaction of 2-bromo-3-bromomethyl-1,4-dimethoxynaphthalene 94 
with allylamine 95, followed by protection of the nitrogen and an oxidative demethylation reaction of the 
hydroquinone methyl ether 93. In an alternative pathway, an acid-promoted intramolecular cyclization 
might be performed using compound 96. This compound could bear either an amino or imino moiety 
and could be prepared by a condensation reaction of 2-formyl-1,4-dimethoxynaphthalene 14 and α-
aminoacetone 97. However, since α-aminoacetone 97 is prone to self-condensation, the synthesis of 2-
aminomethyl-2-methyl-1,3-dioxolane 15a or aminoacetone acetal 15b was envisaged. 
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Scheme 3-3. Retrosynthetic analysis of 2-azacleistopholine 10b 
3.1.1. Synthesis of 2-azacleistopholine 10b with the Heck reaction in key step 
 
The Heck reaction is a palladium-catalyzed coupling of olefins with aryl or alkenyl halides or triflates.88 It 
is one of the prime tools for building carbon-carbon bond formation in organic synthesis and as a result 
this reaction is of paramount importance. Usually, the Heck reaction is carried out with 1-5 mol% of a 
palladium catalyst along with a phosphine ligand in the presence of a suitable base.89 Numerous 
nitrogen heterocycles have been prepared by intramolecular Heck cyclization.90 In order to prepare 2-
azacleistopholine 10b by the Heck reaction, the appropriate substrate 13 needed to be synthesized. In 
this way, 2-bromo-3-bromomethyl-1,4-dimethoxynaphthalene 94, which was obtained according to the 
literature procedure from 1,4-dimethoxy-2-methylnaphthalene 98 via selective bromination,91,92 was 
reacted at room temperature for 48 hours with an excess of allylamine 95 in absolute ethanol to afford 
2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 100 in 91% yield (Scheme 3-4). 
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Scheme 3-4. Synthesis of 2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 10092 
 
The 2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 100 was converted to N-methanesulfonyl-
2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 93 in 60% yield by reaction with 
methanesulfonyl chloride in dichloromethane in the presence of triethylamine. The oxidative 
demethylation of this first Heck reaction substrate 93 with CAN gave rise to the corresponding 
naphthoquinone 13. Different phosphine ligands and bases (amongst which the standard Heck reaction 
conditions) were screened for the intramolecular palladium-catalyzed cyclization of N-methanesulfonyl-
2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 93 and N-methanesulfonyl 2-
(allylaminomethyl)-3-bromo-1,4-naphthoquinone 13 in a previous synthetic study of our department.92 
Next, different ligand-free conditions were tested (Table 1) since it was reported that Pd(OAc)2 in 
combination with K3PO4 as a base and N,N-dimethylacetamide (DMA) as a solvent can be used as 
suitable reactions conditions for the Heck reaction of both activated and deactivated aryl bromides.93 
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Scheme 3-5. Synthesis of 2-azacleistopholine 10b using the Heck reaction in the key step 
 
Table 1: Reaction conditions used in the Heck reaction to convert N-methanesulfonyl-2-
(allylaminomethyl)-3-bromo-1,4-naphthoquinone 13 to 2-azacleistopholine 10b 
       
Entry 
           
Pd(OAc)2 
(mol%) 
         
Solvent 
                        
Base (equiv.) 
       
Temperature 
(°C) 
              
Reaction time 
(h) 
                                
Product 10b yield 
(%)a (%)b 
                
1 
                         
0.1 
                      
DMA 
                      
K3PO4 (1.4) 
                            
Rt 
                                  
4 
                           
0 
                     
- 
                
2 
                        
1.0 
                     
DMA 
            
K3PO4 (1.4) 
                              
80 
                                  
4 
                 
35 
                         
- 
                 
3 
                       
1.0 
                   
DMA 
            
K3PO4 (1.4) 
                          
140 
                                  
19 
              
34 
                          
- 
                  
4 
                            
10 
                  
DMA 
              
K3PO4 (3.5) 
                             
140 
                                    
19 
                
35 
                          
- 
                 
5 
                                      
50 
          
CH3CN 
            
K2CO3 (5) 
                      
Reflux 
                                  
3 
                 
45 
                        
30 
apresence of compound 10b in reaction crude judged upon LC-MS. bisolated yield. 
 
Unfortunately, starting from N-methanesulfonyl-2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaph-
thalene 93, these reaction conditions failed to give intramolecular ring closure and complex reaction 
mixtures were retrieved. This result is attributed to the fact that electron-rich aromatics are relatively 
unreactive to oxidative addition.94 Since none of these test reactions gave the Heck cyclization product 
92, N-methanesulfonyl-2-(allylaminomethyl)-3-bromo-1,4-naphthoquinone 13 was tested as a substrate 
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towards the direct synthesis of 2-azacleistopholine 10b (Table 1). To this end, upon reflux 
naphthoquinone 13 for 3 hours in acetonitrile in the presence of 50 mol% Pd(OAc)2 and 5 equivalents of 
K2CO3, 2-azacleistopholine 10b was obtained in an isolated yield of 30%. Although the exact 
mechanism to explain the formation of 2-azacleistopholine 10b was not established, the expected 
mechanism involves the formation of compound 101 (Scheme 3-6) by the oxidative addition across the 
carbon-bromide bond of substrate 13. Slippage would afford intermediate 102 after which 
carbopalladation would form the cyclized compound 103. β-Hydride elimination would break the 
intermediate 103 into compound 104. Base promoted-reductive elimination would regenerate the 
catalytic palladium(II) acetate, while the intermediate 104 would aromatize to 2-azacleistopholine 10b.  
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Scheme 3-6. Reaction mechanism of the intramolecular Heck reaction 
 
An attempt to scale-up the Heck reaction on substrate 13 from 250 mg (0.65 mmole) to 500 mg (1.30 
mmoles) under the same reaction conditions failed to reproduce the abovementioned isolated yield. 
These low yields reflect the relative instability of quinones to rigorous reaction conditions and the 
interaction of the palladium metal with the quinone function, thereby reducing the catalytic activity of 
Pd(OAc)2 reoxidation of Pd(0). The low yields, harsh reaction conditions, high catalyst load and tedious 
scale-up severely plagued this linear synthesis and as a result, an alternative pathway to 2-
azacleistopholine 10b was investigated.  
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3.1.2. Synthesis of 2-azacleistopholine 10b by acid-promoted intramolecular condensation- 
Pomeranz-Fritsch reaction in the key step 
 
Retrosynthetic analysis of 2-azacleistopholine 10b by this alternative route gave 2-formyl-1,4-
dimethoxynaphthalene 14 and protected aminoacetone 15a as synthetic precursors (Scheme 3-7). 
Imination of 2-formyl-1,4-dimethoxynaphthoquinone 14 would occur by nucleophilic attack of the amino 
group of the aminoacetal 15a across the aldehyde function of 2-formyl-1,4-dimethoxynaphthoquinone 
14 to give the imine 96 after elimination of water. A subsequent acid-promoted intramolecular 
condensation of imine 96 under water-free conditions, would afford 2-aza-9,10-dimethoxy-4-
methylanthracene 92, which can be converted to 4-methylbenzo[g]isoquinoline-5,10-dione 10b upon 
oxidative demethylation. 
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Scheme 3-7. Retrosynthetic analysis of 2-cleistopholine 10b using the Pomeranz-Fritsch reaction 
  
Synthesis of 2-aminomethyl-2-methyl-1,3-dioxolane 15a was carried out according to a literature 
procedure (Scheme 3-8).95 It commenced with a Gabriel synthesis using potassium phthalimide 105 and 
α-chloroacetone 106. These starting materials were reacted in boiling toluene for 2 hours to form the N-
acetonylphthalimide 107 in 74% yield. The reaction of N-acetonylphthalimide 107 with ethylene glycol 
108 in boiling toluene for 16 hours in the presence of methanesulfonic acid as catalyst afforded the 
dioxolanyl protected ketone 109 in a yield of 56%. Subsequently, the imide function was cleaved by 
hydroxylamine in ethanol to afford 2-aminomethyl-2-methyl-1,3-dioxolane 15a in 68% yield.  
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 Scheme 3-8. Synthesis of 2-aminomethyl-2-methyl-1,3-dioxolane 15a95 
 
The second precursor, 2-formyl-1,4-dimethoxynaphthalene 14, was obtained in 75% yield through a 
Vilsmeier formylation of 1,4-dimethoxynaphthalene 110 in boiling chloroform for 80 hours under nitrogen 
atmosphere (Scheme 3-9).96  
10 equiv. POCl3
10 equiv. DMF
CHCl3, ∆,
 80 h
OMe
OMe
CHO
14 (75%)
OMe
OMe
110  
Scheme 3-9. Synthesis of 2-formyl-1,4-dimethoxynaphthalene 1496 
 
The condensation reaction of 2-formyl-1,4-dimethoxynaphthalene 14 and 2-aminomethyl-2-methyl-1,3-
dioxolane 15a occurred smoothly in anhydrous dichloromethane in the presence of magnesium(II) 
sulfate at room temperature furnishing the intermediate imine 96, which was reduced quantitatively to 
the corresponding amine 111 by two equivalents of sodium borohydride in methanol at room 
temperature for 16 hours. Different reaction conditions were tested to induce the intramolecular 
cyclization of the amine 111 using different acids to 4-methyl-9,10-dimethoxyanthracene 92 (Table 2, 
page 34). Mild acidic conditions proved to produce no reaction (entries 1-5) due most likely to the 
relative stability of the dioxolane ring while rigorous conditions led to complex mixtures containing minor 
amounts of 2-azacleistopholine 10b (entries 10 and 12). The use of gaseous HCl or diluted H2SO4 led to 
the formation of ammonium salt 112 (entries 11 and 14). The conversion to 2-azacleistopholine 10b 
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could be carried out by treating the amine 111 with H3PO4 (entry 6) or H2SO4 in dichloromethane 
(entries 7 and 8) for a relatively short reaction time.   
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Scheme 3-10. Synthesis of 2-azacleistopholine 10b using the Pomeranz-Fritsch reaction 
 
In this way, 2-azacleistopholine 10b was obtained directly in yield of 50% upon reaction of amine 111 for 
2 days in a mixture of sulfuric acid and dichloromethane (2/1) at room temperature (Table 2, entry 8). It 
is important to note that the yield of this Pomeranz-Fritsch process is affected by the acid-base 
character of the workup because of the simutanous presence of a fairly acidic benzylic proton and basic 
isoquinoline nitrogen in 2-azacleistopholine 10b. Therefore the neutrality of the aqueous phase is 
required for an optimumal extraction.      
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Table 2: Optimization process of the acid mediated conversion of amine 111 to 2-azacleistopholine 10b 
             
Entry 
                                                                             
Reaction conditions 
            
Results 
                                   
Yield (%) 
                
1 
                                                                                                
AcOH, H2SO4 (cat), 1 h at rt to 4 h of reflux 
       
No reaction 
                                           
- 
                  
2 
                                                                                                    
10 equiv. PPA, EtOH, 1 h at rt to 4 h of reflux No reaction 
                                          
- 
                  
3 
                                                                                                                 
6 M HCl, THF, 1 h at rt to 4 h of reflux No reaction 
                              
- 
                 
4 
                                                                                                         
2 equiv. p-TsOH, PhMe, 1 h at rt to 3 h of reflux No reaction 
                                          
- 
                   
5 
                                                                                                         
2 equiv. PPTS, PhMe, 1 h at rt to 3 h of reflux No reaction 
                                         
- 
                  
6 
                                                                                                  
98% H3PO4, 130 °C, 3 h Compound 10b 
                                        
10 
                 
7 
                                                                                                   
H2SO4 (conc.): CH2Cl2 (2:1), rt, 60 h (2.5 d) Compound 10b 
                                       
35 
               
8 
                                                                                                
H2SO4 (conc.): CH2Cl2 (2:1), rt, 48 h (2 d) Compound 10b 
                               
50 
                    
9 
                                                                                                  
H2SO4 (conc.), rt, 3 h No reaction 
                                         
- 
                 
1 0 
                                                                                                  
H2SO4 (conc.), rt, 48 h Complex mixture 
                                           
- 
                
11 
                                                                                                  
HCl(g), dry Et2O, rt, 1 h Formation of 112 
                                          
- 
                
12 
                                                                                                      
10 equiv. ClSO3H, CH2Cl2, rt, 1 h Complex mixture 
                                           
- 
                
13 
                                                                                                       
10 equiv. ClSO3H, CH2Cl2, -5°C to ∆, 10 min. Complex mixture 
                                          
- 
        
14 
                                                                                                      
15% H2SO4, CH2Cl2 (1:1)-SiO2, rt, 2 h Formation of 112 
                                             
- 
 
The mechanism of this multistep transformation implies an acid-catalyzed deprotection of compound 
111 in the presence of excess of strong acid to form simutaneously the ammonium and the oxonium 
centers to allow subsequent cyclization and oxidative demethylation as visualized in the accompanying 
scheme (Scheme 3-11). 
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Scheme 3-11. Reaction mechanism of the Pomeranz-Fritsch reaction 
3.1.3. Synthesis of 4-[2-(dimethyl)aminovinyl]benzo[g]isoquinoline 11b starting from 2-
azacleistopholine 10b and effort towards the synthesis of 2-azasampangine 12b 
Having 2-azacleistopholine 10b in hand, the synthesis of 2-azasampangine 12b was envisaged parallel 
to the literature report on the synthesis of sampangine 12a (Scheme 3-1).15a In this way, (E)-4-[2-
(dimethylaminovinyl]benzo[g]isoquinoline-5,10-dione 11b was obtained in 86% yield upon reacting 5 
equivalents of DMF-DMA with 2-azacleistopholine 10b in DMF at 125°C under a nitrogen atmosphere. 
The reaction was followed up by thin layer chromatography and was run to completion upon 2.5 hours, 
after which the workup resulted in the isolation of compound 11b in high purity (Scheme 3-12). 
Then, the latter enamine 11b was introduced in a reaction with an excess of ammonium chloride in 
boiling acetic acid. The idea was that this would induce transamination of the enamine function of 2-
azaanthraquinone 11b, after which a spontaneous aza-ring closure across the quinone group would 
afford the targeted 2-azasampangine 12b. However, in practice these reaction conditions only resulted 
in the formation of intractable complex reaction mixtures and as a result, the synthesis of 2-
azasampangine 12b still remains a challenge. 
 
 
36 Chapter 3: Results and discussion 
N
O
O Me
N
O
N
N
O
O
NMe Me
10b
11b (86%)
12b
5 equiv.
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AcOH, ∆,
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X
 
Scheme 3-12. Attempt to synthesize 2-azasampangine 12b from 2-azacleistopholine 10b 
 
The mechanism of this DMF-DMA-assisted synthesis of (E)-4-[2-(dimethylamino)-
vinyl]benzo[g]isoquinoline-5,10-dione 11b (Scheme 3-13) can be explained by a deprotonation of the 2-
azacleistopholine 10b at the benzylic position by a methoxide anion 114 which is eliminated from the 
DMF-DMA. The resulting intermediate anion 117 then reacts with the iminium salt 115 to form a 
hemiaminal intermediate 118. This latter transient species eliminates methanol due to the presence of 
an acidic benzylic proton to generate the enamine function of 11b.  
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Scheme 3-13. Reaction mechanism for the synthesis of (E)-4-[2-
(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione 11b 
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3.2. Synthesis of 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-diones 16, 3-aryl-1-methyl 
benzo[g]isoquinoline-5,10-diones 17 and methyl 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-
dione-4-carboxylates 18  
2-Azaanthraquinones bearing a hydroxy substituent at the C-1 peri-carbonyl position such as 3-aryl-1-
hydroxybenzo[g]isoquinoline-5,10-diones 16, methyl 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-dione-4-
carboxylates 18 (Figure 1-4) are interesting targets to synthetic organic chemists due to their promising 
biological activities as stated in the introduction of this dissertation. It has been shown that the presence 
of a hydroxyl group at the C-1 peri-carbonyl position on 2-azaanthraquinones enhances their 
antimicrobial activity.16a Moreover, 2-azaanthraquinones with an aryl group fixed at C-1 inhibit the 
proliferation of MT-4 cells at micromolar concentrations,97 while the antifungal activity of 1,4-
naphthoquinone epoxide was shown to require the presence of a hydroxyl group at the C-1 peri-
carbonyl position.16b In a perspective of building a library of 1-substituted 2-aza-3-arylanthraquinones for 
biological activity tests, the hydroxyl group and its isostere, the methyl group, were considered in order 
to develop potential lead molecules in the search for new antibiotics. The presence of a methyl group at 
the peri-carbonyl position is expected to eliminate any hydrogen bond formation in comparison with the 
hydroxyl group and will increase the lipophilicity of these compounds, as well as their membrane 
permeability. Therefore, syntheses of 3-aryl-2-aza-1-hydroxyanthraquinones 16, 3-aryl-2-aza-1-
methylanthraquinones 17 and 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylanthraquinones 18 became 
interesting research targets from both synthetic and medicinal points of view. 
 
Compounds 120 bearing a substituent at the C-1 peri-carbonyl position, can be prepared starting from 
substrates 119, bearing a 1,5-dicarbonyl functionality, and a source of nitrogen such as ammonia, 
hydroxylamine or ammonium salts (Scheme 3-14). Submitting the appropriate substrate 119 to a 
nitrogen source would form a pyridone ring, which would tautomerize to the hydroxypyridine ring 120 
(R1 = OH). Actually, the hydroxypyridine tautomer is more stable than the pyridone form98 because of 
the hydrogen bond that is formed between the carbonyl and hydroxyl groups and because of the 
aromaticity of the compound. 
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N
R1
R2COR
2
COR1
Nitrogen-source
119 120
R1 = H, OH, OR, alkyl or aryl
R2 = H, alkyl, aryl
R1 = H, OH, alkyl or aryl
R2 = H, alkyl, aryl
OO
 
Scheme 3-14. Preparation of peri-carbonyl substituted compounds 120 
 
Since pyridinium ylids already proved to be very useful to introduce acetonyl side chains onto quinone 
moieties,99 the reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a and 2-acetyl-1,4-
naphthoquinone 19b with different pyridinium ylids 20 and ammonia, which would be produced in situ 
from ammonium acetate 121a in acetic acid and are known as Kröhnke conditions,99b were envisaged 
(Scheme 3-15).  
N
R1
O
O
R2
O
O
R3
O
+
R2 N
O
X
+ NH4OAc
20 R2 = aryl
     X = Cl, Br
19a R3 = OMe
19b R3 = Me
16 R1 = OH, R2 = aryl
17 R1 = Me, R2 = aryl
HOAc
121a
 
Scheme 3-15. Retrosynthetic analysis of 1-substituted-2-azaanthraquinones 16 and 17 
 
The presence of a methoxycarbonyl group at position C-4 on the third type of targeted 2-
azaanthraquinones 18 requires an adjustment of starting materials to achieve their synthesis (Scheme 
3-16). Therefore, enaminoesters 23 will be reacted with 2-methoxycarbonyl-1,4-naphthoquinone 19a, 
replacing both pyridinium salts 20 and ammonium acetate 121a.   
O
O
OMe
O
N
R
O
O
OH
COOMe
+
R
NH2
OMe
O
18  R = Ar 19a 23 R = aryl
 
Scheme 3-16. Retrosynthetic analysis of methyl 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-dione-4-
carboxylates 18 
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3.2.1. Synthesis of 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-diones 16 
 
The synthesis of 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-diones 16 under Kröhnke conditions called 
upon N-phenacylpyridinium salts 20. These salts can be easily converted to highly reactive N-
methylenepyridinium ylids by deprotonation with an appropriate base such as hydroxide, ammonia, 
triethylamine, DABCO, DBU, etc. The rates of the deprotonation reactions of N-phenacylpyridinium salts 
20 are substituent and solvent dependent.100 Moreover, Kröhnke pyridines 123 are traditionally 
synthesized in excellent yields through the reaction of N-phenacylpyridinium salts 20 with α,β-
unsaturated carbonyl compounds 122 (Michael acceptors) in the presence of ammonium acetate 121a 
in acetic acid or methanol99 which are referred to as Kröhnke conditions (Figure 3-17).99k 
R1
O
N
Br
+
R2 R3
O
N
R3
R2
R1AcOH or MeOH, 
20-120°C
20 122 123
R1 = R2 = R3 = H, alkyl, aryl
 NH4OAc
 
Scheme 3-17. Synthesis of Kröhnke pyridines 12399k 
 
Analogously, a one-step synthesis of 3-aryl-1-hydroxybenz[g]isoquinoline-5,10-diones 16 required the 
presence of a α,β-unsaturated ketone system (found in 2-methoxycarbonyl-1,4-naphthoquinone 19a) 
onto which phenacyl groups (originating from the pyridinium salts 20) could be added to create a 5-
oxoester system. The azacyclization of this 5-oxoester system and tautomerization would afford the 
fused 1-hydroxypyridine ring of the targeted compounds 16. 
 
In continuation of previous studies in the reseach group101 and according to the goals set for the PhD 
research, it was envisaged to use N-phenacylpyridinium salts 20c,d (Scheme 3-19) with electron-
withdrawing substituents (4’-NO2, 2’,4’-di-Cl) attached to the acetophenone moiety and unsubstituted N-
phenacylpyridinium salt 20a as a reference compound. Indeed, the pyridinium salts 20a,b were obtained 
nearly in quantitative yield according to the procedure described in the literature102 by the reaction of α-
bromoacetophenones 124a,b with 1.05 equivalents of pyridine 125 in anhydrous ethyl acetate at room 
temperature for 24 hours.  
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R
O
Br
N
R
O
N
Br
1.05 equiv.
anhydrous EtOAc,
 24 h, rt
125
124a R = H
124b R = Cl
20a R = H (quant.)
20b R = Cl (quant.)
 
Scheme 3-18. Preparation of pyridinium salts 20a and 20b 
 
The preparation of α-bromoacetophenones 124c,d were attempted by the usual acid-catalyzed 
bromination of commercially available acetophenones 126c,d (Scheme 3-19).103 Although α-
bromoacetophenones 124c,d are known, literature procedures for their synthesis were not affording 
pure products in our hands. Under these typical conditions (bromine in acetic acid at 60°C for one hour), 
the corresponding α-bromoacetophenones 126c,d could not be obtained with acceptable purity to be 
used in the subsequent step.  
R1
Me
O
R1
O
Br N
R1
O
N
Br
1.05 equiv.
1.0 equiv. Br2
AcOH, 60°C, 
1 h
 EtOAc,
 rt, 24 h
125
R2 R2 R2
X
126c R1 = NO2, R2 = H
126d R1 = Cl, R2 = Cl
124c R1 = NO2, R2 = H
124d R1 = Cl, R2 = Cl
20c R1 = NO2, R2 = H
20d R1 = Cl, R2 = Cl
X
 
Scheme 3-19. Attempt to prepare α-bromoacetophenones 124c and 124d 
 
The synthesis of 2-methoxycarbonyl-1,4-naphthoquinone 19a was achieved by a successful large scale 
protocol established in our group (Scheme 3-20),101,104 the protocol of which implied treatment of the 
commercially available 1,4-dihydroxy-2-naphthoic acid 127 with 1.1 equivalents of diisopropylethylamine 
as base and 2.2 equivalents of dimethyl sulfate in N,N-dimethylformamide at 85 °C for 1 h, after which 
methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 was isolated in 84% yield. Finally, silver(I) oxide 
mediated oxidation of the methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 afforded 2-
methoxycarbonyl-1,4-naphthoquinone 19a in 98% yield.  
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OH
OH
OH
O
OMe
OH
OH
O
OMe
O
O
O2.2 equiv. 
Me2SO4
1.1 equiv 
DIPEA
DMF, 85°C, 1 h
3.3 equiv. 
Ag2O
MgSO4
Et2O, rt, 30 min
128 (84%)127 19a (98%)  
Scheme 3-20. Preparation of 2-methoxycarbonyl-1,4-naphthoquinone 19a101,104 
 
Having in hands both the appropriate Michael acceptor 19a and the N-phenacylpyridinium bromides 
20a,b for Kröhnke conditions, these substrates were subsequently reacted in a 10 wt% solution of 
ammonium acetate in acetic acid104 and the targeted 3-aryl-1-hydroxybenz[g]isoquinoline-5,10-diones 
16a,b were isolated in 44 and 75% yield, respectively (Table 3, entries 1 and 2). The reaction with the 
electron-deficient N-phenacylpyridinium bromide 20b finished after 1 hour while it took 4 hours for the 
more electron-rich N-phenacylpyridinium bromide 20a. The reaction was affected by the electron-
withdrawing effects of the chlorine of N-phenacylpyridinium bromide 20a. To have a clear view on these 
electronic effects, the activated quinone 19a was later treated with pyridinium salts 20e-g (Table 3, 
entries 3-5), which were previously prepared in our group, after checking their quality using 1H NMR 
spectroscopy. The formation of 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a as a side product 
was observed in 15-20% yield next to a mixture of unidentified material. The electron-withdrawing 
effects of the substituents on N-phenacylpyridinium salts 20 were best delineated by treating the 
activated 2-methoxycarbonyl-1,4-naphthoquinone 19a with pyridinium salts 20f,g, in which these effects 
are completely absent. Indeed, under Kröhnke conditions, there exists a competition between the 
addition of the pyridinium ylids and the direct addition of ammonia across the activated naphthoquinone 
19a. It was found that under these conditions, the in situ production of N-pyridinium acetate ylid and N-
pyridinium acetamide ylid was not sufficient enough to add across the activated naphthoquinone 19a. 
Probably, the ammonia produced in situ is not strong enough to deprotonate these pyridinium salts 
20f,g to produce their corresponding ylids.105 Therefore, the formation of the targeted products 16f,g 
was prevented, while the formation of the competitive side product 129a was promoted.  
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Table 3: Synthesis of 1-hydroxybenz[g]isoquinoline-5,10-diones 16 under Kröhnke conditions 
R N
O
N
R
OHO
O
Br
1.05 equiv.
10%wt NH4OAc
in HOAc, ∆, 1-4 h
+
OMe
NH2
O
O
O
129a16a,b,e
20a,b,e-g
O
O
OMe
O
19a  
 
Entry 
                     
Compound 20 
                            
R 
               
Reaction time (h) 
                             
Compound 16 (%) 
                                 
Compound 129a (%) 
                           
1 
                                  
20a 
                    
C6H5 
                                     
4 
                                
16a (44) 
                                                 
- 
                            
2 
                                 
20b 
                 
p-Cl-C6H4 
                                   
1 
                                
16b (75) 
                                                 
- 
                         
3 
                                  
20e 
                     
t-Bu 
                                    
4 
                                 
16e (40) 
                                              
15 
                       
4 
                                  
20f 
                     
EtO 
                                     
4 
                                            
- 
                                             
20 
                            
5 
                                  
20g 
                        
NH2 
                                     
4 
                                              
- 
                                            
18 
 
The reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a with ammonium acetate in boiling acetic 
acid was conducted in the absence of N-pyridinium salts 20. 3-Amino-2-methoxycarbonyl-1,4-
naphthoquinone derivative 129a was smoothly formed in 72% yield after 4 hours.  
 
The reaction mechanism involved in the formation of the side-product 3-amino-2-methoxycarbonyl-1,4-
naphthoquinone 129a (Scheme 3-21) implies a conjugate addition of ammonia across the activated 
naphthoquinone 19a to form the intermediate 130, which tautomerizes to 3-amino-1,4-dihydroxy-2-
methoxycarbonylnaphthalene 131, which is oxidized by air and affords the corresponding 
naphthoquinone 129a.  
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OMe
O
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O
O
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O
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OH
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O
128
R = H, alkyl, aryl  
Scheme 3-21. Synthesis of 3-amino- and 3-alkylamino-2-methoxycarbonyl-1,4-naphthoquinones 129 
 
Alkylammonium and arylammonium acetates 121b,c and 121d were also reacted with the activated 
naphthoquinone 19a in boiling mixture of toluene and acetic acid (5/1) for 4 hours to add more insight to 
this reaction. It resulted in the synthesis 2-methoxycarbonyl-3-(n-propylamino)-, 2-methoxycarbonyl-3-
(n-butylamino)- and 2-methoxycarbonyl-3-phenylamino-1,4-naphthoquinones 129b-d in 69-87% yields 
and different small amounts of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 (Table 4). Although 
the exact source of the reductant has not been identified, the formation of compound 128 can be 
explained by the autooxido-reduction cycle of the starting material 19a and the hydroquinone form of 
alkylaminonaphthoquinone 131.  
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Table 4: Reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a with ammonium acetate salts 121 for 
4 hours 
O
O
OMe
O O
O
OMe
O
N
H
R
121
RNH3OAc in AcOH
Solvent, ∆, 4 h
19a 129
+
OMe
OH
OH
O
128  
 
         
Entry 
                      
Ammonium salt 
                         
R 
        
Equiv. 
                       
Solvent 
                                    
Compound 129 (%) 
              
Compound 
128 (%) 
             
1 
                              
121a 
                      
H 
                        
28 
                         
AcOH 
                                
129a (72) 
                                    
12 
             
2 
                               
121b 
           
n-Pr 
                          
4 
               
 PhMe/AcOH 
(5/1) 
                                      
129b (87) 
                                         
- 
             
3 
                               
121c 
           
n-Bu 
                          
4 
               
PhMe/AcOH 
(5/1) 
                                        
129c (75) 
                                      
- 
              
4 
                                 
121d 
        
Ph 
                        
4 
              
PhMe/AcOH 
(5/1) 
                                       
129d (69) 
                                      
- 
 
In view of the potential biological activity of aminonaphthoquinones 129 and their use in human 
medicine, 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a was reported to prevent intestinal 
carcinogenesis.106 3-Anilino-2-ethoxycarbonyl-1,4-naphthoquinones 132 (Figure 3-1) were prepared in 
order to exhibit bacteriostatic activity against Mycobacterium tuberculosis.107 N-Substituted 3-amino-2-
chloro-1,4-naphthoquinones 133 (Figure 3-1) are reported to possess significantly enhanced 
antimalarial activity making these compounds a novel type of antiplasmodial agents.108 Finally, 2-amino-
1,4-naphthoquinone derivatives 134 (Figure 3-1) have been found to possess some level of haemolytic 
activity and nephrotoxicity.109  
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O
O
Cl
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O
O
NH
OEt
O
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133 R = NH2, C6H5NH 
(also pyrrolidino, morpholino)
132 R = Br, COOH, 
       COOEt, SO2NH2
O
O
R1
NHR2
134 R1 = H, OH, Cl
       R2 = H, Me, Ph
 
Figure 3-1. Examples of 3-alkyl- and 3-arylamino-1,4-naphthoquinones in the literature 
 
Different attempts were performed to react 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a with 
common carbonyl electrophiles 135 such as ethyl acetoacetate 135a, benzaldehyde 135b, acetic 
anhydride 135c and acetyl chloride 135d (Table 5) under mild neutral, basic and acid conditions. The 
electrophiles 135 were reacted according to the increasing order of their chemical reactivity. 
All the reactions in Table 5 were performed at room temperature and checked by TLC analysis. Since 
TLC only showed the presence of the starting materials, the reaction mixture was boiled under reflux 
and followed up by TLC analysis up to 4 hours. Ethyl acetoacetate 135a was the first compound to be 
used in the reaction because of the double electrophile, i.e the ester and the ketone functionality, 
present in the compound. The acidic condition was tested to improve the formation of the corresponding 
adduct treating 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a with 10 mol% of p-
toluenesulfonic acid and 1.05 equivalents of ethyl acetoacetate 135a under Dean-Stark conditions. After 
boiling the reaction mixture for 4 hours, no sign of the adduct formation was observed and only starting 
materials were retrieved. Since the ester and ketone functionality failed to react with 3-amino-2-
methoxycarbonyl-1,4-naphthoquinone 129a, benzaldehyde 135b was attempted as an electrophile. 
Therefore, 1.5 equivalents of MgSO4 in boiling dichloromethane or benzene were used. Unfortunately, 
after 4 hours of reaction time, only the starting materials were observed upon TLC analysis and 
retrieved from the reaction mixture. Subsequently, it was attempted to acetylate 3-amino-2-
methoxycarbonyl-1,4-naphthoquinone 129a under different conditions. All the acetylating reactions 
failed to afford the acetylated product 137.  
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Table 5: Reaction of 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a with electrophiles 135 
OMe
NH2
O
O
O
+ R1 R2
O
O
O
OMe
N
R2R1
O
129a 135 136
+
NH
R1O
OMe
O O
O
137  
 
Entry 
 
  
Electrophile 
                 
R1 
                          
R2 
                                                        
Reaction conditions Expected 
product 
                    
Result 
 
 
1 
 
                    
135a 
 
 
 
Me 
 
 
CH2COOEt 
 
(1) 0.1 equiv. p-TsOH.H2O, 
   PhH, ∆, 4 h. 
(2) 0.1 equiv. p-TsOH.H2O, 
   PhMe, ∆, 4 h. 
            
136        
            
136 
 
No reaction 
 
No reaction 
                 
2 
                   
135b 
              
Ph 
                           
H 
 
(1) 1.5 equiv. MgSO4, 
           CH2Cl2, ∆, 2 h 
(2) 1.5 equiv. MgSO4,               
   PhH, ∆, 4 h 
            
136 
                   
136 
                               
No reaction 
                        
No reaction 
                 
3 
                    
135c 
               
Me 
                       
OAc 
 
(1) 4.0 equiv. K2CO3,        
   PhMe, ∆, 4 h 
(2) 2 drops H2SO4,           
   PhMe, ∆, 24 h 
            
137         
            
137 
                        
No reaction 
                        
Tar formation 
                
4 
                    
135d 
              
Me 
                           
Cl 
 
(1) 1.0 equiv. Et3N,            
   PhMe, ∆, 4 h 
(2) 1.0 equiv. DMAP,          
   PhMe, ∆, 4 h 
            
137         
            
137 
                     
No reaction 
                        
No reaction 
 
In contrast to the amino group in 2-amino-1,4-naphthoquinone 138 (Figure 3-2), which is somehow 
reactive towards electrophiles, and is found in many heteroannulation reactions,109 the amino group of 
3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a was found to be less reactive. This chemical 
inactivity might be rationalized by the formation of intramolecular hydrogen bonds between the amino 
group hydrogens and the oxygen atoms of the 2-methoxycarbonyl and the quinone function. A second 
reason may be found in the vinylogous amide character of the 3-amino group.110 However, the reaction 
with acetic anhydride occurred when a catalytic amount of sulfuric acid was used in boiling toluene, but 
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prolonging the reaction time to 24 hours caused the degradation of starting materials (Table 5, entry 3). 
Since the synthesis of 1-azaanthraquinones was not a goal for this research work, the chemical 
reactivity of 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a under acid conditions was not 
investigated further. 
138
O
O
N
H
O
O
O
N H
H
OMe
129a
H
 
Figure 3-2. Hydrogen bond formation in aminonaphthoquinones 129a and 138 
 
Nevertheless, the unexpected reaction of 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a with 
pivaloylaldehyde 139 in hydrobromic acid and acetic acid (scheme 3-22) as a new entry to the synthesis 
of 2-methoxycarbonyl-3-(pivaloylamine)-1,4-naphthoquinone 141 in 56 and 51% yield, respectively, via 
CAN- and PIFA-mediated oxidation of the intermediate 2-tert-butyl-5-hydroxy-4-
methoxycarbonylnaphtho[2,1-d]oxazole 140 has been reported recently.111 Perhaps, the reaction 
conditions used in this article can be used in the future to produce the desired N-acylated 3-amino-2-
methoxycarbonyl-1,4-naphthoquinones 137.  
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O
O
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Me
Scheme 3-22. Synthesis of 2-methoxycarbonyl-3-(pivaloylamine)-1,4-naphthoquinone 141 
 
In need of an optimized synthesis of 3-aryl-2-aza-1-hydroxyanthraquinones 16 under Kröhnke 
conditions, the competing formation of the side product 3-amino-2-methoxycarbonyl-1,4-
naphthoquinone 129a should be minimized. The synthesis of the targeted 3-aryl-2-aza-1-
hydroxyanthraquinones 16 should be achieved shortly, efficiently and with an easy workup. Nowadays, 
microwave-mediated multicomponent reactions constitute an attractive synthetic strategy for rapid and 
efficient production of libraries of chemicals with cleaner products and simple manipulation.112 
Therefore, conditions established previously in our group101b,104 were used and, in this way, quinone 19a 
was reacted with 4-chlorophenacylpyridinium bromide 20b under Kröhnke conditions using microwave 
irradiation in a 5 wt% solution of ammonium acetate in methanol at 115°C for 5 min (Scheme 3-23). 
Methanol was used instead of acetic acid since methanol behaves better as solvent (i.e has a higher 
absorption) under microwave conditions compared to acetic acid.112a,113 Morever, the target compound 
16b crystallized after cooling down the reaction mixture to room temperature. Therefore, the target 
compound 16b could then be easily recovered by filtration. After washing with ice-cold methanol, pure 
3-(4-chlorophenyl)-1-hydroxybenz[g]isoquinoline-5,10-dione 16b was isolated in 35% yield.  
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Scheme 3-23. Synthesis of 1-hydroxy-2-azaanthraquinone 16b using a microwave reactor 
 
The reaction mechanism involved in this short and efficient synthesis of 1-hydroxybenz[g]isoquinoline-
5,10-diones 16 might be explained as follows (Figure 3-24). After conjugate addition of the pyridinium 
ylid 142, which is formed in situ by deprotonation of the corresponding pyridinium salt 20b, onto the 
activated naphthoquinone 19a, the pyridinium moiety is eliminated in a 1,2-fashion from the intermediate 
143 thanks to the presence of an acidic α-hydrogen. Subsequently, cyclization occurred to form 1-oxo-
3,4-dehydropyranonaphthoquinone 145, which contains a novel Michael acceptor, to allow the addition 
of ammonia. Next, the pyran moiety in 146 undergoes ring opening, which leads to the formation of the 
intermediate imine 147. Acid-catalyzed ring closure of the intermediate 147 forms lactam 148, which 
tautomerizes to the targeted 3-substituted 1-hydroxybenz[g]isoquinoline-5,10-diones 16.104 
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Scheme 3-24. Reaction mechanism for the formation of 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-
diones 16 
3.2.2. Synthesis of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17  
 
The synthesis of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17, requires 2-acetyl-1,4-
naphthoquinone 19b and pyridinium salts 20 as key intermediates as depicted in the following 
retrosynthetic scheme (Scheme 3-25).  
N
Me
O
O
R2
O
O
Me
O
+
R2 N
O
Br
+ NH4OAc
2019b17 R = aryl 121a
HOAc
 
Scheme 3-25. Retrosynthetic analysis of 1-methylbenzogisoquinoline-5,10-diones 17 
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Different literature routes exist to prepare the substrate 19b, but complicated procedures, harsh 
conditions and low yields are important drawbacks for these routes. Although the usefullness of 
phthalide annulation, the preparation of 3-cyanophthalide 149 is not so efficient for a large scale 
synthesis in addition to the fact that the use of a cyanide salt in acidic solution101a causes the process to 
be environmentally unfriendly and even dangerous. The use of 1,4-naphthoquinone 152 as the starting 
material towards the synthesis of 2-acetyl-1,4-naphthoquinone 19b would be the one of choice. 
Unfortunately the process is recognized to be the longest and the most expensive.115 In addition, this 
process was not efficiently reproducible in our hands. The use of cheap 1-naphthol 155 as starting 
material is severely plagued by poor overall yield (≤18%).115 
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Scheme 3-26. Literature routes for the synthesis of 2-acetyl-1,4-naphthoquinone 19b 
 
Therefore, the synthesis of 2-acetyl-1,4-naphthoquinone 19b was achieved using the cerium(IV) 
ammonium nitrate induced-oxidation of 2-acetyl-4-methoxy-1-naphthol 158, which was prepared by the 
literature procedure previously worked out in our group (Figure 3-27).116 4-Methoxynaphthol 156 was 
prepared by the reaction of 1,4-naphthoquinone 152 with 3.5 equivalents of tin(II) chloride in a boiling 
mixture of methanol and concentrated hydrochloride acid. Pure 4-methoxynaphthol 156 was obtained in 
72% yield after column chromatography, which was acetylated nearly quantitatively after treatment with 
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excess of acetic anhydride in pyridine at room temperature to afford the 1-acetoxy-4-
methoxynaphthalene 157. Subsequent Fries rearrangement with 1.5 equivalents of boron(III) fluoride 
etherate gave 2-acetyl-4-methoxy-1-naphthol 158 in 98% yield. Then, oxidative demethylation of 2-
acetyl-4-methoxy-1-naphthol 158 with 2.2 equivalents of cerium(VI) ammonium nitrate in aqueous 
acetonitrile at room temperature afforded 2-acetyl-1,4-naphthoquinone 19b in 69% yield after 
recrystallization from diethyl ether/hexane (9/1).    
OH
OMe
OH
OMe
O
O
O
OMe
Me
O
Me
O
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 Ac2O
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overnight
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158 (98%)
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2.2 equiv.
CAN
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156 (72%)
O
O
3.5 equiv.
SnCl2,
12 M HCl
MeOH, ∆, 3 h
152
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Scheme 3-27. Synthesis of 2-acetyl-1,4-naphthoquinone 19b 
 
Microwave reaction of 2-acetyl-1,4-naphthoquinone 19b and different pyridinium salts 20 was run for 6 
minutes in 5% (w/v) solution of ammonium acetate in methanol. Afterwards, the reaction mixtures were 
cooled down to room temperature and then in a bath of ice-water. The filtration of the cold reaction 
mixture afforded 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 in 47-67% yield after washing the 
crystals with cooled methanol and a second recrystallization from methanol (Table 6). 
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Table 6: Microwave-assisted synthesis of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 
N
O
O
Me
R
Br
5% (w/t) NH4OAc in MeOH,
 µW, 6 min, 90°C
 17
1.05 equiv
O
O
Me
O
19b
N
O
R
20
 
                                  
Entry 
                              
Pyridinium salt 20 
                                         
R 
                        
Compound 17 
                                
Isolated yield (%) 
                                           
1 
                                 
20a 
                                       
H 
                                     
17a 
                                        
52 
                                            
2 
                              
20b 
                                      
Cl 
                                     
17b 
                                       
67 
                                           
3 
                                 
20i 
                                         
F 
                                   
17i 
                                       
51 
                                           
4 
                                 
20j 
                                   
OMe 
                                      
17j 
                                       
47 
                                           
5 
                                 
20k 
                                        
Me 
                                    
17k 
                                       
48 
 
The presence of the methyl group at C-1 in 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 allowed 
its conversion to a 2-(dimethylamino)vinyl moiety. Therefore, the 3-aryl-1-methylbenzo[g]isoquinoline-
5,10-diones 17 were reacted with an excess of DMF-DMA in DMF at 125°C for 4-20 hours to give 3-
aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones 21 in 23-77% yield (Table 7). The 
reaction of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 with DMF-DMA was strongly influenced 
by the electronic effects of the 3-substituents on substrate 17, which could be observed by the acidity of 
hydrogens of the methyl at C-1. Since 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones 
21 were found to be instable on silica gel and since the deprotonation of 3-aryl-1-
methylbenzo[g]isoquinoline-5,10-diones 17 is a reversible reaction, the addition reaction required an 
excess of DMF-DMA and longer reaction time for derivatives bearing-electron donating substituents at 
C-3 in order to run the reaction to completion (Table 7). 
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 Table 7: Synthesis of (E)-3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones 21 
N
O
O R
NMe Me
DMF, 125°C,
 4-20 h
N
O
O
Me
R
5-10 equiv.
DMF-DMA
17 21  
          
Entry 
          
Compounds 17 
                                 
R 
                       
DMF-DMA 
(equiv.) 
              
Reaction time 
(h) 
             
Compound 21 
             
Isolated yield 
(%) 
                        
1 
                              
17a 
                                
H 
                           
10 
                            
16 
                             
21a 
                               
52 
                           
2 
                            
17b 
                              
Cl 
                               
5 
                              
4 
                          
21b 
                             
77 
                          
3 
                             
17i 
                                
F 
                            
10 
                         
19 
                               
21i 
                                  
-* 
              
4 
                               
17j 
                          
OMe 
                               
10 
                           
19 
                                 
21j 
                              
23 
                      
5 
                              
17k 
                               
Me 
                              
10 
                              
20 
                          
21k 
                               
39 
*Complex mixture was retrieved  
 
Attempts to convert 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones 21a,b to the 
corresponding naphthonaphthyridines (sampangine analogues) 22a,b using a boiling solution of 33% 
(w/v) NH4Cl in AcOH or stirring in a solution of 25% (w/v) NH4Cl in AcOH/DMF (5/1) at 125°C15a,117 gave 
complex reaction mixtures. However, boiling 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-
dione 21a in 5% (w/v) solution of NH4OAc in methanol for 4 hours afforded 5-phenyl-7H-naphtho[3,2,1-
de]naphthyridine-7-one 18a in 89% yield (Table 8, entry 5). 
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Table 8: Synthesis of 7H-naphtho[3,2,1-de]naphthyridine-7-ones 22 
N
O
O R
NMe Me
N
N
O R
21 22  
      
Entry 
        
Compound 
21 
                 
R 
                                                                              
Reaction conditions 
         
Result 
         
Compound 
22 (%) 
         
1 
                      
21a 
              
H 
                                             
33% (w/v) NH4Cl, ∆, AcOH, 1 hb 
                         
Complex 
mixture 
                                
- 
2 21b Cl Complex 
mixture 
- 
          
3 
                         
21a 
           
H 
                                                       
25% (w/v) NH4Cl, AcOH/DMF (5/1), 125°C, 1 ha 
                          
Complex 
mixture 
                                
-               
4 21b Cl Complex 
mixture 
-               
         
5 
                       
21a 
             
H 
                                                                                      
5% (w/v) NH4OAc, ∆, MeOH, 4 h Naphthyridin-
7-one 22 
                             
89 
    aRef 117 and bRef 15a 
From the mechanistic viewpoint, the reaction mechanism for the synthesis of 3-aryl-2-aza-1-methyl 
anthraquinones 17 is analogous to the mechanism for the synthesis of 3-aryl-2-aza-1-
hydroxyanthraquinones 16 (page 49), except for the last step, in which a dehydration reaction instead of 
a tautomerization affords the target compounds 17. The reaction mechanism for the synthesis of 3-aryl-
2-aza-1-[2-(dimethylamino)vinyl]anthraquinones 21 is completely analogous to the mechanism for the 
synthesis of 1-[2-(dimethylamino)vinyl]cleistopholine 11a (page 36). The mechanism for the formation of 
5-(phenyl)-7H-naphtho[3,2,1-de]naphthyridin-7-ones 22 implies a transamination reaction through the 
Michael acceptor present in the 3-aryl-2-aza-1-[2-(dimethylamino)vinyl]anthraquinones 21. The 
conjugate addition of ammonia generated in situ accros this Michael acceptor system causes the 
formation of the intermediate 159a, which forms the intermediate 159b after prototropy. Next, 
elimination of dimethylamine affords enamine 160, which can undergo ring closure to form intermediates 
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161. Subsequent dehydration affords the targeted sampangine analogues, i.e. 5-phenyl-7H-
naphtho[3,2,1-de]naphthyridin-7-one 22. 
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Scheme 3-28. Reaction mechanism for the formation of (7H)-naphtho[3,2,1-de]naphthyridin-7-one 22 
3.2.3. Efforts towards the synthesis of methyl 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-dione-
4-carboxylates 18  
 
Retrosynthetic analysis of 4-methoxycarbonyl-2-azaanthraquinones 18 gives enaminoesters 23 and 2-
methoxycarbonyl-1,4-naphthoquinone 19a as potential starting material. This synthesis calls upon the 
utilization of the Nenitzescu reaction which is one of the key straigthforward strategies for the 
preparation of a 5-hydroxyindole library.  
O
O
OMe
O
N
R
O
O
OH
X
+
NH2
OMe
O
R
18  X = COOMe 19a 23 R = H, Cl, F, MeO, Me 
Scheme 3-29. Retrosynthetic analysis of 1-hydroxy-2-azaanthraquinones 18 
 
However, the condensation reaction of an equimolecular quantity of 2-methoxycarbonyl-1,4-
benzoquinone 162 and ethyl 3-aminocrotonate 23a in boiling methanol gave the Michael adduct 163 in 
59% yield after 2 hours (Figure 3-30).118 It appeared that subsequent treatment of the adduct 163 in the 
presence of an appropriate oxidizing agent would complete the Nenitzescu synthesis with the formation 
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of ethyl 5-hydroxy-4-methoxycarbonyl-2-methylindole-3-carboxylate 164 while the absence of an 
oxidizing agent would favour the formation of 4-ethoxy-5,8-dihydroxy-3-methylisoquinolin-1(2H)-one 
165. Indeed further treatement of the adduct 163 in boiling acetic acid in the presence 0.18 equivalent of 
2-methoxycarbonyl-1,4-benzoquinone 162 as the oxidizing agent for 15 hours, gave the indole 164 
(30% yield) and the isoquinolone 165 (23% yield) while isoquinolone 165 (25% yield) was retrieved as 
the only product in the absence of the oxidizing agent, proving that the formation of the isoquinolone 
165 occurs when the adduct 163 is still in the hydroquinone form.  
O
O
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O
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O
1.0 equiv.
MeOH, ∆, 2 h, 
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Figure 3-30. Reaction of 2-methoxy-1,4-benzoquinone 162 and enaminoester 23a 
 
Based on these results, the reaction of 2-methoxycarbonyl-1,4-napthoquinone 19a with methyl 3-
aminocrotonate 23a was screened to set up optimized reaction conditions for the synthesis of methyl 3-
aryl-1-hydroxybenzo[g]isoquinoline-5,10-dione-4-carboxylates 18. Different reactions conditions were 
tested and produced three different compounds (Scheme 3-31). The reaction of 2-methoxycarbonyl-1,4-
napthoquinone 19a with methyl 3-aminocrotonate 23a in a boiling mixture of toluene and acetic acid 
(5/1) gave the 5-hydroxyindole 167a and the indole 168 in the presence a catalytic amount of sulfuric 
acid. The product 168 could also be obtained by treatment of compound 167 with a catalytic amount of 
sulfuric acid. When the reaction is conducted at 80°C, only adduct 166a could be isolated in a 25% 
yield. Attemps to cyclize this Michael adduct 166a to the corresponding 1-hydroxy-3-
methylbenzo[g]isoquinoline-5,10-dione-4-carboxylate 18b using heat or ZnCl2 (Table 9) failed.  
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Scheme 3-31. Reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a and enaminoester 23a 
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Table 9: Applied attempts to synthesize 2-aza-1-hydroxy-3-methyl-4-methoxycarbonylanthraquinone 
18b 
OMe
O
COOMe
H2N Me
O
O
N
O
O
COOMe
Me
OH
18b166a  
                         
Entry 
                                                                                                                    
Reaction conditions 
                                                 
Results 
                             
1 
                                                                                                               
PhMe, ∆, 24 h 
                                                 
Starting material 
                              
2 
                                                                                                               
PhMe/AcOH (5/1), ∆, 2 h 
                                                
Starting material 
                             
3 
                                                                                                                             
2 equiv. K2CO3, PhMe, 80°C, 6 h 
                                             
Complex mixture 
                              
4 
                                                                                                                            
1.0 equiv. ZnCl2, Et2O, rt, 24 h 
                                               
Starting material 
                               
5 
                                                                                                                                  
1.0 equiv. ZnCl2, Et2O, ∆, 2 h 
                                              
Complex mixture 
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Table 10: Optimization of the reaction of 3-methoxycarbonyl-1,4-napthoquinone 19a with methyl 3-
aminocrotonate 23a to afford compounds 166a, 167a and 168. 
         
Entry 
                                                                                                         
Reaction conditions 
                                 
Result 
                                
Isolated product (%) 
                          
1 
                                                                                                              
Et2O, ∆, 4 h 
                                   
No reaction 
                                            
- 
                 
2 
                                                                                                                  
4.0 equiv. K2CO3, Et2O 
                                  
No reaction 
                                            
- 
                         
3 
                                                                                                              
4.0 equiv. K2CO3, EtOH, 50°C 
                           
Reaction 
                                     
166a (8%) 
                           
4 
                                                                                                        
PhMe, ∆, 4 h 
                                       
Complex mixture 
                                      
- 
                             
5 
                                                                                                  
PhMe/AcOH (5/1), ∆, 4 h 
                                         
Reaction 
                              
167a (48%) 
                         
6 
                                                                                                  
PhMe/AcOH (5/1), ∆, 24 h 
                             
Reaction 
                                     
167a (39%) 
                         
7 
                                                                                                            
PhMe, H2SO4(2 drops), ∆, 4 h 
                            
Reaction 
                                        
168 (68%) 
                         
8 
                                                                                                                  
3.0 equiv. Ag2O, CH2Cl2, ∆, 3 h 
                                  
No reaction 
                                                      
- 
                      
9 
                                                                                                               
3.0 equiv. Ag2O, PhMe, ∆, 3.5 h 
                           
Reaction 
                                    
166a (12%) 
                       
10 
                                                                                                   
PhMe/AcOH (5/1), 80°C, 4 h 
                                  
Reaction 
                                     
166a (25%) 
                
11 
                                                                                                                     
3.0 equiv. MnO2, PhMe, ∆, 1 h 
                
Complex mixture 
                                             
- 
             
12 
                                                                                                                    
3.0 equiv. MnO2, PhMe/AcOH (5/1), ∆, 1 h 
                             
Complex mixture 
                                           
- 
 
In order to arrange a more suitable action of the amino group of enaminoesters 23, methyl N-isopropyl-
3-aminocrotonate 23b was reacted with the activated quinone 19a in a boiling mixture of toluene and 
acetic acid (5/1). After 36 hours, only the enaminolactone 169 was retrieved. Therefore, it was 
considered that N-substituted 3-alkylbenzo[g]furo[4,3,2-de]isoquinoline-1-ones 170 obtained upon 
prolonged heating of enaminolactone 169 could be key intermediates towards the synthesis of 
benzo[g]isoquinoline-1,5,10(2H)-triones 171 (Figure 3-3). Yet, this type of azaanthraquinones is 
unknown in the literature. Unfortunely, the prolongation of heating to 12 hours of compound 169 did not 
give the desired product 170b (Scheme 3-32). 
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Scheme 3-32. Reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a and enaminoester 23b 
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Figure 3-3. Benzo[g]isoquinoline-1,5,10(2H)-triones 171 and 172 
  
However, N-substituted 3-alkylbenzo[g]isoquinoline-1,5,10(2H)-triones 172, a partial structural pattern 
found in Kibdelone A 173 (Figure 3-4), has been synthesized to a very limited extend.119a Kibdelone A 
173 belongs to a novel family of bioactive heterocyclic polyketides produced by a rare soil actinomycete 
Kibdelosporangium sp. (MST-108465) and exhibits potent selective cytotoxicity against a panel of 
human tumor cell lines as well as significant antibiotic and nematocidal activity.119 
N
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O Cl
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Figure 3-4. Structure of kibdelone A 173 
 
In this manuscript, the first synthesis of substituted benzo[g]isoquinoline-1,5,10(2H)-triones 171 is 
reported. Retrosynthetic analysis suggested that three possible routes could lead to the synthesis of the 
targeted alkyl 2,3-dialkylbenzo[g]isoquinoline-1,5,10(2H)-trione-4-carboxylates 171 (Scheme 3-33). Two 
routes rely on the synthesis of 3,4-dialkyl-6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-diones 
170 as key intermediates, which may most likely be prepared by treating 2-methoxycarbonyl-1,4-
naphthoquinone 19a with either β-ketoesters 174 and primary amines 175 (Route A) or ready-made N-
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alkyl enaminoesters 23 (Route B). A third route, which will be investigated, concerns the oxidative 
addition reaction of N-alkyl enaminoesters 23 with methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 
(Route C) as entries towards the synthesis of alkyl 2,3-dialkylbenzo[g]isoquinoline-1,5,10(2H)-trione-4-
carboxylates 171. 
N R
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O
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Scheme 3-33. Retrosynthetic analysis of benzo[g]isoquinoline-1,5,10(2H)-triones 171 
3.2.3.1. Route A 
The addition of β-ketoesters to quinones under basic120 and radical121 conditions has been well 
described, but few reports are disclosed on this addition reaction under acidic conditions122 despite the 
fact that experiments121-122 and ab initio calculations123 showed that quinones behave better as 
electrophiles under acidic conditions. Therefore, the addition of β-ketoesters 174 to 2-methoxycarbonyl-
1,4-naphthoquinone 19a was conducted under acidic conditions in order to avoid the formation of the 
kinetic product of the reaction, i.e ethyl 5-hydroxy-3-methoxycarbonyl-2-methylnaphtho[1,2-b]furan-4-
carboxylate 177 and its subsequent decarboxylated derivative 178, which would divert the course of the 
synthesis (Scheme 3-36).122 The naphtho[1,2-b]furan 177 arises from the intramolecular nucleophilic 
attack of the intermediate phenol of the adduct 176a across the ketone function of the acetonyl moiety. 
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Scheme 3-34. Reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a with ethyl acetoacetate 174a 
 
Therefore, test reactions were conducted under different reaction conditions treating the activated 
naphthoquinone 19a with ethyl acetoacetate 174a. The desired naphtho[1,2-b]furan-2(3H)-one 177 was 
obtained in 54% yield when using a mixture of toluene and acetic acid (5/1) under reflux for 4 hours. 
Extending the optimized reaction conditions for the synthesis of other derivatives 177b-d from 2-
methoxycarbonyl-1,4-naphthoquinone 19a and higher β-ketoesters 174 was successful in low (17%) to 
moderate yield (54%) except for compound 177e due to the steric hindrance of the bulky t-butyl group, 
which afforded a very complex mixture without a trace of the targeted compound 176e as checked by 
NMR and LC-MS analysis. 
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Scheme 3-35. Synthesis of naphtho[1,2-b]furan-2(3H)-ones 177 
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In a following part, a one-pot synthesis of benzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-diones 179 was 
investigated by reaction of the activated naphthoquinone 19a with ethyl acetoacetate 174a and 
ammonium acetate in boiling acetic acid (Scheme 3-36). However, no trace of compound 179 was 
observed while the naphtho[1,2-b]furan 178 was isolated albeit in low yield (13%) in conjunction with 
methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 and 3-amino-2-methoxycarbonyl-1,4-
naphthoquinone 129 in 6% and 41% yields, respectively after column chromatographic purification. 
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Scheme 3-36. Reaction of 2-methoxycarbonyl-1,2-naphthoquinone 19a and ethyl acetoacetate 174a 
with NH4OAc in acetic acid 
 
The formation of the tricyclic compound 178 arose from a condensation reaction outlined previously. 
The formation of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 and 3-amino-2-methoxycarbonyl-
1,4-naphthoquinone 129a was also observed recently by the reaction of the activated naphthoquinone 
19a with an excess of ammonium acetate in boiling acetic acid.122 Therefore, the outcome of the 
competitive addition of ammonia and the enolate of ethyl acetoacetate 174a to 2-methoxycarbonyl-1,4-
naphthoquinone 19a led favorably towards the facile ammonia addition compared to that of ethyl 
acetoacetate 174a. Under these conditions, the ammonia adduct 129a is formed preferentially in 
comparison with compound 178. This fact was supported by the respective isolated yields of each 
addition product, and as a consequence, treatment of the activated naphthoquinone 19a with β-
ketoesters 174 and ammonium acetate in boiling acetic acid did not appear to be the right condition for 
an efficient one-pot three-components synthesis of 3,4-dialkylbenzo[g]furo[4,3,2-de]isoquinoline-
2,5(4H)-diones 170. Thus, an alternative synthesis was to be envisaged in order to prepare the target 
intermediates 170 from methyl 3-acyl-2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylates 
178 and primary amines 175. Unfortunately, treatment of methyl 3-acetyl-2,3-dihydro-5-hydroxy-2-
oxonaphtho[1,2-b]furan-4-carboxylate 177a with two equivalents of n-propylammonium acetate 121b, 
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which was generated in situ by the reaction of the corresponding equivalents of n-propylamine 175b and 
acetic acid at 0°C for 30 minutes, in boiling in toluene-acetic acid (5/1) resulted in the formation of 
methyl 2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 in 53% yield instead of the 
targeted 6-hydroxy-3-methyl-4-n-propylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170b. Facing 
this drawback, different attempts were made to insert the nitrogen atom using excess of ammonium 
acetate in different solvents in order to reduce the eventual steric effect that might be exhibited by an 
alkyl group.  
However, all the attempts failed to afford 170a and provided the same unexpected methyl 2,3-dihydro-5-
hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 in 46-67% yield (Table 11, entries 2-4), a novel 
compound so far undescribed in the literature. An attempt to increase the substrate electrophilicity of the 
carbonyl group by substitution of the methyl group in methyl 3-acetyl-2,3-dihydro-5-hydroxy-2-
oxonaphtho[1,2-b]furan-4-carboxylate 177a with a phenyl group in methyl 3-benzoyl-2,3-dihydro-5-
hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 177d improved the yield of the same product 180 to 91 
% (Table 11, entry 5), probably by limiting side reactions. 
N
O
R1
R2
O
OH O
R1NH2.HOAc 121 
(R1 = n-Pr, 2 equiv.)
(R1 = H, 12 equiv.)
180
PhMe/AcOH (5:1), 
∆, 3-4 h
(53-91%)
O
O
OH
OMe
O
O
O
R2
OMe
OOH
O
177a R2 = Me
177d R2 = Ph
170a R1 = H, R2 = Me
170b R1 = n-Pr, R2 = Me
170d R1 = H, R2 = Ph
From 177a: R1 = n-Pr and R2 = Me, 180 (53%)
From 177a: R1 = H and R2 = Me, 180 (67%)
From 177d: R1 = H and R2 = Ph, 180 (91%)
X
 
Scheme 3-37. Synthesis of methyl 2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 
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Table 11: Reaction conditions for the conversion of methyl 3-acyl-2,3-dihydro-5-hydroxy-2-
oxonaphtho[1,2-b]furan-4-carboxylates 177a,d to methyl 2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-
b]furan-4-carboxylate 180 
R1NH2.HOAc 121 
(R1 = n-Pr, 2 equiv.)
(R1 = H, 12 equiv.)
180
PhMe/AcOH (5/1), 
∆, 3-4 h O
O
OH
OMe
O
O
O
R2
OMe
OOH
O
177  
         
Entry 
               
Substrate 
                                              
Equiv. of R1NH2.HOAc 
                                                         
Solvent and reaction conditions 
                                   
Isolated yield of 180 (%) 
                       
1 
             
177a 
                                                    
2 (R1 = n-Pr) 
                                          
PhMe/AcOH (5/1), ∆, 3 h 
                                              
53 
                         
2 
                    
177a 
                                                  
12 (R1 = H) 
                                                         
PhMe, ∆, 4 h 
                                            
46 
                     
3 
                
177a 
                                                
12 (R1 = H) 
                                                   
AcOH, ∆, 4 h 
                                               
54 
                     
4 
             
177a 
                                                
12 (R1 = H) 
                                            
Toluene/AcOH (5/1), ∆, 4 h 
                                              
67 
                      
5 
            
177d 
                                  
12 (R1 = Ph) 
                                            
Toluene/AcOH (5/1), ∆, 4 h 
                                               
91 
 
The formation of methyl 2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 can be 
explained by a nucleofuge group expulsion of the intermediate 181, which is formed after the addition of 
the amine across the acyl or benzoyl group of naphthofuran derivatives 177, and subsequent keto-enol 
tautomerism (Scheme 3-38). The difficult access to the key intermediates 170 by reaction of 
naphthofurans 177 with amines 175 put a serious impediment to this first route A towards the targeted 
benzo[g]isoquinoline-1,5,10(2H)-triones 171 and prompted us to work out the second route B, which 
calls upon N-substituted enaminoesters 23. 
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O
O
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OMe
O
O
O
R2CONHR1
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H
H
+ R1NH2
175
R1 = H, alkyl, aryl
R2 = alkyl, aryl
Scheme 3-38. Reaction mechanism of formation of compound 180 
3.2.3.2. Route B 
The reaction of enaminoesters with simple quinones is known in the literature as the Nenitzescu 
reaction.124 In case of 2-methoxycarbonyl-1,4-naphthoquinone 19a as the substrate, enaminoesters 
23125 add to this activated quinone to form tautomeric intermediates 183a and 183b, which can cyclize 
in two modes. The first mode implies a nucleophilic attack of the amino group of 183a across the ketone 
moiety leading to an annelated indole 167b, while the second mode implies a nucleophilic attack of the 
amino group of 183b across the ester carbonyl leading to benzo[g]isoquinoline-1,5,10(2H)-triones 171 
(Scheme 3-39). 
O
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O HN R1
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Scheme 3-39. Reaction of 2-methoxycarbonyl-2,4-naphthoquinone 19a with enaminoesters 23 
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The reaction of the activated naphthoquinone 19a with N-n-propyl- and N-ethylamino-2-butenoates 23c 
and 23d in boiling toluene:acetic acid (5:1), as previously established in the case of β-ketoesters, 
furnished the hydroquinone adducts 184, which hardly cyclized to 6-hydroxy-4-n-propyl-3-
methylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170c and 4-ethyl-6-hydroxy-3-methyl-
benzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170d (Table 12, entries 1 and 2). Nevertheless, the 
use of N-ethylamino-2-pentenoate 23e resulted in a spontaneous cyclization to the targeted 
benzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170e upon boiling in toluene/acetic acid (5/1) for 4 
hours (Table 12, entry 3). Other substituent combinations utilizing enaminoesters 23f-g gave intractable 
mixtures of compounds, from which the targeted compounds could not be isolated by column 
chromatography and/or recrystallization. This can be ascribed to a difficult cyclization of intermediate 
naphtho[1,2-b]furans 185, even upon prolongation of the reaction time to 48 hours, which results in a 
partial degradation of the compounds (Table 12). 
 
Table 12: Reaction of different N-substituted enaminoesters 23 with 2-methoxycarbonyl-1,4-
naphthoquinone 19a in boiling toluene: acetic acid (5/1) to afford 3,4-dialkyl-6-
hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-diones 170. 
O
O
OMe
O
R2 OR3
NH OR
1
N
O
O
OH O
R1
R2
19a
+
1.05 equiv.
PhMe/AcOH
(5/1)
∆, 4-48 h
23 170  
               
Entry 
                
Enaminoester 
                       
R1 
                         
R2 
                            
Reaction time (h) 
                        
Isolated 
product 
                      
Yield (%) 
                    
1 
                                
23c 
                          
n-Pr 
                      
Me 
                                   
36 
                          
169c 
                         
19 
                     
2 
                               
23d 
                         
Et 
                        
Me 
                                   
36 
                        
169d 
                           
33 
                    
3 
                              
23e 
                         
Et 
                        
Et 
                                     
4 
                        
169e 
                          
47 
                      
4 
                                
23f 
                        
Et 
                        
Ph 
                                  
48 
                               
- 
                        
- 
                    
5 
                                 
23g 
                      
n-Pr 
                           
Ph 
                                    
48 
                                 
- 
                      
- 
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Finally, 4-ethyl-6-hydroxy-3-methylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-one 170d and 3,4-diethyl-
6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170e were hydrolyzed to 2-ethyl-3-methyl-
1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187d and 2,3-diethyl-1,2,5,10-
tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187e in 40 and 98% of crude yield, 
respectively, at 50°C using 4 M NaOH/THF/MeOH (2/1/1) for 1.5 hours and subsequent spontaneous 
air oxygen oxidation (Scheme 3-40). However, hydrolysis of 6-hydroxy-3-methyl-4-n-
propylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170c under the same conditions gave a complex 
mixture of reaction products. All attempts to purify compounds 187d and 187e by chromatography and 
recrystallization techniques failed.  
O
O
OMe
O
R2 OEt
NH OR
1 OH
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EtO O
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H O
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184
19a
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170c (19%)
170d (33%)
170e (47%)
170f  (-)
170g (-)
186187c (-)
187d (40%)
187e (98%)
23c R1 = n-Pr, R2 = Me
23d R1 = Et, R2 = Me
23e R1 = Et, R2 = Et
23f R1 = Et, R2 = Ph
23g R1 = n-Pr, R2 = Ph
- EtOH
- MeOH
4 M NaOH/THF/ MeOH
 (2/1/1) O2 (air)
+
1.5 h, 50°C
1.05 equiv.
PhMe/ AcOH
(5:1)
∆, 4-48 h
23
Scheme 3-40. Syntesis of 1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187 
 
Therefore, the crude extracts of the hydrolysis reactions containing 2-ethyl-3-methyl-1,2,5,10-tetrahydro-
-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187d and 2,3-diethyl-1,2,5,10-tetrahydro-1,5,10-
trioxobenzo[g]isoquinoline-4-carboxylic acid 187e, respectively, have been converted to the 
corresponding methyl esters by treatment with a solution of diazomethane in anhydrous diethyl ether at 
room temperature. In the first case, methyl 2-ethyl-3-methyl-1,2,5,10-tetrahydro-1,5,10-
trioxobenzo[g]isoquinoline-4-carboxylate 171d was isolated together with methyl 2-ethyl-1,2-dihydro-
5,10-dihydroxy-3-methyl-1-oxobenzo[g]isoquinoline-4-carboxylate 188d in 14% and 22% yield, 
respectively. Different attempts to purify compound 188d by preparative TLC and recrystallization failed. 
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In order to get full conversion of the intermediate hydroquinone 188d to benzo[g]isoquinoline-
1,5,10(2H)-trione 171d, the workup extract of the diazomethane reaction was stirred with magnesium(II) 
sulfate or silica gel for 24 hours in the presence of air oxygen. Unfortunately, this operation failed to fully 
convert the reaction substrate to the targeted benzo[g]isoquinoline-1,5,10(2H)-trione 171d. Secondly, 
methyl 2,3-diethyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 171e was 
isolated as the sole product in an excellent yield of 97% directly after the treatment of compound 185e 
with diazomethane in the presence of air. An attempt to obtain methyl 2,3-diethyl-1,2-dihydro-5,10-
dihydroxy-1-oxobenzo[g]isoquinoline-4-carboxylate 188e by running the reaction with diazomethane 
under nitrogen atmosphere and quickly performing the workup of the reaction gave methyl 2,3-diethyl-
1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 171e in 28% yield and a complex 
fraction, which revealed the presence of very minute quantity of methyl 2,3-diethyl-1,2-dihydro-5,10-
dihydroxy-1-oxobenzo[g]isoquinoline-4-carboxylate 188e upon LC-MS analysis. 
 
N
O
COOH
R1
R2
O
O
N
O
COOMe
R1
R2
O
O
THF/CH3CN (1/4),
 rt, overnight
187d  
187e
171d (14%)
171e (97%)
5 equiv. CH2N2/Et2O
N R
1
R2
O
COOHOH
OH
N
OH
OH
O
COOMe
R2
R15 equiv. CH2N2/Et2O
THF/CH3CN (1/4),
 rt, overnight
186d R1 = Et, R2 = Me 
186e R1= Et, R2 = Et
188d (22%)
188e (-) + 171 (28%)
X
O2 (air)
MgSO4
or
SiO2
24 h, rt
 
Scheme 3-41. Synthesis of methyl 1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinolines 171 
 
The remarkable differences observed in chemical behavior of compound 188d compared to compound 
188e on the one hand and of benzo[g]isoquinoline-1,5,10(2H)-trione 187d compared to 187e on the 
other hand, were clues for the development of a short alternative procedure such as the direct reaction 
of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 with enaminoesters 23 under oxidative 
conditions. 
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3.2.3.3. Route C 
First, the reaction of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 with enaminoester 23e was 
screened in order to optimize the oxidative addition reaction of these reaction substrates. An excess of 
oxidant was needed to assure the oxidation of hydroquinone 128 before and of the adduct after the 
addition of enaminoester 23e. Therefore, methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 and 
enaminoester 23e were reacted using manganese(IV) oxide as the oxidant of choice. At the end, methyl 
2,3-diethyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 171e was obtained in 
69% yield over two steps using 6 equivalents of manganese(IV) dioxide and 10 equivalents of 
magnesium(II) sulfate in anhydrous dichloromethane for 3.5 hours at room temperature to afford a 
mixture of the targeted benzo[g]isoquinoline-1,5,10(2H)-trione 171e and its precursor 166e, which was 
converted subsequently in the target compound 171e by boiling in a mixture of toluene and acetic acid 
(5/1) (Table 13, entry 1). In the absence of acetic acid in the second step, the yield of the reaction was 
lowered (Table 14, entry 2).  
The attempts to prepare methyl 2,3-diethyl-1,2,5,6-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-
carboxylate 171e in a single step resulted in lower yields (Table 13, entries 3 and 4). It was noticed that 
the presence of acetic acid was detrimental to this direct one step procedure. 
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Table 13: Test reactions towards the synthesis of 2,3-diethylbenzo[g]isoquinoline-1,5,10(2H)-trione 
171e 
O
OMe
OH
OH
NHEt O
OMe
23e
6 equiv. MnO2
10 equiv. MgSO4
CH2Cl2, rt, 3.5 h
N
O
O
O
COOMe
Et
+
O
O
128 171e 166e
∆
N
O
O
O
COOMe
171e (69%)
NHEt
MeOOC
COOMe
 
      
Entry 
                                                 
Scale 
(mmol) 
                                                                                         
Reaction conditions 
                       
Yield 171e (%) 
        
1 
                                                   
1.15 
                                                                                                        
(1) CH2Cl2, rt, 3.5 h, (2) ∆, PhMe/AcOH (5/1), 1 h 
                                     
69 
        
2 
                                                   
2.30 
                                                                                                      
(1) CH2Cl2, rt, 3.5 h (2) ∆, PhMe, 1 h 
                         
59 
         
3 
                                                 
2.30 
                                                                                                 
∆, PhMe for 1.5 h 
                                   
44 
        
4 
                                                   
2.30 
                                                                                              
∆, PhMe/AcOH (5/1), 1.5 h 
                                      
12 
 
Referring to the overall yield of each route, the two-steps procedure (Route C) appeared to be the best 
entry towards benzo[g]isoquinoline-1,5,10(2H)-triones 171 compared to the direct one-step oxidative 
addition (Table 13, entries 3 and 4) and the multistep procedures previously elaborated and described in 
this manuscript (3.2.3.1 and 3.2.3.2). Having in hand this two-steps procedure, other derivatives 
(171c,e-j) were prepared accordingly in 29-71% yields (Table 14).  
 
 
 
73 Chapter 3: Results and discussion 
Table 14: Synthesis of alkyl 2,3-disubstituted 1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-
carboxylates 171 by a two steps procedure involving oxidative addition of enaminoesters 23 to methyl 
1,4-dihydroxynaphthalene-2-carboxylate 128 
O
OMe
OH
OH
R2
NHR
1
O
OR3
23
6 equiv. MnO2 , 10 equiv. MgSO4
CH2Cl2, rt, 3.5 h
(2) PhMe/AcOH (5/1), ∆, 1.5 h
128
N
O
O
O
COOR3
R1
R2
171
1.05 equiv.
(1)
 
          
Entry 
           
Enaminoester 
                 
R1 
                          
R2 
                             
R3 
                   
Isolated product 
              
Yield (%) 
                   
1 
                                
23c 
                           
n-Pr 
                        
Me 
                             
Me 
                               
171c 
                        
46 
               
2 
                                
23d 
                           
Et 
                      
Me 
                           
Et 
                                 
171d 
                         
-* 
             
3 
                                  
23e 
                         
Et 
                       
Et 
                           
Me 
                                
171e 
                      
69 
                       
4 
                                 
23g 
                           
Et 
                      
Ph 
                              
Et 
                               
171g 
                         
32 
             
5 
                                 
23h 
                          
n-Pr 
                       
Ph 
                          
Et 
                                 
171h 
                     
56 
             
6 
                                 
23i 
                           
n-Pr 
                       
Me 
                              
Et 
                                  
171i 
                   
29 
             
7 
                                     
14j 
                    
n-Pr 
                             
Et 
                              
Me 
                                   
171j 
                      
71 
     *Complex mixture 
3.3. Efforts towards the first total synthesis of paepalantine 24 
Paepalantine 24 is the first isocoumarin isolated from Paepalanthus bromelioides (Eriocaulaceae).19 
This natural isocoumarin has a broad spectrum of biological activities including the respiratory burst,20 
antimicrobial,21 mutagenic and cytotoxic activities.22 Despite of its biological activity, paepalantine 24 
has not been synthesized to date. In continuation of our efforts towards the synthesis of natural products 
and their derivatives for biological screening, the first synthesis of paepalantine 24 was planned. The 
phthalide annulation reaction (Michael addition-Dieckmann type reaction) starting from 3-cyanophthalide 
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25 and pyran-2-one 26 was thought to construct the heterocyclic skeleton of 5,10-dihydroxy-7,9-
dimethoxy-(1H)-benzo[g]isochromen-1-one 27, the key intermediate towards paepalantine 24 (Scheme 
3-42). 
  
O
Me
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OMe
OH
MeO
O
24 paepalantine
O
OMe
MeO Me
OOMe
OMe
O
OMe
MeO Me
OOH
OH
29 27
O
MeO
OMe O
CN
+
O
O
OMe
Me
25 26
Scheme 3-42. Retrosynthetic analysis of paepalantine 24 
From the mechanistic point of view (Scheme 3-43), the convergent synthesis of paepalantine 24, 
involves deprotonation of 3-cyanophthalide 25 with lithium tert-butoxide to generate the anion 189, 
which will undergo Michael addition to the pyranone 25 to form the adduct 190. The latter will undergo 
intramolecular Dieckmann cyclization onto the lactone carbonyl group of the 3-cyanophthalide moiety, 
after which cyanide is eliminated. Consecutive base promoted tautomerization of 191 will finally give the 
key intermediate hydroquinone 27. Total methylation of the latter compound using dimethyl sulfate and 
selective demethylation using boron(III) bromide should give the paepalantine 24. 
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Scheme 3-43. Reaction mechanism for the formation of paepalantine 24 
Thus, the synthesis of paepalantine 24 implies coupling of the 3-cyanophthalide 25 and the pyran-2-one 
26. The synthesis of 3-cyanophthalide 25 (Scheme 3-44) started by conversion of the commercially 
available 2,4-dimethoxybenzoic acid 193 to the corresponding N,N-diethyl-2,4-dimethoxybenzamide 195 
in 80% yield using 3 equivalents of thionyl chloride in boiling toluene for 2 hours and treating the 
resulting intermediate acid chloride with 3 equivalents of diethylamine 194 at 0°C for 2 hours.126 
Treating N,N-diethyl-2,4-dimethoxybenzamide 195 with 1.1 equivalents of tert-butyllithium for 20 
minutes at – 78°C, after which the reaction was quenched with 4.0 equivalents of DMF in THF afforded 
N,N-diethyl-2-formyl-4,6-dimethylbenzamide 196 in 90% yield. Subsequent hydrolysis of N,N-diethyl 2-
formyl-4,6-dimethylbenzamide 196 with acetic acid and 10% HCl under reflux for 24 hours caused 
intramolecular cyclization to give 3-hydroxy-5,7-dimethoxyphthalide 197. Finally, the desired to 3-cyano-
5,7-dimethoxyphthalide 25 was obtained in 78% yield by reaction with hydrogen cyanide, wich was 
generated in situ using potassium cyanide and concentrated hydrochloric acid. 
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AcOH, ∆, 24 h
excess KCN, 
excess HCl conc.
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1) 3 equiv. SOCl2 
   PhMe, ∆, 2.5 h
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Scheme 3-44. Synthesis of 3-cyanophthalide 25126 
The synthesis of the second substrate (Scheme 3-45) for the envisaged annulation reaction 
commenced with a Grignard reaction reaction of methylmagnesium chloride across furfural 198 
(Scheme 3-45). In this way, 1-(2-furyl)ethanol 199 was obtained in 98% yield and subsequently an 
Achmatowicz rearrangement was envisaged to afford pyran-3-one 200. A set of reaction conditions was 
screened in order to optimize the Achmatowicz rearrangement (Table 15). During this screening 
process, it was found that the rearrangement reaction was a highly sensitive reaction, which required 
careful monitoring of the reaction temperature. Although the use of both m-CPBA and Br2 has been 
reported in the literature,127 NBS was found to give the best results in our hands. In the end, pyran-3-
one 200 was obtained in 91% yield by the reaction of 1-(2-furyl)ethanol 199 with NBS in the presence of 
sodium acetate as base in a mixture of THF and water (4/1).  
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Scheme 3-45. Attempt for the synthesis of pyran-2-one 26   
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Table 15: Applied reaction conditions for the Achmatowicz rearrangement reaction of 1-(2-furyl)ethanol 
199  
 
The literature reported that pyran-2-one 202 could be obtained efficiently from the Achmatowicz reaction 
product 200 through oxidation of this pyran-3-one 200 by a CrO3.NH4Cl complex to the intermediate 201 
and subsequent Luche reduction with NaBH4 in the presence of CeCl3.127a 
 
 
 
 
 
 
 
                       
Entry 
                                       
Oxidant (equiv.) 
                                   
Solvent 
             
Temperature (°C) 
       
Reaction 
time (h) 
                              
Result 
                                 
1 
                                         
m-CPBA (1.5) 
                                
CH2Cl2 
                                          
-4 to 0 
        
1 
                          
Complex mixture 
                                  
2 
                                                  
m-CPBA (1.5) 
                        
CH2Cl2 
                                          
-4 to 0 
           
3 
                          
Complex mixture 
                      
3 
                                             
m-CPBA (1.5)/        
NaOAc (1.5) 
                             
CH2Cl2 
                                            
-4 to 0 
        
1 
                         
Complex mixture 
                    
4 
                                                   
m-CPBA (1.1)/        
NaOAc (1.1) 
                       
CH2Cl2 
                                                
-4 to 0 (addition m-
CPBA) then rt 
      
3 
                         
Complex mixture 
                                 
5 
                                                
Br2 
                            
MeOH 
                                               
- 40 
            
1 
                                 
200 (10%) 
                                                   
6 
                                
NBS (1.1)/                     
NaOAc (1.1) 
                         
THF/H2O (4/1) 
                           
-4 to 0 (addition 
NBS)  then rt 
                       
3 
                                
200 (20%) 
                                  
7 
                                           
NBS (1.1)/                        
NaOAc (1.1) 
                                    
THF/H2O (4/1) 
                                            
-4 to 0 (addition 
NBS)  then rt 
         
1 
                                
200 (57%) 
                                  
8 
                        
NBS (1.1)/            
NaOAc(2.2)/          
NaHCO3 (1.1) 
                                        
THF/H2O (4/1) 
                             
-4 to 0 (addition 
NBS)  then rt 
                         
1 
 
                              
200 (91%) 
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Table 16: Applied reaction conditions in the oxidation-reduction protocol for the synthesis of pyran-2-
one 200 
O
OH
Me
O
Oxidation O
O
OH
Me
Reduction
200
O
O
O
Me
202201
 
                       
Entry 
                                                        
Oxidation 
                                                                  
Reduction 
                                         
Result 
                           
1 
                                                               
4.0 equiv.CrO 3.NH4Cl           
CH2Cl2, rt, 1.5 h 
                                                                                
1.5 equiv. NaBH4                               
CH2Cl2/MeOH (1/1), 0°C, 1.5 h 
                                      
Complex reaction 
mixture 
                          
2 
                                                                
3.0 equiv.CrO 3.NH4Cl           
CH2Cl2, rt, 1.5 h 
                                                                        
1.5 equiv. NaBH4                     
CH2Cl2/MeOH (1/1), 0°C, 1.5 h 
                                          
Complex reaction 
mixture 
                          
3 
                                                              
3.0 equiv.CrO 3.NH4Cl           
CH2Cl2, rt, 0.5 h 
                                                                                  
1.5 equiv. NaBH4, 2.0 equiv CeCl3           
CH2Cl2/MeOH (1/1), 0°C, 1.5 h 
                                       
Complex reaction 
mixture 
                            
4 
                                                                
3.0 equiv.CrO 3.NH4Cl                     
CH2Cl2, rt, 0.5 h 
                                                                            
1.5 equiv. NaBH4 ,1.0 equiv. CeCl3      
CH2Cl2/MeOH (1/1), 0°C, 1.5 h 
                                        
Complex reaction 
mixture 
 
However, despite numerous attempts this procedure only gave complex mixtures in our hands. Although 
the oxidation reaction could be performed successfully, the resulting compound 201 was found to be 
highly sensitive towards overoxidation and was found to decompose rapidly at room temperature. As a 
result, this compound could not be purified and had to be used as such in the next step. However, 
standard reaction conditions for the Luche reduction failed to give good results (Table 16), which is 
probably due to the instability of the intermediate 201. Despite contacting the corresponding author of 
the literature report127a on several occasions, we have never received any reply to our request for 
information regarding this reaction. Therefore, alternative reaction pathways to the pyran-2-one 202 will 
have to be investigated in order to obtain a proper substrate for the phthalide annulation reaction after 
which a first total synthesis of paepalantine can be attempted.  
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3.4. Conclusion  
The present PhD dissertation is an account of a contribution on a series of syntheses of naturally 
occurring quinones and their analogues, performed at the Laboratory of Sustainable Organic Chemistry 
and Technology (Faculty of Bioscience Engeneering, Ghent University). It particularly covers the 
continuing efforts towards the synthesis of 2-azaanthraquinone and naphthyridinone alkaloids. In this 
respect, the results of three synthetic projects are disclosed.  
The first project envisaged the synthesis of 2-azasampangine 12b from 2-azacleistopholine 10b 
analogous to the literature based synthesis of sampangine 12a from cleistopholine 10a (Scheme 3-1). 
The preparation of 2-azacleistopholine 10b was accomplished under ligand-free Heck and Pomeranz-
Fritsch reaction conditions in 30% and 50% yield, respectively. These low and moderate yields urge a 
continuing need of an optimized process. Although the obtained 2-azacleistopholine 10b was smoothly 
converted to 4-[2-(dimethyl)aminovinyl]benzo[g]isoquinoline 11b in 86%, the conversion of the latter to 
2-azasampangine 12b failed (Scheme 3-12). Therefore, milder conditions than the one described in 
literature are needed in order to accomplish this conversion.  
YX
MeO
O
YX
N
O
N
O
O
NMe Me10a X = N, Y = CH
10b  X = CH, Y = N 11b
12a X = N, Y = CH
12b X = CH, Y =  N
 
The second project concerned the syntheses of 2-azaanthraquinones 16, 17 and 18 substituted at the 
C-1 peri-carbonyl position and linked to phenyl groups through a biaryl axis (Figure 1-4). Thanks to the 
efficiency of pyridium ylid chemisty and reaction conditions previously established in our research group, 
the syntheses of 2-azaanthraquinones 16 and 17 were smoothly accomplished in 44-75% and 47-67%, 
respectively (Tables 3 and 6). 
N
OHO
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N
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N
OHO
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16 17 18 X = COOMe
X RRR
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In addition, the presence of a methyl group at C-1 in 2-azaanthraquinones 17 allowed their 
condensation with DMF-DMA to the corresponding 1-[2-(dimethyl)aminovinyl]benzo[g]isoquinolines 21 
in 23-77% yield (Scheme 7). Boiling 1-[2-(dimethyl)aminovinyl]-3-phenylbenzo[g]isoquinoline 21a in a 
5% solution of ammonium acetate in methanol afforded the corresponding 5-phenyl-7H-
naphtho[3,2,1]naphthyridin-7-one 22 in 89% yield (Table 8, entry 5). The reaction conditions used in this 
conversion established new and milder reaction conditions to obtain naphthyridone derivatives from the 
corresponding methylarenes via 2-(dimethyl)aminovinyl intermediates. 
N
O
O
N
N
O
21
R
NMe Me
22
N
O
O COOR3
R1
R2
O
171
 
The difficult access to 2-azaanthraquinones 18 through the direct utilization of the Nenitzescu reaction 
led to an investigation towards the synthesis of benzo[g]isoquinoline-1,5,10(2H)-triones 171 (Figure 3-
2). Therefore, three synthetic routes were explored. The first route consisted of the reaction of β-
ketoesters to 2-methoxycarbonyl-1,4-naphthoquinone 19a in a toluene-acetic acid (5/1) under reflux, 
which gave methyl 3-acyl-2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylates 177. 
Subsequent reaction of the latter compounds with primary amines afforded methyl 2,3-dihydro-5-
hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 instead of 3,4-diakyl-6-hydroxybenzo[g]furo[4,3,2-
de]isoquinoline-2,5(4H)-diones 170 which could lead to the targeted benzo[g]isoquinoline-1,5,10(2H)-
triones 171. The second route implied the reaction of 2-methoxycarbonyl-1,4-naphthoquinone 19a with 
N-subtituted enaminoesters 23, which gave 3,4-diakyl-6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-
2,5(4H)-diones 170 in 19-47% yield. Subsequent hydrolysis of the latter compounds followed by 
methylation using diazomethane afforded the target compounds 171 in 14-97% yield. 
N
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O177 180  
 The third route consisted of the oxidative addition of enaminoesters 23 to methyl 1,4-
dihydroxynaphthalene-2-carboxylate 128 in the presence of an excess of manganese(IV) oxide in 
 
82 Chapter 3: Results and discussion 
dichloromethane at room temperature, which was followed by boiling in a mixture of toluene and acetic 
acid (5/1). This third route gave the targeted 2,3-disubstituted 1,2,5,10-tetrahydro-1,5,10-
trioxobenzo[g]isoquinoline-4-carboxylates 171 in 29-71% yield (Table 14). 
The third project aimed at the first total synthesis of paepalantine 24 (Figure 1-5) by the phthalide 
annulation reaction of 3-cyanophthalide 25 and pyran-2-one 26 (Scheme 1-5).  Since the preparation of 
pyran-2-one 26 was not accomplished due to the unstability of its precursor, the synthesis of 
paepalantine 24 remains a challenge.    
O
Me
OH
OMe
OH
MeO
O
24 paepalantine
O
OMe
MeO
CN
O
O
O
OMe
Me
25 26
 
3.5. Perspectives 
Through the course of this research work, a number of interesting areas of azaanthraquinone chemistry 
have been explored and some reaction pathways still need to be completed.  
2-Azasampangine 10b and 5-aryl-7H-naphtho[3,2,1-de]naphthyridin-7-ones 22 are potentially bioactive 
compounds. In the present research work, mild and efficient conditions to obtain 5-aryl-7H-
naphtho[3,2,1-de]naphthyridin-7-one 22a from heating 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]-
isoquinoline-5,10-dione 21a in a 5% (w/v) solution of ammonium acetate in methanol were established 
(Scheme 3-36). 
N
O
O
21a
N
O
N5%(w/v) NH4OAc,
 MeOH
∆, 4 h
22a (89%)
NMe Me
 
Scheme 3-46. Synthesis of naphthyridone 22a 
 
Therefore, the synthesis of other 5-aryl-7H-naphtho[3,2,1-de]naphthyridine-7-one derivatives 22b-e will 
be executed in the future using the same procedure. This procedure will also be used to accomplish the 
synthesis of 2-azasampangine 12b from 4-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione 11b 
(Scheme 3-47). 
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Scheme 3-47. Pathways to the synthesis of naphthyridones 22b-e and 2-azasampangine 12b  
Paepalantine 24 (Figure 3-5) is a naturally occurring isocoumarine with a large spectrum of biological 
activity. Due to the importance of the phthalide annulation reaction strategy in the synthesis of 
pyranonaphthoquinone derivatives and the availability of several procedures to construct pyran-2-one 
26 (Figure 3-5), the total synthesis of paepalantine 24 with the phthalide annulation reaction in the key 
step still remains a challenge.  
O
OHOH
MeO
OMe
Me
O
24
O
O
OMe
Me
26  
Figure 3-5. Structures of paepalantine 24 and pyran-2-one 26  
 
Therefore, alternative routes to the synthesis of pyran-3-one 26 as the key step have to be considered 
(Scheme 3-48). Notably, the use of a rhamnose derivative 203 as a starting material (Route A), ring-
closing metathesis in the key step (Route B) or ethyl sorbate 209 as starting material (Route C) are 
potential routes. Considering the availability of the starting materials, route C appears to be the most 
straightforward choice.  
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Scheme 3-48. Alternative routes to the synthesis of pyran-3-one 26 
 
Tuberculosis is an infectious and deadly disease caused by Mycobacterium tuberculosis. A serious 
illness causing about 2-3 million deaths each year worldwide with an important incidence in Sub-
Saharan regions.133a Although more than a dozen of antimycobacterial drugs (first and second-line 
drugs) are currently available for the therapy, there is still need for new, affordable and effective 
antibiotics that may shorten TB therapy duration and eliminate drug-resistant strains. Quinones, and in 
particularly, cleistopholine 10a and sampangine 12a, the two lead-molecules of the present research 
work, are recognized to be active against Mycobacterium species. Cleistopholine 10a displays a strong 
antimycobacterial activity (MIC 12.5 µg/ml).65 An even stronger MIC-value (MIC 1.56 µg/ml) is found for 
the synthetic 4-[2-(dimethylaminovinyl)]cleistopholine 11a and benzo[2,3]cleistopholine 211. 
Sampangine 12a has been reported with a MIC value of 0.78 µg/ml, ressembling rifampicin 213 (MIC 
0.78 µg/ml),101 a current first-line drug for the treatment of tuberculosis. Synthetic derivatives such as 
benzo[4,5]sampangin 212a (MIC 0.39 µg/ml) and ascididemin 212b (MIC 0.25 µg/ml) are even more 
promising.  
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Figure 3-6. Examples of active coumpounds against Mycobacterium species 
 
Since 2-azaanthraquinones display improved biological activity in comparison with their 1-
azaanthraquinone analogues, 2-azacleistopholine 10b, 2-aza-4-dimethylvinylcleistopholine 11b, 3-aryl-
1-methylbenzo[g]isoquinoline-5,10-diones 17a-e, 3-aryl-1-dimethylaminovinylbenzo[g]isoquinoline-5,10-
diones 21a-e, 5-phenyl-7H-naphtho[3,2,1-de]naphthyridine-7-one 22 and 2,3-disubstituted alkyl 
1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylates 171, which have been synthesized 
in the course of this PhD research are expected to be bioactive compounds. Since quinones are 
increasingly recognized as active agents against Mycobacterium species,15e,101,133 they will be tested in 
the future against M. tuberculosis, which causes the infectious and deadly disease tuberculosis.  
 
Since the classical plating techniques are plagued by the slow growth of M. tuberculosis and intensive 
work in enumeration of colony forming units (CFU), these compounds (Figure 3-7) will be tested by the 
luciferase screening assay. This method developed in collaboration with the Department of 
Mycobacterial Immunology (Scientific Institute of Public health, Brussels) uses a lumiscent strain of M. 
tuberculosis H37Rv.134  
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Figure 3-7. Compounds to be tested against Mycobacterium species 
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Chapter 4: Experimental section 
4.1. Instrumental material 
4.1.1. Column chromatography 
Column chromatography was carried out using a glass column with silica gel (Aldrich, particle size 
0.035-0.070 mm, pore diameter ca. 6 nm). Solvent systems were determined via initial TLC analysis on 
silica gel (Merck, Kieselgel 60F254, precoated 0.25 mm). Compounds were revealed by UV light (λ = 
254 and 366 nm) or KMnO4 oxidation. 
4.1.2. NMR spectroscopy 
1H NMR (300 MHz) and 13C NMR (75 MHz) spectra were recorded with a Jeol JNM-EX 300 NMR 
spectrometer. Peak assignments were performed with the aid of the DEPT, 2D COSY, HSQC, HMBC 
techniques. The NMR samples were prepared with commercially available deuterated solvents with 
tetramethylsilane as an internal standard. 
4.1.3. Mass spectroscopy 
Low resolution mass spectra were recorded using an Agilent 1100 series VS (ESI, 4000 V) mass 
spectrometer [ESI: Electron Spray Ionisation positive (M+H+) and negative (M-H+) modes] via a direct 
inlet or via LC-MS coupling [Phenomenen huna column; 250×3 mm length, 5 µm particle size, 100 A 
pore size with 5 mM NH4OAc in H2O (LC-MS grade) and Acetonitrile (LC-MS grade) as eluents]. High 
resolution mass spectra were recorded on a Finnigan MAT 95 XPAPI-GC-Trap tandem mass 
spectrometer or a tandem spectrometer Agilent 6220 TOF-LC/MS 
4.1.4. Infrared spectroscopy 
Infrared (IR) spectra were recorded with a Perkin Elmer BX FT-IR spectrometer using the attenuated 
total reflection technology (ATR). 
4.1.5. Elementary analysis 
Elemental analyses were executed with a Perkin Elmer Series II CHNS/O Analyzer 2400. 
4.1.6. Melting point 
Melting points were recorded on a Buchi Melting point B-540 apparatus and are not corrected. 
4.1.7. Microwave reactions 
Microwave reactions were performed in a CEM Discover® microwave 
 
88 Chapter 4: Experimental section 
4.2. Effort towards a short and efficient synthesis of 2-azacleistopholine 10b and 2-
azasampangine 12b 
4.2.1. Synthesis of 2-bromo-3-bromomethyl-1,4-dimethoxynaphthalene 9491 
A mixture of 1,4-dimethoxy-2-methylnaphthalene 9891 (0.02 mol, 4.04 g) and N-bromosuccinimide 
(0.021 mol, 3.74 g) in tetrachloromethane (100 ml) was stirred at room temperature for 2 hours. A 
second portion of N-bromosuccinimide (0.021 mol, 3.74 g) was added to the stirred suspension together 
with dibenzoyl peroxide (2 mmol, 0.48 g) and the mixture was heated under reflux for 2 hours, then 
cooled to 0°C, filtered and washed with ice cold CCl4 and evaporated in vacuo to give 94 (5.62 g, 78 %) 
after crystallization from diethyl ether/hexane (9/1). All the spectral data were in accordance with data in 
the literature.91 
1H NMR (CDCl3): δ 3.99 (3H, s, CH3O), 4.08 (3H, s, CH3O), 4.93 (2H, s, ArCH2Br),  
7.55-7.59 (2H, m, H-6 and H-7), 8.06-8.12 (2H, m, H-5 and H-8). 
 
 
4.2.2. Synthesis of 2-[(allylamino)methyl]-3-bromo-1,4-dimethoxynaphthalene 1009  
To a stirred solution of allylamine (0.175 mol, 10 g) in ethanol (20 ml) was added dropwise a solution of 
2-bromo-3-bromomethyl-1,4-dimethoxynaphthalene 94 (0.0175 mol, 6.3 g) in ethanol (100 ml) and the 
reaction mixture was stirred in a flask fitted with a CaCl2 tube at room temperature for 2 days. Most of 
the solvent was evaporated in vacuo and the residue was dissolved in dichloromethane (100 ml), 
washed twice with water and dried (MgSO4). Flash chromatography on silica gel using 2% methanol in 
chloroform as eluent gave 2-[(allylamino)methyl]-3-bromo-1,4-dimethoxynaphthalene 100 (4.12 g, 91% 
yield) as a brown oil, which was found to decompose rapidly. Therefore, this compound was used as 
such in the next step. 
1H NMR (CDCl3): δ 3.30-3.33 (2H, m, NCH2CH=CH2), 3.97 (3H, s, OCH3), 
3.98 (3H, s, OCH3), 4.12 (2H, s, ArCH2), 5.08-5.30 (2H, m, CH=CH2), 5.88-
6.01 (1H, m, CH=CH2), 7.51-7.58 (2H, m, H-6 and H-7), 8.06-8.11 (2H, m, H-
5 and H-8). 
 
4.2.3. Synthesis of N-methanesulfonyl-2-[(allylamino)methyl]-3-bromo-1,4-dimethoxynaphthalene 
939 
A solution of methanesulfonyl chloride (0.012 mol, 1.37 g) in dichloromethane (10 ml) was added 
dropwise to a stirred solution of 2-[(allylamino)methyl]-3-bromo-1,4-dimethoxynaphthalene 100 (0.012 
mol, 4.12 g) and triethylamine (0.012 mol, 1.21 g) in dichloromethane (50 ml) under a nitrogen 
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OMe
Br
N
H
OMe
OMe
Br
Br
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atmosphere. After 2 h, the solution was washed with 2 M aqueous HCl and then with a saturated 
aqueous solution of sodium bicarbonate. The organic phase was dried (MgSO4) and evaporated in 
vacuo. Flash chromatography on silica gel with ethyl acetate/hexane (1/4) as eluent gave N-
methanesulfonyl-2-[(allylamino)methyl]-3-bromo-1,4-dimethoxynaphthalene 93 (2.41 g, 60% yield) as 
white crystals. 
1H NMR (CDCl3): δ 3.01 (3H, s, SO2CH3), 3.78 (2H, dt, J = 1.3, 6.3 Hz, 
NCH2CH=CH2), 3.97 (3H, s, OCH3), 3.98 (3H, s, OCH3), 4.85 (2H, s, ArCH2), 
4.95-5.13 (2H, m, CH=CH2), 5.70 (1H, ddt, J = 6.3, 10.2, 17.2 Hz, CH=CH2), 
7.56-7.62 (2H, m, H-6 and H-7), 8.06-8.15 (2H, m, H-5 and H-8). 
4.2.4. Synthesis of N-methanesulfonyl-2-(allylaminomethyl)-3-bromo-1,4-naphthoquinone 139 
 A solution of cerium(IV) ammonium nitrate (1.63 g, 3 mmol) in water (10 ml) was added dropwise to a 
cooled (0°C) solution of N-methanesulfonyl-2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene 93 
(0.41 g, 1 mmol) in acetonitrile (20 ml) and the reaction mixture was stirred for an additional 30 min at 
the same temperature. After the addition of water, the aqueous solution was extracted with small 
portions of ethyl acetate. The combined organic extracts were washed with brine, dried (MgSO4) and 
evaporated in vacuo. Recrystallization from ethyl acetate afforded N-methanesulfonyl-2-
[(allylamino)methyl]-3-bromo-1,4-naphthoquinone 13 (0.17 g, 45% yield).  
1H NMR (CDCl3): δ 3.02 (3H, s, SO2CH3), 3.96 (2H, br d, J = 6.3 Hz, 
NCH2CH=CH2, 4.58 (2H, s, ArCH2), 5.17-5.31 (2H, m, CH=CH2), 5.88 (1H, 
ddt, J = 6.3, 10.2, 17.2 Hz, CH=CH2), 7.74-7.84 (2H, m, H-7 and H-8), 8.11-
8.19 (2H, m, H-6 and H-9). 
4.2.5. Synthesis of N-acetonylphthalimide 107, 2-(phthalimidomethyl)-2-methyl-1,3-dioxolane 109 
and 2-aminomethyl-2-methyl-1,3-dioxolane 15a 
N-Acetonylphthalimide 107, 2-(phthalimidomethyl)-2-methyl-1,3-dioxolane 109 and 2-aminomethyl-2-
methyl-1,3-dioxolane 15a were synthesized according to a literature procedure.95 
4.2.5.1. N-Acetonylphthalimide 107 
Potassium phthalimide 105 (21.6 g, 0.17 mol) and toluene (29 ml) were stirred in a flask fitted with reflux 
condenser under nitrogen atmosphere. Then, α-chloroacetone (13.3 g, 0.15 mol) was added and the 
mixture was boiled for 2 hours. After cooling to room temperature, toluene was distilled off in vacuo. The 
solid residue was dissolved by the addition of water (30 ml) and dichloromethane (30 ml). After strong 
agitation, the mixture was transferred to a separating funnel, after which the organic phase was 
separated. The remaining aqueous phase was extracted twice with dichloromethane (2×30 ml). The 
dichloromethane extracts were combined, washed twice with brine and dried over magnesium sulfate. 
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After filtration, the filtrate was concentrated in vacuum to afford 17.6 g (74%) of N-acetonylphthalimide 
107, which was used as such in the following step. All the spectral data were in accordance with the 
literature.95 
1H NMR (CDCl3): δ 2.30 (3H, s, H-3'), 4.51 (2H, s, H-1'), 7.70-7.83 (2H, m, H-4 
and H-5), 7.85-7.90 (2H, m, H-3 and H-6). 
 
4.2.5.2. 2-(Phthalimidomethyl)-2-methyl-1,3-dioxolane 109 
Phthalimidoacetone 107 (17.6 g, 86.7 mmol) was dissolved in toluene (93 ml) and ethylene glycol (10,8 
g, 173,4 mmol), followed by the addition of methanesulfonic acid (0.44 g, 4.36 mmol). The mixture was 
refluxed using a Dean-Stark trap. After 16 hours, the reaction mixture was cooled to room temperature. 
The reaction was washed with water (2×10 ml) and then with a saturated aqueous NaHCO3 solution 
(2×10 ml). The organic phase was dried with magnesium sulfate, filtered then concentrated in vacuo. 
The solid residue was recrystallized from methanol to afford 2-(phthalimidomethyl)-2-methyl-1,3-
dioxolane 109 (12.01 g, 56% yield). All the spectral data were in accordance with the literature.95 
1H NMR (CDCl3): δ 1.46 (3H, s, H-3'), 3.82 (2H, s, H-1'), 3.90-4.04 (2H, m, OCH2-
CH2O), 4.07-4.14 (2H, m, OCH2-CH2O), 7.70-7.83 (2H, m, H-4 and H-5), 7.85-
7.90 (2H, m, H-3 and H-6). 
 
4.2.5.3. 2-Aminomethyl-2-methyl-1,3-dioxolane 15a  
Hydroxylamine hydrochloride (8.12 g, 0.12 mol) was dissolved in ethanol (185 ml) in a flask fitted with a 
reflux condenser, and a CaCl2 tube. Then, the mixture was boiled under reflux to dissolve the 
hydroxylamine hydrochloride and then cooled to room temperature. Sodium methoxide (5.40 g of Na in 
54 ml of methanol, 0.24 mol) was added cautiously, and the contents were stirred while the flask was 
cooled in an ice bath. 2-(Phthalimidomethyl)-2-methyl-1,3-dioxolane 109 (8.4 g, 0.04 mol) was dissolved 
in ethanol (75 ml) and the solution was added to the flask. The reaction mixture was stirred at 0°C for 2 
hours and kept overnight under nitrogen atmosphere in the freezer at about – 18 °C. The final solution 
was filtered through Celite, which was washed with diethyl ether (5×50 ml). The combined filtrates were 
reduced in vacuo to about 25 ml on a rotavapor at low temperature (< 40°C). The residual viscous oil 
was suspended in ether (80 ml) and filtered through Celite a second time. Then, the filtrate was passed 
through to a short Florisil column which was washed with ether. The filtrate from the Florisil column was 
concentrated in vacuo to remove the diethyl ether. The oily residue was distilled using a short vigreux 
column (10 cm long) and high vacuum (about 0.25 atm). The fraction boiling at 59-61°C afforded a 
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solution of 2-aminomethyl-2-methyl-1,3-dioxolane 15a. All the spectral data were in accordance with the 
literature.95 
1H NMR (CDCl3): δ 1.30 (3H, s, CH3), 2.77 (2H, s, NCH2), 3.90-4.15 (4H, br s, 
OCH2CH2O). 
4.2.6. Synthesis of 2-formyl-1,4-dimethoxynaphthalene 1496 
Under a nitrogen atmosphere, phosphorus oxychloride (POCl3) (4.86 ml, 8.1 g, 53.1 mmol, 10 equiv.) 
was added dropwise to N,N-dimethylformamide (4.1 ml, 53.1 mmol, 10 equiv.) at 0°C in a flame-dried 
flask. The Vilsmeier-Haack reagent was allowed to form during 30 minutes at 0°C. In the meantime, a 
solution of 1,4-dimethoxynaphthalene 110 (1g, 5.31 mmol) in CHCl3 (17 ml) was prepared in a flame-
dried flask and under a nitrogen atmosphere, after which it was added to the reaction mixture. After 
stirring for 10 minutes at room temperature, the reaction mixture was heated under reflux for 80 hours. 
The reaction mixture was allowed to cool down to room temperature and was placed in an ice bath, after 
which little pieces of ice were added slowly to the flask. When the reaction mixture was cooled down, it 
was extracted with chloroform (3×30 ml). The combined organic extracts were washed thoroughly with 
brine (3×30 ml) and dried over MgSO4. The solvent was evaporated in vacuo. Flash chromatography 
(petroleum ether/ethyl acetate = 85/15) gave 2-formyl-1,4-dimethoxynaphthalene 14 (0.86 g, 75% yield) 
as yellow needles. Spectral data were in accordance with the literature.96 
1H NMR (CDCl3): δ 3.96 (3H, s, CH3O), 4.09 (3H, s, CH3O), 7.13 (1H, s, H-3), 7.64-
7.65 (2H, m, H-6 and H-7), 8.02 (1H, J = 2.2 Hz, H-5 or H-8), 8.30 (1H, J = 2.2 Hz, 
H-5 or H-8), 10.58 (1H, s, CHO). 
 
4.2.7. Synthesis of 2-[N-(1,4-dimethoxy-2-naphthyl)-aminomethyl]-2-methyl-1,3-dioxolane 111 
1,4-Dimethoxy-2-formylnaphthalene 14 (1.0 g, 4.62 mmol), 2-aminomethyl-2-methyl-1,3-dioxolane 15a 
(0.57 g, 4.62 mmol), and magnesium(II) sulfate (1.12 g, 9.24 mmol) were dissolved in dichloromethane 
in a flask fitted with a calcium chloride tube and the mixture was stirred for 2 hours at room temperature. 
After filtration and evaporation of the solvent in vacuo, the crude imine was used as such in the next 
step. In this way, the imine intermediate was dissolved in methanol (10 ml), after which sodium 
borohydride (0.35 g, 9.24 mmol) was added portion-wise at 0°C. Then, the reaction mixture was stirred 
for 16 h at room temperature in a flask fitted with a calcium chloride tube. The reaction was quenched 
by the careful addition of water (5 ml) and the aqueous solution was extracted with dichloromethane 
(3×10 ml). The combined organic extracts were washed with brine, dried (MgSO4), and evaporated in 
vacuo to afford 2-[N-(1,4-dimethoxy-2-naphthyl)aminomethyl]-2-methyl-1,3-dioxalane 111 (1.45 g, 100% 
crude yield) as a viscous oil. 
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Viscous oil. 1H NMR (CDCl3): δ 1.40 (3H, s, H-3'), 2.76 (2H, s, ArCH2N), 
3.89 (3H, s, CH3O), 3.96 (4H, m, OCH2CH2O), 3.99 (3H, s, CH3O), 4.04 
(2H, s, H-2'), 6.86 (1H, s, H-3), 7.46 (1H, dd, J = 10.0, 9.0 Hz, H-5 or H-6), 
7.55 (1H, dd, J = 10.0, 9.0 Hz, H-5 or H-6), 8.04 (1H, d, J = 10.0 Hz, H-5 or 
H-6), 8.23 (1H, d, J = 10.0 Hz, H-5 or H-6). 13C NMR (CDCl3): δ 23.00 (CH3), 48.44 (ArCH2N), 55.54 
(OCH3), 55.7, (OCH3), 62.36 (NCH2), 65.07 (2×CH2O), 103.88 (O-C-O), 104.79 (CH), 109.54 (Cquat), 
121.88 (CH), 122.38 (CH), 125.21 (CH), 126.57 (CH), 128.23 (Cquat), 128.61 (Cquat), 146.45 (Cquat), 
151.26 (Cquat). IR (ATR): νmax 3332, 3069, 2936, 1595, 1459, 1368, 1266, 1213, 1162, 1121, 1091, 
1055, 768 cm-1. MS m/z (%): 318 ([M+H]+ ,100). 
4.2.8. Synthesis of N-[(1,4-dimethoxynaphthalen-3-yl)methyl](2-methyl-1,3-dioxolan-2-
yl)methylammonium chloride 112 
To a solution of 2-[N-(1,4-dimethoxy-2-naphthyl)aminomethyl]-2-methyl-1,3-dioxalane 111 (100 mg, 
0.32 mmol) in diethyl ether (10 ml) in a flask equipped with an air outlet, was bubbled freshly prepared 
gaseous HCl in a fume hood. After 1 hour, the reaction mixture was filtered. The resulting crystals were 
recrystallized from a solution of diethyl ether and hexane (19/1) to afford N-[(1,4-dimethoxynaphthalen-
3-yl)methyl](2-methyl-1,3-dioxolan-2-yl)methylammonium chloride 112 (113 mg, 99% yield) as white 
crystals.  
White crystals, m.p.: 161.2-161.7°C. 1H NMR (CDCl3): δ 1.38 (3H, s, H-3'), 
2.98-3.02 (2H, m, ArCH2N), 3.91 (3H, s, OCH3), 3.93-3.96 (2H, m, 
OCH2CH2O), 4.09 (3H, s, OCH3), 4.29-4.33 (2H, m, OCH2CH2O), 4.37 (2H, 
s, H-2'), 7.51-7.61 (2H, m, H-6 and H-7), 7.66 (1H, s, H-3), 8.05 (1H, d, J = 
10.0 Hz, H-5 or H-8), 8.23 (1H, d, J = 10.0 Hz, H-5 or H-8), 9.80 (2H, br s, NH). 13C NMR (CDCl3): δ 
22.68 (CH3), 45.37 (O-C-O), (ArCH2N), 56.57, (OCH3), 63.28 (OCH3), 65.17 (2×CH2O), 104.95 (CH), 
106.08 (CH), 118.78 (CH), 122.23 (CH), 122.86 (CH), 126.50 (CH), 127.13 (CH), 127.30 (Cquat), 128.14 
(Cquat), 148.27 (Cquat), 151.86 (Cquat). IR (ATR): νmax 2889, 2205, 1597, 1458, 1406, 1356, 1266, 1236, 
1094, 1036, 923, 885 cm-1. MS m/z (%): 318 ([M+H-37]+ ,100). 
4.2.9. Synthesis of 4-methylbenzo[g]isoquinoline-5,10-dione 10b (2-azacleistopholine). 
Procedure A: 
A mixture of N-methanesulfonyl-2-[(allylamino)methyl]-3-bromo-1,4-naphthoquinone 13 (0.65 mmol, 250 
mg), potassium carbonate (4.0 mmol, 0.55 g) and palladium(II) acetate (0.33 mmol, 74 mg) in 
acetonitrile (25 ml) was heated under reflux for 3 hours. Water was added and the aqueous solution was 
extracted with small portions of ethyl acetate. The combined organic extracts were washed with brine, 
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dried (MgSO4) and evaporated in vacuo. Flash chromatography on silica gel using ethyl 
acetate/petroleum ether (1/4) as eluent gave 4-methylbenzo[g]isoquinoline-5,10-dione 10b (44 mg, 30% 
yield). 
Procedure B: 
To a solution of 2-[N-(1,4-dimethoxy-2-naphthyl)-aminomethyl]-2-methyl-1,3-dioxolane 111 (0.32 mmol, 
100 mg) in dichloromethane (2 ml) was added 4 ml of concentrared sulfuric acid. The mixture was 
stirred for 2 days at room temperature. After completion, the reaction mixture was cooled to 0°C, then 
quenched with ice, neutralized with an aqueous solution of 2 M NaOH and extracted with 
dichloromethane (3×10 ml). The combined organic layers were washed with brine, dried with MgSO4 
and evaporated in vacuo to give a brown solid. Preparative thin layer chromatography with ethyl 
acetate/petroleum ether (1/4) as eluent gave 4-methylbenzo[g]isoquinoline-5,10-dione 10b (35 mg, 50% 
yield).  
Yellow crystals, m.p.:130.5-131.9 °C. 1H NMR (CDCl3): δ 2.84 (3H, s, CH3), 7.82- 
7.86 (2H, m, H-7 and H-8), 8.25-8.30 (2H, m, H-6 and H-9), 8.89 (1H, s, H-3), 9.45 
(H-1). 13C NMR (CDCl3): δ 19.4 (CH), 126.6 (Cquat), 126.8 (CH), 127.3 (CH), 132.5 
(Cquat), 133.4 (Cquat), 134.1 (Cquat), 134.5 (CH), 134.6 (CH), 135.5 (Cquat), 147.2 (CH), 
157.5 (CH), 183.1 (C=O), 184.8 (C=O). IR (ATR): νmax 1678, 1638, 1617 cm-1. MS m/z (%): 224 
([M+H]+, 100).  
4.2.10. Synthesis of (E)-4-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione 11b 
To a solution of 2-azacleistopholine 10b (103 mg, 4.61 mmol) in DMF (3 ml), 5 equivalents of DMF-DMA 
were added under a nitrogen atmosphere and the reaction mixture was heated for 2.5 hours in an oil 
bath, which was preheated at 125°C. The reaction was followed up by thin layer chromatography and 
after completion, the reaction mixture was cooled down to room temperature and poured in 30 ml of 
water, which was extracted with 5×20 ml of CH2Cl2. The organic layers were combined and washed 
several times with brine, dried over MgSO4, then the solvent was evaporated in vacuo to efford (E)-4-[2-
(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione 11b (110 mg, 86% yield) in high purity. 
Dark blue crystals, m.p: 201.0-201.7°C; 1H NMR (CDCl3): δ 3.05 (6H, s, N(CH3)2, 
6.96 (1H, d, J =14.3 Hz, H-1'), 7.26 (1H, d, J = 14.3 Hz, H-2), 7.78 (2H, m, H-7 and 
H-8), 8,25 (2H, m, H-6 and H-9), 9.02 (1H, s, H-3), 9.13 (1H, s, H-1). 13C NMR 
(CDCl3): δ 29.80 (CH3), 41.02 (CH3), 92.54 (CH), 126.52 (CH), 126.83 (Cquat), 127.22 
(CH), 132.60 (Cqaut), 133.68 (CH), 134.41 (CH), 135.12 (Cquat), 135.38 (2×Cquat), 
146.45 (CH), 152.72 (CH), 184.17 (C=O), 185.13 (C=O). IR (ATR): νmax 2920, 1662, 1641, 1690, 1407, 
1390, 1373, 1318, 1275, 1246 cm-1. MS m/z (%): 279 ([M+H]+, 100).  
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4.3. Synthesis of 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-diones 16 
4.3.1. Synthesis of pyridinium salts 20 
The pyridinium salts 20 were prepared according to the literature procedure.102 
General procedure To a solution of α-bromoacetophenones 124 (5 g, 25.12 mmoles of 124a and 21.65 
mmoles of 124b) in 50 ml of anhydrous ethyl acetate were added a solution of 1.05 equivalents of 
pyridine in 10 ml of anhydrous ethyl acetate. The solution was stirred for 24 hours at room temperature 
and filtered off. The obtained crystals were washed with 10 ml of anhydrous ethyl acetate and dried 
under high vacuum. After drying over P2O5 in a dessicator, the pyridinium salts 20 were stored under a 
nitrogen atmosphere. All spectral data were in accordance with the literature.100b 
4.3.1.1. N-Phenacylpyridinium bromide 20a 
1H NMR (CDCl3): δ 7.28 (2H, s, NCH2COAr), 7.55 (2H, t, J = 7.7 Hz, H-2), 7.68 
(1H, t, J = 7.7 Hz, H-3), 8.07 (2H, t, J = 7.1 Hz, H-2’), 8.19 (2H, d, J = 7.7 H-1), 
8.51 (1H, t, J = 7.1 Hz, H-3’), 9.33 (2H, d, J = 7.1 Hz, H-1’). 
4.3.1.2. N-(4-Chlorophenacyl)pyridinium bromide 20b 
1H NMR (CDCl3): δ 7.31 (2H, s, NCH2COAr), 7.48 (2H, d, J = 8.2 Hz, H-2), 
8.06 (2H, t, J = 7.1 Hz, H-2’), 8.16 (2H, d, J = 7.7 Hz, H-1), 8.51 (1H, t, 7.1 Hz, 
H-3’), 9.36 (2H, d, J = 7.1 Hz, H-1’). 
4.3.2. Synthesis of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 and 2-methoxycarbonyl-
1,4-naphthoquinone 19a 
Methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 and 2-methoxycarbonyl-1,4-naphthoquinone 19a 
were prepared according to the literature procedure.101,104 
4.3.2.1. Methyl 1,4-dihydroxynaphthalene-2-carboxylate 128101,104 
Dimethyl sulfate (0.22 mol, 27.75 g) and N,N-diisopropylethylamine (0.11 mol, 14.22 g) were added to a 
solution of 1,4-dihydroxynaphthoic acid 127 (0.10 mol, 20.4 g) in DMF (140 ml). The reaction mixture 
was heated for 1 h at 85°C and after cooling to room temperature, it was poured in a saturated solution 
of aqueous sodium bicarbonate. The aqueous phase was extracted with small portions of ethyl acetate 
(3×85 ml) and the combined organic extracts were washed for an additional time with saturated 
aqueous sodium bicarbonate and three times with brine. After drying (MgSO4) and solvent evaporation 
in vacuo, methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 was obtained in 84% yield.  
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1H NMR (CDCl3): δ 3.98 (3H, s, OCH3), 4.86 (1H, s, OH), 7.11 (1H, s, H-3), 7.57 
(1H, t, J = 8.5 Hz, H-7 or H-8), 7.62 (1H, t, J = 8.5 Hz, H-7 or H-8), 8.13 (1H, d, J 
= 8.5 Hz, H-6 or H-9), 8.40 (1H, d, J = 8.5 Hz, H-6 or H-9), 11.56 (1H, s, OH). 
  
4.3.2.2. 2-Methoxycarbonyl-1,4-naphthoquinone 19a101,104  
Freshly prepared silver(I) oxide (0.17 mol, 39.39 g)135 and magnesium(II) sulfate (11 g) were added to a 
solution of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 (0.05 mol, 10.91 g) in diethyl ether. The 
reaction mixture was stirred for 30 min at room temperature, after which it was filtered. Solvent 
evaporation in vacuo of the filtrate furnished the activated naphthoquinone 19a. Chromatography or 
recrystalization of 2-methoxycarbonyl-1,4-naphthoquinone 19a is not advised, since this compound 
decomposes on silica gel or upon heating. However, minor impurities could be removed by washing the 
crystals with cold diethyl ether and the activated quinone 19a could be isolated in a yield of 98%.  
1H NMR (CDCl3): δ 3.95 (3H, s, OCH3), 7.23 (1H, s, H-3), 7.74-7.85 (2H, m, H-7 
and H-8), 8.08 (1H, m, H-6 and H-9), 8.15 (1H, m, H-6 and H-9). 
 
 
4.3.3. Synthesis of 3-substituted 1-hydroxybenz[g]isoquinoline-5,10-diones 16 and 3-amino-2-
methoxycarbonyl-1,4-naphthoquinone 129a 
3-Substitited 1-hydroxybenz[g]isoquinoline-5,10-diones 16 and 3-amino-2-methoxycarbonyl-1,4-
naphthoquinone 129a were prepared according to literature procedures.101,104  
General procedure A: 
To a 10 wt % solution of ammonium acetate (2.0 g) in acetic acid (20 ml) were added 2-
methoxycarbonyl-1,4-naphthoquinone 19a (0.5 g, 2.4 mmol) and a pyridinium salt 20 (2.4 mmol), and 
the reaction mixture was subsequently boiled under reflux for 1-4 h. After cooling to room temperature, 
the reaction mixture was poured in water and extracted with dichloromethane. The combined organic 
extracts were washed with a saturated aqueous solution of sodium bicarbonate and dried over 
magnesium(II) sulfate. After solvent evaporation in vacuo, the crude mixture was purified by column 
chromatography on silica gel to yield the 3-substituted 1-hydroxybenz[g]isoquinoline-5,10-diones 16. 
General procedure B:  
2-Methoxycarbonyl-1,4-naphthoquinone 19a (0.3 g, 1.38 mmol) and 4-chlorophenacylpyridinium 
bromide 20b (1.38 mmol) were added to a previously prepared 5 wt % solution of ammonium acetate in 
methanol (6 ml). The sealed reaction vessel was introduced in a CEM Discover® microwave apparatus 
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(ramp time 5 min, pmax 275 psi). After 5 min at 115°C, the reaction mixture was cooled to room 
temperature and then cooled further in air and an ice bath, after which the reaction mixture was filtered. 
The solid was washed with 20 ml cold methanol and dried in vacuo to yield 1-hydroxy-3-(4-
chlorophenyl)benz[g]isoquinoline-5,10-dione 16b in 35% yield. 
Procedure C:  
To a 10 wt % solution of ammonium acetate (2.0 g) in acetic acid (20 ml) was added 2-
methoxycarbonyl-1,4-naphthoquinone 19a (2.4 mmol, 0.5 g) and the reaction mixture was subsequently 
boiled under reflux for 4 h. After cooling to room temperature, the reaction mixture was poured in water 
and extracted with dichloromethane. The combined organic extracts were washed with a saturated 
aqueous solution of sodium hydrogencarbonate and dried over magnesium(II) sulfate. Solvent 
evaporation in vacuo gave 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a, which was purified 
by column chromatography on silica gel with petroleum ether/ethyl acetate (4/1) in 72% yield.  
4.3.3.1. 1-Hydroxy-3-phenylbenz[g]isoquinoline-5,10-dione 16a 
1H NMR (CDCl3): δ 7.52-7.56 (3H, m, H-3’, H-4’ and H-5’), 7.84–7.94 (2H, m, 
H-7 and H-8), 8.19 (1H, s, H-4), 8.22–8.27 (2H, m, H-2’ and H-6’), 8.32–8.39 
(2H, m, H-6 and H-9).  
 
4.3.3.2. 3-(4-Chlorophenyl)-1-hydroxybenz[g]isoquinoline-5,10-dione 16b 
1H NMR (CDCl3): δ 7.48-7.57 (3H, m, H-4, H-3’ and H-5’), 7.84-7.94 (2H, 
m, H-7 and H-8), 8.32-8.39 (2H, m, H-6 and H-9).  
 
 
4.3.3.3. 3-tert-Butyl-1-hydroxybenz[g]isoquinoline-5,10-dione 16e 
1H NMR (CDCl3): δ 1.44 (9H, s, 3×CH3), 7.25 (1H, s, H-4), 7.81-7.89 (2H, m, H-
7 and H-8), 8.26-8.33 (2H, m, H-6 and H-9).  
 
 
4.3.3.4. 3-Amino-2-methoxycarbonyl-1,4-naphthoquinone 129a 
1H NMR (CDCl3): δ 3.92 (3H, s, OCH3), 7.01 (1H, br s, NH), 7.64-7.70 (1H, m, H-
6 or H-7), 7.79-7.85 (1H, m, H-6 or H-7), 8.07-8.10 (1H, m, H-5 or H-8), 8.22-8.24 
(1H, m, H-5 or H-8), 9.15 (1H, br s, NH). 
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4.3.4. Synthesis of 3-alkylamino-2-methoxycarbonyl-1,4-naphthoquinone 129b-d 
General procedure: To a solution of 4 equivalents of alkylammonium acetate in acetic acid (2 ml) was 
added a solution of 2-methoxycarbonyl-1,4-naphthoquinone 19a (1.2 mmol, 0.25 g) in 10 ml of toluene 
at 0°C and the reaction mixture was subsequently boiled under reflux for 4 hours. After cooling to room 
temperature, the reaction mixture was poured in water and extracted with dichloromethane. The 
combined organic extracts were washed with a saturated aqueous solution of sodium 
hydrogencarbonate and dried over magnesium(II) sulfate. Solvent evaporation in vacuo gave 3-
alkylamino-2-methoxycarbonyl-1,4-naphthoquinones 129b-d, which were purified by column 
chromatography on silica gel with petroleum ether/ethyl acetate (4/1). 
4.3.4.1. 2-Methoxycarbonyl-3-(n-propylamino)-1,4-naphthoquinone 129b 
Yield: 87%, reddish brown crystals, m.p : 117.8-118.3°C 1H NMR (CDCl3): δ 
1.03 (3H, t, J = 7.2 Hz, H-3’), 1.72 (2H, m, H-2’), 3.27 (2H, m, H-1’), 3.98 (3H, s, 
OCH3), 6.27 (1H, broad s, NH), 7.64 (1H, m, H-6 or H-7), 7.77 (1H, m, H-6 or H-
7), 8.06 (1H, m, H-5 or H-8), 8.14 (1H, m, H-5 or H-8).13C NMR (CDCl3): To 
date, a decent 13C NMR spectrum of this derivative could not be recorded even upon prolongation of the 
relaxation delay and increasing the number of recorded scans, δ 11.41 (NCH2CH2CH3), 22.91 
(NCH2CH2CH3), 45.60 (NCH2CH2CH3), 52.49 (OCH3), 126.52 (CH), 126.70 (CH), 132.43 (CH), 135.44 
(CH). IR (ATR): νmax 3248, 1717, 1683, 1599, 1568 cm-1. MS m/z (%): 274 ([M+H]+, 100). Anal. Calcd 
for C15H15NO4: C 65.92, H 5.53, N 5.13, Found: C 65.25, H 5.24, N 5.05 
4.3.4.2. 3-n-Butylamino-2-methoxycarbonyl-1,4-naphthoquinone 129b 
Yield: 75%, reddish brown crystals, m.p : 120.1-121.4°C 1H NMR (CDCl3) : 
0.97 (3H, t, J = 7.2 Hz, H-4’), 1.46 (2H, q, J = 7.2, H-3’), 1.68 (2H, m, H-2’), 
3.24 (2H, m, H-1’), 3.94 (3H, s, OCH3), 6.33 (1H, broad s, NH), 7.64 (1H, m, 
H-6 or H-7), 7.76 (1H, m, H-6 or H-7), 8.03 (1H, m, H-5 or H-8), 8.13 (1H, m, 
H-5 or H-8). 13C NMR (CDCl3): To date, a decent 13C NMR spectrum of this derivative could not be 
recorded even upon prolongation of the relaxation delay and increasing the number of recorded scans, 
δ 13.75 (NCH2CH2CH2CH3), 20.10 (NCH2CH2CH2CH3), 31.49 (NCH2CH2CH2CH3), 42.90 
(NCH2CH2CH2CH3), 52.49 (OCH3), 126.52 (CH), 126.70 (CH), 132.43 (CH), 135.44 (CH). IR (ATR): 
νmax 3288, 1711, 1688, 1621, 1600, 1514 cm-1. MS m/z (%): 288 ([M+H]+, 100). Anal. Calcd for 
C16H17NO4: C 66.89, H 5.96, N 4.88, Found: C 66.16, H 5.73, N 4.77 
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4.3.4.3. 2-Methoxycarbonyl-3-arylamino-1,4-naphthoquinone 129d 
Yield 69%, red crystals, m.p : 166.0-166.9°C 1H NMR (CDCl3): δ 3.24 (3H, s, 
OCH3), 7.19 (2H, d, J = 7.1 , H-1’), 7.25 (2H, m, H-2’), 7.40, (2H, m, H-3’ and H-6 
or H-7), 7.70 (1H, m, H-6 or H-7), 7.80 (1H, m, H-5 or H-8), 8.02 (1H, br s, NH), 
8.45 (1H, m, H-5 or H-8). 13C NMR (CDCl3): δ 51.8 (OCH3), 124.6 (2×CH), 126.7 
(CH), 126.1 (CH), 127.1 (CH), 129.4 (2×CH), 129.7 (Cquat), 132.8 (CH), 132.9 
(Cquat), 135.7 (CH), 137.2 (Cquat), 143.2 (Cquat), 165.1 (O=C-O), 180.47 (C=O), 182.04 (C=O). IR (ATR): 
νmax 3298, 3061, 1722, 1676, 1633, 1607 cm-1. MS m/z (%): 308 ([M+H]+, 100). Anal. Calcd for 
C18H13NO4: C 70.35, H 4.26, N 4.56. Found: C 69.92, H 3.72, N 4.50 
4.4. Synthesis of 3-aryl-1-methyl-3-benzo[g]isoquinoline-5,10-diones 17 
4.4.1. Syntheses of 4-methoxy-1-naphthol 156, 1-acetoxy-4-methoxynaphthalene 157 and 2-
acetyl-4-methoxy-1-naphthol 158. 
4.4.1.1. 4-Methoxy-1-naphthol 156136 
To a solution of 1,4-naphthoquinone 152 (15.8 g, 0.1 mol) in methanol (200 ml) was added dropwise a 
solution of SnCl2 (0.35 mol) in 12 M HCl (70 ml) at room temperature over a period of 30 minutes. The 
solution was boiled for 3 hours and cooled to room temperature. Then, methanol was reduced in vacuo 
to about 1/5 of the starting volume. Then, the residue was poured in cold water to give a precipitate 
which was dissolved in dichloromethane. The organic phase was dried over magnesium sulfate and 
concentrated in vacuo to give pure 4-methoxy-1-naphthol 156 (12,5 g, 72%) after column 
chromatography using ethyl acetate-hexane (1/9). All spectra data were in accordance with the 
literature.136 
1H NMR (CDCl3): δ 3.92 (3H, s, OCH3), 6.61 (1H, d, J = 8.1 Hz, H-3), 6.70 (1H, d, J = 8.1 
Hz, H-2), 7.47-7.52 (2H, m, H-6 and H-7), 8.08-8.13 (1H, m, H-5), 8.19-8.22 (1H, m, H-8). 
 
 
4.4.1.2. 1-Acetoxy-4-methoxynaphthalene 157136  
A mixture of 4-methoxy-1-naphthol 156 (4.5 g, 25.8 mmol), pyridine (21.0 ml, 258 mmol) and acetic 
anhydride (25.0 ml, 258 mmol) was stirred at room temperature overnight. After addition of 150 ml of 
water, the mixture was extracted with 3×100 ml of ethyl acetate. The combined organic extracts were 
successively washed with 120 ml of aqueous HCl 2M, 120 ml of water and 149 ml of brine. The organic 
phase was dried over magnesium sulfate, filtered and evaporated in vacuo to furnished 1-acetoxy-4-
methoxynaphthalene 157 (5.52 g, 99%). All spectra data were in accordance with the literature.136 
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1H NMR (CDCl3): δ 2.45 (3H, s, COCH3), 3.99 (3H, s, OCH3), 6.78 (1H, d, J = 8.5 Hz, 
H-3), 7.14 (1H, d, J = 8.5 Hz, H-2), 7.52 (2H, m, H-5 and H-6), 7.78 (1H, d, J = 7.1 Hz, 
H-6 or H-7), 8.27 (1H, d, J = 7.1 Hz, H-6 or H-7). 
 
 
4.4.1.3. 2-Acetyl-4-methoxy-1-naphthol 158136 
A solution of 1-acetoxy-4-methoxynaphthalene 157 (5.0 g, 23.1 mmol) in 5 ml of diethyl ether was 
heated at 120 °C, after which 5 ml of BF3.OEt2 was added by a syringe and to afford after 5 minutes 
greenish-orange solid. The solid was decomposed by cautious addition of 100 ml. The aqueous layer 
was extracted with 3×100 ml of ethyl acetate. The combined organic extracts were washed with brine, 
dried over magnesium(II) sulfate and filtered. The solvent was evaporated in vacuum to give pure 2-
acetyl-4-methoxy-1-naphthol 151 (4.90 g, 98%). All spectra data were in accordance with the 
literature.136 
1H NMR (CDCl3): δ 2.83 (3H, s, COCH3), 3.99 (3H, s, OCH3), 6.52 (1H, s, H-3), 
7.67 (1H, d, J = 7.1 Hz, H-5 or H-6), 7.84 (1H, t, J = 7.1 Hz, H-5 or H-6), 8.11 (1H, 
d, J = 7.1 Hz, H-6 or H-7), 8.19 (1H, d, J = 7.1 Hz, H-6 or H-7). 
 
4.4.2. Synthesis of 2-acetyl-1,4-naphthoquinone 19b 
A solution of CAN (14.0 g, 26.3 mmol) in water (50 ml) was added to a stirred solution of 2-acetyl-4-
methoxy-1-naphthol 158 (2.5 g, 11.6 mmol) in acetonitrile (149 ml). After 5 minutes, the reaction mixture 
was poured in a solution of 100 ml of ethyl acetate and 50 ml of water prepared beforehand. The 
aqueous layer was separated from the organic phase and extracted with 2×100 ml of ethyl acetate. The 
combined organic extracts were washed with brine, dried over MgSO4 and evaporated in vacuo to give 
a red solid. Recrystallization using a mixture of diethyl ether-hexane afforded 2-acetyl-1,4-
naphthoquinone 19b (69%) as red crystals.  
1H NMR (CDCl3): δ 2.67 (3H, s, COCH3), 7.17 (1H, s, H-3), 7.75-7.86 (2H, m, H-6 
and H-7), 8.05-8.17 (2H, m, H-5 and H-8).   
 
 
4.3.3. Synthesis of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 
General procedure: 2-Acetyl-1,4-naphthoquinone 19a (0.35 g, 1.75 mmol) and phenacylpyridinium 
bromide 20 (1.83 mmol) were added to a previously prepared 5 wt% solution of ammonium acetate in 
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methanol (6 ml). The sealed reaction vessel was introduced in a CEM Discover® microwave apparatus 
(ramp time 6 min, pmax 10.0 psi). After 6 min at 90°C, the reaction mixture was cooled to room 
temperature and then in ice water, after which the reaction mixture was filtered. The solid was washed 
with 20 ml of cold methanol and dried in vacuo to yield 3-aryl-1-methoxybenz[g]isoquinoline-5,10-diones 
17. 
4.4.3.1. 1-Methyl-3-phenylbenzo[g]isoquinoline-5,10-dione 17a 
Yield: 52%, brown solid, m.p.: 190.3-191.7°C. 1H NMR (CDCl3): δ 3.17 (3H, 
s, CH3), 7.47-7.56 (3H, m, H-3’, H-4’ and H-5’), 7.80 (1H, t, J = 7.4 Hz, H-6 or 
H-7), 7.86 (1H, t, J = 7.4 Hz, H-7 or H-8), 8.33 (2H, dd, J = 4.9 and 1.7 Hz, H-
2’), 8.29 (2H, dd, J = 7.4 and 1.7 Hz, H-6 and H-9), 8.45 (1H, s, H-4). 13C 
NMR (CDCl3): δ 26.93 (CH3), 114.34 (CH), 123.15 (Cquat), 126.98 (CH), 127.51 (CH), 127.65 (2×CH), 
129.09 (2×CH), 130.66 (CH), 132.57 (Cquat), 133.90 (CH), 134.55 (Cquat), 135.10 (CH), 137.76 (Cquat), 
141.12 (Cquat), 160.74 (Cquat), 162.19 (Cquat), 183.36 (Cquat), 183.78 (Cquat). IR (ATR): νmax 3070, 2362, 
1677, 1664, 1573, 1375, 1329, 1278, 1243, 1158, 880, 735, 711, 684 cm-1. MS m/z (%): 300 ([M+H]+, 
100).  
4.4.3.2. 3-(4-Chlorophenyl)-1-methylbenzo[g]isoquinoline-5,10-dione 17b 
Yield: 67%, brown solid, m.p.: 223.8-225.4°C. 1H NMR (CDCl3): δ 3.16 
(3H, s, CH3), 7.51 (2H, d, J = 8.5 Hz, H-3’ and H-5’), 7.80 (1H, t, J = 7.4 
Hz, H-6 or H-7), 7.86 (1H, t, J = 7.42 Hz, H-7 or H-8), 8.19 (2H, d, J = 8.5 
Hz, H-2’), 8.30 (2H, dd, J = 7.4 and 1.7 Hz, H-6 and H-9), 8.42 (1H, s, H-
4). 13C NMR (CDCl3): δ 26.88 (CH3), 114.09 (CH), 123.22 (Cquat), 127.02 (CH), 127.57 (CH), 128.92 
(2×CH), 129.31 (2×CH), 132.52 (Cquat), 133.97 (CH), 134.54 (Cquat), 135.19 (CH), 136.15 (Cquat), 136.97 
(Cquat), 141.25 (Cquat), 159.39 (Cquat), 162.30 (Cquat), 183.25 (Cquat), 183.68 (Cquat). IR (ATR): νmax 3069, 
1670, 1661, 1570, 1408, 1370, 1329, 1279, 1092, 845, 706 cm-1. MS m/z (%): 334 ([M+H]+, 100).  
4.4.3.3. 3-(4-Fluorophenyl)-1-methylbenzo[g]isoquinoline-5,10-dione 17i 
Yield: 51%, brown solid, m.p.: 203.0-204.6°C. 1H NMR (CDCl3): δ 3.13 
(3H, s, CH3), 7.20 (2H, d, J = 8.8 Hz, H-3’ and H-5’), 7.78 (1H, t, J = 7.0 
Hz, H-6 or H-7), 7.84 (1H, t, J = 7.0 Hz, H-7 or H-8), 8.20 (2H, d, J = 8.8 
Hz, H-2’ and H-5’), 8.23-8.30 (2H, m, H-6 and H-9), 8.36 (1H, s, H-4). 13C 
NMR (CDCl3): δ 26.86 (CH3), 113.86 (CH), 115.96 (CH), 116.25 (CH), 122.95 (Cquat), 126.96 (CH), 
127.51 (CH), 129.60 (CH), 129.71 (CH), 132.47 (Cquat), 133.90 (CH), 134.49 (Cquat), 135.12 (CH), 
141.15 (Cquat), 159.47 (Cquat), 162.22 (Cquat), 162.81 (Cquat), 166.14 (Cquat), 183.23 (Cquat), 183.62 (Cquat). 
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IR (ATR): νmax 3079, 1671, 1662, 1506, 1414, 1370, 1373, 1332, 1275, 1192, 1155, 1017, 843, 748, 
710 cm-1. MS m/z (%): 318 ([M+H]+, 100).  
4.4.3.4. 3-(4-Methoxyphenyl)-1-methylbenzo[g]isoquinoline-5,10-dione 17j 
Yield: 47%, brown solid, m.p.: 192.8-193.5°C. 1H NMR (CDCl3): δ 
3.13 (3H, s, CH3), 3.88 (3H, s, OCH3), 7.02 (2H, d, J = 7.8 Hz, H-3’ 
and H-5’), 7.82 (1H, t, J = 7.4 Hz, H-6 or H-7), 7.84 (1H, t, J = 7.4 Hz, 
H-6 or H-7), 8.21 (2H, d, J = 7.8 Hz, H-2’and H-5’), 8.27 (2H, dd, J = 
7.4 and 1.7 Hz, H-6 and H-9), 8.36 (1H, s, H-4). 13C NMR (CDCl3): δ 26.94 (CH3), 55.54 (OCH3), 113.39 
(CH), 114.46 (2×CH), 126.92 (CH) 127.48 (CH), 129.24 (2×CH), 130.36 (Cquart), 131.57(Cquat), 132.61 
(Cquat), 133.74 (CH), 134.66 (Cquat), 135.03 (CH), 141.02 (Cquat), 160.30 (Cquat), 161.91 (Cquat), 162.14 
(Cquat), 183.53 (Cquat), 183.65 (Cquat). IR (ATR): νmax 2926, 1672, 1663, 1573, 1514, 1375, 1375, 1333, 
1278, 1261, 1175, 1030, 842, 713 cm-1. MS m/z (%): 330 ([M+H]+, 100).  
4.4.3.5. 1-Methyl-3-(4-methylphenyl)benzo[g]isoquinoline-5,10-dione 17k 
Yield: 48%, brown solid, m.p.: 203.4-204.7°C. 1H NMR (CDCl3): δ 2.44 
(3H, s, CH3), 3.16 (3H, s, CH3), 7.33 (2H, d, J = 8.3 Hz, H-3’ and H-5’), 
7.82 (1H, t, J = 7.4 Hz, H-7 or H-8), 7.86 (1H, t, J = 7.4 Hz, H-7 or H-8), 
7.99 (1H, s, H-4), 8.15 (2H, d, J = 8.3 Hz, H-2’), 8.31 (2H, dd, J = 7.4 
and 1.7 Hz, H-6 and H-7), 8.45 (1H, s, H-4). 13C NMR (CDCl3): δ 21.55 (CH3), 26.93 (CH3), 113.96 
(CH), 122.90 (Cquat), 126.96 (CH), 127.51 (CH), 127.57 (2×CH), 129.24 (2×CH), 129.24 (Cquart), 132.63 
(Cquat), 133.82 (CH), 134.64 (Cquat), 135.06 (CH), 135.06 (Cquat), 141.09 (Cquat), 160.77 (Cquat), 162.16 
(Cquat), 183.49 (C=O), 183.76 (C=O). IR (ATR): νmax 2925, 2358, 1671, 1662, 1570, 1511, 1374, 1332, 
1274, 1261, 1155, 1018, 882, 844, 708 cm.-1 MS m/z (%): 314 ([M+H]+, 100). 
4.4.4. Synthesis of 1-[2-(dimethylamino)vinyl]-3-phenylbenzo[g]isoquinoline-5,10-diones 21 
General procedure: To a solution of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones 17 (250 mg) in 
DMF (5 ml), 5-10 equivalents of DMF-DMA were added under a nitrogen atmosphere and the reaction 
mixture was heated for 4-20 hours in an oil bath at 125°C. The reaction was monitored up by thin layer 
chromatography and after completion; the reaction mixture was cooled down to room temperature and 
poured in 30 ml of water, and extraction was performed with 3×40 ml of CH2Cl2. The organic layers 
were combined and washed several times with brine, dried over MgSO4, then concentrated under high 
vacuum. 3-Aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones 21 were obtained in high 
purity. 
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4.4.4.1. 1-[2-(Dimethylamino)vinyl]-3-phenylbenzo[g]isoquinoline-5,10-dione 21a 
Yield: 52%, black solid, m.p.: 215.3-216.9°C. 1H NMR (CDCl3): δ 3.12 (6H, s, 
N(CH3)2), 7.24 (1H, d, J = 12.0 Hz, CH=CH-N(CH3)2), 7.45-7.55 (3H, m, H-3’, 
H-4’ and H-5’), 7.71 (1H, t, J = 7.5 Hz, H-7 or H-8), 7.81 (1H, t, J = 7.5 Hz, H-
7 or H-8), 8.03 (1H, s, H-4), 8.17 (2H, d, J = 9.0 Hz, H-2’ and H-5’), 8.23 (1H, 
d, J = 6.0 Hz, H-6 or H-9), 8.30 (1H, d, J = 6.0 Hz, H-6 or H-9), 8.41 (1H, d, J 
= 12.0 Hz, CH=CH-N(CH3)2).13C NMR (CDCl3): δ 95.43 (CH), 109.97 (CH), 
115.31 (Cquat), 126.52 (CH), 127.25 (CH), 127.51 (2×CH), 128.78 (2×CH), 130.14 (CH), 132.46 (Cquat), 
132.83 (CH), 134.72 (CH), 135.48 (Cquat), 138.84 (Cquat), 141.96 (Cquat), 151.12 (CH), 160.20 (Cquat), 
183.55 (C=O), 184.40 (C=O). IR (ATR): νmax 2907, 1667, 1602, 1557, 1531, 1492, 1425, 1360, 1304, 
1240, 1090, 1061, 964, 907, 859 cm-1. MS m/z (%): 355 ([M+H]+, 100).  
4.4.4.2. 3-(4-Chlorophenyl)-1-[2-(dimethylamino)viny]lbenzo[g]isoquinoline-5,10-dione 21b 
Yield: 77%, black solid, m.p.: 248.9-251.0°C. 1H NMR (CDCl3): δ 3.12 
(6H, s, N(CH3)2), 7.22 (1H, d, J = 12.0 Hz, CH=CH-N(CH3)2), 7.48 (2H, d, 
J = 9.0 Hz, H-3’ and H-5’), 7.72 (1H, t, J = 7.5 Hz, H-7 or H-8), 7.81 (1H, 
t, J = 7.5 Hz, H-7 or H-8), 7.97 (1H, s, H-4), 8.10 (2H, d, J = 9.0 Hz, H-2’ 
and H-5’), 8.23 (1H, d, J = 6.0 Hz, H-6 or H-9), 8.30 (1H, d, J = 6.0 Hz, 
H-6 or H-9), 8.40 (1H, d, J = 12.0 Hz, CH=CH-N(CH3)2).13C NMR 
(CDCl3): δ 95.31 (CH), 109.59 (CH), 115.45 (Cquat), 126.55 (CH), 127.28 (CH), 128.78 (2×CH), 128.99 
(2×CH), 132.38 (Cquat), 132.90 (CH), 134.80 (CH), 135.44 (Cquat), 136.34 (Cquat), 137.25 (Cquat), 142.06 
(Cquat), 151.12 (CH), 158.89 (Cquat), 160.19 (Cquat), 183.47 (C=O), 184.26 (C=O). IR (ATR): νmax 2907, 
1667, 1602, 1557, 1531, 1492, 1425, 1360, 1304, 1240, 1090, 1061, 964, 907, 859 cm.-1 MS m/z (%): 
389 ([M+H]+, 100).  
4.4.4.3. 1-[2-(Dimethylamino)vinyl]-3-(4-methoxyphenyl)benzo[g]isoquinoline-5,10-dione 21j 
Yield: 23%, black solid, m.p.: 233.3-235.9°C. 1H NMR (CDCl3): δ 3.12 
(6H, s, CH3), 3.89 (3H, s, OCH3), 7.01 (2H, d, J = 8.7 Hz, H-3’ and H-
5’), 7.22 (1H, d, J = 12.3 Hz, CH=CHN(CH3)2), 7.71 (1H, t, J = 7.8 Hz, 
H-7 or H-8), 7.80 (1H, t, J = 7.8 Hz, H-7 or H-8), 8.06 (1H, s, H-4), 
8.15 (2H, d, J = 8.7 Hz, H-2’ and H-5’), 8.22 (1H, d, J = 7.8 Hz, H-6 or 
H-9), 8.30 (1H, d, J = 7.80 Hz, H-6 or H-9), 8.43 (1H, d, J = 12.3 Hz, 
CH=CHN(CH3)2). 13C NMR (CDCl3): δ 29.80 (N(CH3)2), 55.51 (OCH3), 95.50 (CH), 109.36 (CH), 114.14 
(2×CH), 114.80 (Cquat), 126.48 (CH) 127.22 (CH), 129.05 (2×CH), 131.39 (Cquart), 132.45 (Cquat), 132.74 
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(CH), 134.69 (CH), 135.54 (Cquat), 141.77 (Cquat), 150.95 (CH), 159.65 (Cquat), 160.07 (Cquat), 161.50 
(Cquat), 183.35 (C=O), 184.52 (C=O). IR (ATR): νmax 2923, 1669, 1636, 1599, 1527, 1428, 1361, 1302, 
1236, 1174, 1103, 1015, 834, 709 cm-1. MS m/z (%): 385 ([M+H]+, 100).  
4.4.4.4. 1-[2-(Dimethylamino)vinyl]-3-(4-methylphenyl)benzo[g]isoquinoline-5,10-dione 21k 
Yield: 39%, black solid, m.p.: 228.6-229.5°C. 1H NMR (CDCl3): δ 2.43 
(3H, s, CH3), 3.11 (6H, s, N(CH3)2), 7.22 (1H, d, J = 12.6 Hz, 
CH=CHN(CH3)2), 7.33 (2H, d, J = 8.2 Hz, H-3’ and H-5’), 7.78 (1H, t, J = 
7.4 Hz, H-7 or H-8), 7.80 (1H, t, J = 7.4 Hz, H-7 or H-8), 7.99 (1H, s, H-
4), 8.07 (2H, d, J = 8.2 Hz, H-2’), 8.21 (1H, d, J = 7.7 Hz, H-6 or H-9), 
8.29 (1H, d, J = 7.7 Hz, H-6 or H-9), 8.39 (1H, d, J = 12.6 Hz, 
CH=CHN(CH3)2). 13C NMR (CDCl3): δ 21.54 (CH3), 95.46 (CH), 109.77 (CH), 115.09 (Cquat), 126.49 
(CH), 127.24 (CH), 127.43 (2×CH), 127.43 (Cquart), 129.53 (2×CH), 132.46 (Cquat), 132.78 (CH), 134.69 
(CH), 135.52 (Cquat), 136.05 (Cquat), 140.43 (Cquat), 141.84 (Cquat), 151.06 (CH), 160.10 (Cquat), 183.46 
(C=O), 183.76 (C=O). IR (ATR): νmax 2924, 1667, 1606, 1560, 1535, 1507, 1361, 1302, 1269, 1242, 
1102, 806, 844, 709 cm-1. MS m/z (%): 391 ([M+Na]+, 100). 
4.4.5. Synthesis of 5-phenyl-7H-naphtho[3,2,1-de]naphthyridine-7-one 22 
1-[2-(Dimethylamino)vinyl]-3-phenylbenzo[g]isoquinoline-5,10-dione 21a (45 mg, 0.127 mmol) was 
mixed with 10 ml of a 5 %(w/v) solution of ammonium acetate in methanol and then refux for 4 hours. 
After completion of the reaction, the reaction mixture was cooled at room temperature and diluted with 
dichloromethane (15 ml). Then, the reaction mixture was washed with saturated sodium bicarbonate 
solution (25 ml) and brine (3×25 ml). The organic layer was dried over magnesium sulfate and 
concentrated in vacuo. The resulting residue was purified by preparative TLC using dichloromethane as 
eluent to afford 5-phenyl-7H-naphtho[3,2,1-de]naphthyridine-7-one 22 (35 mg, 89 % yield).  
Yellow solid, m.p.: 222.0-223.3°C. 1H NMR (CDCl3): δ 7.54-7.62 (3H, m, H-
3’, H-4’ and H-5’), 7.68 (1H, t, J = 7.4 Hz, H-9 or H-10), 7.87 (1H, t, J = 7.4 
Hz, H-9 or H-10), 8.02 (1H, d, J = 5.9 Hz, H-3), 8.32 (2H, dd, J = 7.7 and 1.7 
Hz, H-2’ and H-6’), 8.41 (1H, d, J = 7.9 Hz, H-11), 8.81 (1H, s, H-6), 8.87 
(1H, d, J = 7.9 Hz, H-8), 8.95 (1H, d, 5.9 Hz, H-2). 13C NMR (CDCl3): δ 
116.72 (Cquat), 118.66 (CH), 122.31 (CH), 125.50 (CH), 128.06 (Cquat), 128.06 (2×CH), 129.27 (2×CH), 
130.84 (CH), 131.01 (CH), 131.93 (Cquat), 135.19 (CH),135.38 (Cquat), 136.48 (Cquat), 138.19 (Cquat), 
148.06 (CH), 149.91 (Cquat), 151.00 (Cquat), 162.80 (Cquat), 183.55 (C=O). IR (ATR): νmax 3054, 1670, 
1592, 1448, 1380, 1367, 1340, 1243, 1233, 1027, 756, 697 cm-1. MS: m/z (%) 309 ([M+H]+, 100). 
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4.5. Efforts towards the synthesis methyl 3-aryl-1-hydroxybenzo[g]isoquinoline-5,10-diones-4-
carboxylate 18 
4.5.1. Synthesis of enaminoesters 23 
The enaminoesters 23 were prepared according to the literature procedure.125 
General procedure: To a solution of the corresponding alkyl β-ketoesters (5 g) in toluene (100 ml) and 
acetic acid (2 ml), ammonium acetate or alkylammonium acetates (76.83 mmoles), prepared in situ from 
equimolecular amounts of alkylamine and acetic acid) was added. The mixture was boiled under reflux 
using a Dean-Stark apparatus. After cooling the mixture is washed with water (100 ml) and saturated 
sodium bicarbonate solution (2×100 ml), brine, dried over magnesium sulfate and evaporated in vacuo 
to give pure enaminoesters 23. 
4.5.1.1. Methyl 3-aminobut-2-enoate 23a137 
1H NMR (CDCl3): δ 1.95 (3H, s, CH3), 3.65 (3H, s, OCH3), 4.53 (1H, s, H-2), 7.9 (1H, br 
s, N-H). 
4.5.1.2. Methyl 3-(N-ethylamino)but-2-enoate 23d137 
1H NMR (CDCl3): δ 1.16 (3H, t, J = 6.6 Hz, NCH2CH3), 1.23 (3H, t, J = 6.8 Hz, 
OCH2CH3), 1.96 (3H, s, H-4), 3.25 (2H, quintet, J = 6.6 Hz, NCH2CH3), 4.13 (2H, q, 
J = 6.8 Hz, OCH2CH3), 4.43 (1H, s, H-2), 8.48 (1H, br s, NH).  
4.5.1.3. Ethyl 3-(N-ethylamino)-3-phenylprop-2-enoate 23g138 
1H NMR (CDCl3): δ 1.12 (3H, t, J = 7.1 Hz, NCH2CH3), 1.28 (3H, t, J = 6.9 Hz, 
OCH2CH3), 3.09 (2H, quintet, J = 6.9 Hz, NCH2CH3), 4.14 (2H, q, J = 7.1 Hz, 
OCH2CH3), 4.57 (1H, s, H-2), 7.34-7.49 (5H, m, C6H5), 8.49 (1H, br s, N-H).  
4.5.1.4. Ethyl 3-(N-n-propylamino)-3-phenylprop-2-enoate 23h139 
1H NMR (CDCl3): δ 0.88 (3H, t, J = 7.1 Hz, NCH2CH2CH3), 1.30 (3H, t, J = 6.9 
Hz, OCH2CH3), 1.53 (2H, sextet, J = 7.1 Hz, NCH2CH2CH3), 3.05 (2H, quintet, J 
= 6.9 Hz, NCH2CH2CH3), 4.12 (2H, q, J = 7.1 Hz, OCH2CH3), 4.58 (1H, s, H-2), 
7.30-7.46 (5H, m, C6H5), 8.57 (1H, br s, N-H). 
4.5.1.5. Methyl 3-(N-n-propylamino)pent-2-enoate 23j 
1H NMR (CDCl3): δ 0.94 (3H, t, J = 6.6 Hz, NCH2CH2CH3), 1.16 (3H, t, J = 6.8 Hz, 
CH2CH3), 1.67 (2H, sextet, J = 6.6 Hz, NCH2CH2CH3), 2.24 (2H, q, J = 6.8 Hz, 
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CH2CH3), 3.18 (2H, q, J = 6.6 Hz, NCH2CH2CH3), 3.63 (3H, s, OCH3), 4.53 (1H, s, H-2), 8.58 (1H, br s, 
NH).  
4.5.2. Synthesis of 2-methoxycarbonyl-3-[1-(methoxycarbonyl)-2-aminoprop-1-enyl]-1,4-naphtho-
quinone 166a 
To a solution of 2-methoxycarbonyl-1,4-naphthoquinone 19a (2.4 mmol, 0.5 g) in toluene (20 ml) were 
added acetic acid (4 ml) and 1.05 equivalents of enaminoesters 23a. The reaction mixture was 
subsequently heated at 80°C for 1 hour. After cooling to room temperature, the reaction mixture was 
poured in a saturated aqueous solution of sodium bicarbonate. The organic phase was separated and 
the remaining aqueous phase was extracted with 3×20 ml of dichloromethane. The combined extracts 
were dried over magnesium(II) sulfate. Solvent evaporation in vacuo furnished a crude solid, which was 
purified by column chromatography. Compound 166a (0.2 g, 25%) was obtained after crystallization 
from diethyl ether/hexane (8/2). 
Yield: 25%, orange crystals, m.p.: 1172-118.4°C 1H NMR (CDCl3): δ 1.99 
(3H, s, CH3), 3.70 (3H, s, OCH3), 3.88 (3H, s, OCH3), 7.80 (2H, m, H-6 and 
H-7), 8.15 (2H, m, H-5 and H-8). 13C NMR (CDCl3) : δ 20.18 (CH), 52.23 
(CH), 52.97 (CH), 94.81 (Cquat), 126.72 (CH), 127.18 (CH), 131.67 (Cquat), 
131.79 (Cquat), 134.43 (CH), 134.51 (CH), 140.67 (Cquat), 141.88 (Cquat), 164.28 (Cquat), 170.91 (Cquat), 
175.62 (Cquat), 181.88 (O-C=O), 183.61 (O-C=O). IR (ATR) : νmax 2970, 1742, 1662, 1594, 1570, 1440, 
1374, 1330, 1276, 979, 843, 714 cm-1. MS m/z (%): 330 ([M+H]+, 100). 
4.5.3. Synthesis of dimethyl 5-hydroxy-2-methyl-1H-benzo[g]indole-3,4-dicarboxylate 167a and 
methyl 2,3-dihydro-5-hydroxy-3-[1-(isopropylamino)ethylidene]-2-oxonaphtho[1,2-b]furan-4-
carboxylate 169 
General procedure: To a solution of 2-methoxycarbonyl-1,4-naphthoquinone 19a (2.4 mmol, 0.5 g) in 
toluene (16.7 ml) were added acetic acid (3.3 ml) and 1.05 equivalents of enaminoesters 23a,b, 
respectively. The reaction mixture was subsequently boiled under reflux for 4-36 hours. After cooling to 
room temperature, the reaction mixture was poured in a saturated aqueous solution of sodium 
bicarbonate. The organic phase was separated and the remaining aqueous phase was extracted with 
3×20 ml of dichloromethane. The combined extracts were dried over magnesium(II) sulfate. Solvent 
evaporation in vacuo furnished a crude solid, which was recrystallized from methanol. 
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4.5.3.1. Dimethyl 5-hydroxy-2-methyl-1H-benzo[g]indole-3,4-dicarboxylate 167a 
Yield: 39-48%, brown solid, m.p : 148.0-148.9°C 1H NMR (CDCl3): δ 2.59 (3H, 
s, H-1’), 3.87 (3H, s, OCH3), 3.92 (3H, s, OCH3), 7.48 (1H, m, H-7 and H-8), 
7.64 (1H, m, H-7 and H-8), 7.83 (1H, m, H-6 or H-9), 8.44 (1H, m, H-6 or H-9), 
8.89 (1H, s, NH), 11.19 (1H, s, OH). 13C NMR (CDCl3): δ 13.55 (CH3), 51.52 
(OCH3), 52.09 (OCH3), 101.08 (Cquat), 109.50 (CH), 117.99 (Cquat), 119.04 
(CH), 122.22 (Cquat), 124.01 (Cquat), 124.35 (CH), 125.46 (CH), 129.48(CH), 138.00 (Cquat), 156.14 
(Cquat), 167.47 (O=C-O), 171.56 (O=C-O). IR (ATR): νmax 3248, 1693, 1664, 1633 cm-1. MS m/z (%): 
282(100), 314 ([M+H]+, 13). 
4.5.3.2. Methyl 2,3-dihydro-5-hydroxy-3-[1-(isopropylamino)ethylidene]-2-oxonaphtho[1,2-
b]furan-4-carboxylate 169 
Yield: 31%, green crystals, m.p: 157.5-158.1°C 1H NMR (CDCl3): δ 1.36 
(6H, d, J = 6.6 Hz, 2×CH3), 2.17 (3H, s, CH3), 3.89 (1H, sept, J = 6.6 Hz, 
CH(CH3)2, 3.91 (3H, s, OCH3), 7.36 (1H, m, H-7 or H-8), 7.57 (1H, m, H-7 or 
H-8), 7.94 (1H, m, H-6 or H-9), 8.28 (1H, m, H-6 or H-9), 9.57 (1H, br d, J = 
8.3 Hz, NH), 11.05 (1H, s, OH). 13C NMR (CDCl3): δ 17.81 (CH3), 23.60 (2×CH3), 45.74 (CH), 52.16 
(OCH3), 92.56 (Cquat), 100.82 (Cquat), 117.44 (Cquat), 120.03 (CH), 121.22 (Cquat), 123.48 (Cquat), 124.23 
(CH), 124.52 (CH), 129.89 (CH), 136.80 (Cquat), 156.42 (Cquat), 162.02 (Cquat), 170.52 (O=C-O), 171.16 
(O=C-O). IR (ATR) νmax: 1638, 1685, 1582 cm-1. MS m/z (%): 342 ([M+H]+, 100). 
4.5.4. Methyl 5-hydroxy-2-methyl-1H-benzo[g]indole-4-carboxylate 168 
Procedure A: To a solution of 2-methoxycarbonyl-1,4-naphthoquinone 19a (2.4 mmol, 0.5 g) in toluene 
(20 ml) were sulfuric acid (3 drops) and enaminoesters 23a (0.29 g, 2,5 mmol). The reaction mixture 
was subsequently boiled under reflux for 4 hours. After cooling to room temperature, the reaction 
mixture was poured in a saturated aqueous solution of sodium bicarbonate. The organic phase was 
separated and the remaining aqueous phase was extracted with 3×20 ml of dichloromethane. The 
combined extracts were dried over magnesium(II) sulfate. Solvent evaporation in vacuo furnished a 
crude solid, which was recrystallized from methanol to give methyl 5-hydroxy-2-methyl-1H-
benzo[g]indole-4-carboxylate 168 (0.42 g, 68% yield). 
Procedure B: To a solution of dimethyl 5-hydroxy-2-methyl-1H-benzo[g]indole-3,4-dicarboxylate 167a 
(200 mg, 0.64 mmol) in toluene (10 ml) were sulfuric acid (1 drop). The reaction mixture was 
subsequently boiled under reflux for 4 hours. After cooling to room temperature, the reaction mixture 
was poured in a saturated aqueous solution of sodium bicarbonate. The organic phase was separated 
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and the remaining aqueous phase was extracted with 3×10 ml of dichloromethane. The combined 
extracts were dried over magnesium(II) sulfate. Solvent evaporation in vacuo furnished a crude solid, 
which was recrystallized from methanol to afford methyl 5-hydroxy-2-methyl-1H-benzo[g]indole-4-
carboxylate 168 (137 mg, 85% yield). 
Brown crystals, m.p : 176.8-177.6°C 1H NMR (CDCl3): δ 2.52 (3H, s, H-1’), 4.08 
(3H, s, OCH3), 6.69 (1H, s, H-3), 7.40 (1H, m, H-7 and H-8), 7.61 (1H, m, H-7 and 
H-8), 7.80 (1H, m, H-6 or H-9), 8.46 (1H, m, H-6 or H-9), 8.50 (1H, s, NH), 12.25 
(1H, s, OH).13C NMR (CDCl3): δ 13.87 (CH3), 52.12 (OCH3), 99.50 (Cquat), 104.02 
(CH), 118.75 (Cquat), 120.50 (Cquat), 121.00 (Cquat), 123.31(CH), 124.00 (Cquat), 
125.01 (Cquat), 125.59(CH), 129.41(CH), 133.53 (Cquat), 157.94 (Cquat), 173.13 (O=C-O). IR (ATR): νmax 
3420, 3250, 1694, 1663, 1633 cm-1. MS m/z (%): 255 ([M+H]+, 100). 
4.5.5. Synthesis of methyl 3-acyl-2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylates 
177.  
General procedure: To a solution of 2-methoxycarbonyl-1,4-naphthoquinone 19a (2.4 mmol, 0.5 g) in 
toluene (16.7 ml) were added acetic acid (3.3 ml) and 1.05 equivalents of β-ketoesters 174a-e, 
respectively. The reaction mixture was subsequently boiled under reflux for 4 h. After cooling to room 
temperature, the reaction mixture was poured in a saturated aqueous solution of sodium bicarbonate. 
The organic phase was separated and the remaining aqueous phase was extracted with 3×20 ml of 
dichloromethane. The combined extracts were dried over magnesium(II) sulfate. Solvent evaporation in 
vacuo furnished a crude solid, which was recrystallized from ethanol. 
4.5.5.1. Methyl 3-acetyl-2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 177a 
Yield: 54%, green crystals, m.p: 180.9-181.8°C. 1H NMR (CDCl3): δ 2.46 (3H, s, 
CH3), 3.93 (3H, s, OCH3), 5.17 (1H, s, H-3), 7.60-7.67 (1H, m, H-7 or H-8), 7.70-
7.77 (1H, m, H-7 or H-8), 7.94 (1H, d, J = 8.3 Hz, H-6 or H-9), 8.46 (1H, d, J = 8.3 
Hz , H-6 or H-9), 11.84 (1H, s, OH). 13C NMR (CDCl3): δ 29.34 (CH3), 52.49 
(CH), 61.17 (OCH3), 101.62 (Cquat), 114.26 (Cquat), 121.10 (CH), 123.51 (Cquat), 
124.87 (CH), 125.56 (Cquat), 127.47 (CH), 130.86 (CH), 143.22 (Cquat), 159.07 (=C-O), 169.74 (O=C-O), 
170.18 (O=C-O), 197.06 (C=O). IR (ATR) : νmax 3099, 1806, 1721, 1667, 1644, 1600 cm-1. MS m/z (%): 
301 ([M+H]+, 100). Anal. Calcd for C16H12O6: C 64.00, H 4.03; found: C 63.83, H 3.98. HRMS (ESI) for 
C16H12O6 : 299.0634 [M-H]+, found 299.0563.  
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4.5.5.2. Methyl 2,3-dihydro-5-hydroxy-3-(1-oxo-n-propyl)naphtho[1,2-b]furan-4-carboxylate 177b 
Yield: 46%, green crystals, m.p: 154.7-156.0°C. 1H NMR (CDCl3): δ 1.15 (3H, t, 
J = 7.2 Hz, CH2CH3), 2.65 (1H, q×d, J = 7.2, 8.9 Hz, CHaHbCH3’), 3.03 (1H, q×d, 
J = 7.2, 8.9 Hz, CHaHbCH3), 3.91 (3H, s, OCH3), 5.17 (1H, s, H-3), 7.60-7.68 
(1H, m, H-7 or H-8), 7.75-7.78 (1H, m, H-7 or H-8), 7.95 (1H, d, J = 8.3 Hz, H-6 
or H-9), 8.47 (1H, d, J = 8.3 Hz, H-6 or H-9), 11.86 (1H, s, OH). 13C NMR 
(CDCl3): δ 7.58 (CH2CH3), 35.74 (CH2), 52.42 (C-3), 60.53 (OCH3), 101.60 (Cquat), 114.41 (Cquat), 
121.10 (CH), 123.56 (Cquat), 124.89 (CH), 125.53 (Cquat), 127.40 (CH), 130.86 (CH), 143.28 (Cquat), 
169.13 (=C-O), 170.76 (O=C-O), 170.48 (O=C-O), 199.85 (C=O). IR (ATR): νmax 3078, 1804, 1745, 
1724, 1660, 1646, 1546, 1598 cm-1. MS m/z (%) : 313 ([M-H]+, 100). Anal. Calcd for C17H14O6: C 64.97, 
H 4.49; found: C 64.54, H 4.00. HRMS (ESI) for C17H14O6: 313.0790 [M-H]+, found 313.0715. 
4.5.5.3. Methyl 2,3-dihydro-5-hydroxy-3-(1-oxoisobutyryl)naphtho[1,2-b]furan-4-carboxylate 177c 
Yield: 17%, green crystals, m.p: 178.6-179.4°C. 1H NMR (CDCl3): δ 1.15 (3H, 
d, J = 6.6 Hz, CH(CH3)(CH3)), 1.25 (1H, d, J = 6.6 Hz, CH(CH3)(CH3)), 3.20 
(1H, sept, J = 6.6 Hz, CH(CH3)2, 3.91 (3H, s, OCH3), 5.30 (1H, s, H-3), 7.64-
7.67 (1H, m, H-7 or H-8), 7.72-7.77 (1H, m, H-7 or H-8), 7.96 (1H, d, J = 8.3 
Hz, H-6 or H-9), 8.48 (1H, d, J = 8.3 Hz, H-6 or H-9), 11.96 (1H, s, OH). 13C 
NMR (CDCl3): δ 17.58 (CH(CH3)(CH3), 19.31 (CH(CH3)(CH3), 39.42 (CH(CH3)2), 52.47 (C-3), 59.65 
(OCH3), 101.92 (Cquat), 114.37 (Cquat), 121.12 (CH), 123.51 (Cquat), 124.89 (CH), 125.53 (Cquat), 127.42 
(CH), 130.82 (CH), 143.12 (Cquat), 159.13 (=C-O), 170.05 (O=C-O), 170.25 (O=C-O), 202.94 (C=O). IR 
(ATR): νmax 3790, 2980, 2921 1798, 1716, 1660, 1598 cm-1. MS m/z (%): 327 ([M-H]+, 100). Anal. Calcd 
for C18H16O6: C 65.85, H 4.91; found: C 65.60, H 4.26. HRMS (ESI) for C18H18O6: 327.0947 [M-H]+, 
found 327.0867. 
4.5.5.4. Methyl 3-benzoyl-2,3-dihydro-5-hydroxy-2-oxo-naphtho[1,2-b]furan-4-carboxylate 177d 
Yield: 44%, green crystals, m.p: 219.1-220.3°C. 1H NMR (CDCl3): δ 3.44 (3H, 
s, OCH3), 6.11 (1H, s, H-3), 7.59-7.71 (3H, m, H-3’, H-4’ and H-5’), 7.72-7.77 
(1H, m, H-7 or H-8), 7.77-7.99 (1H, m, H-7 or H-8), 8.00 (1H, d, J = 8.3 Hz, H-
6 or H-9), 8.17-8.20 (2H, m, H-2’ and H-6’), 8.50 (1H, d, J = 8.3 Hz, H-6 or H-
9), 11.89 (1H, s, OH). 13C NMR (CDCl3): δ 52.10 (C-3), 55.68 (OCH3), 101.50 
(Cquat), 115.56 (Cquat), 121.15 (CH), 123.62 (Cquat), 124.87 (CH), 125.54 (Cquat), 127.34 (CH), 129.18 
(2×CH), 129.51 (2×CH), 130.83 (CH), 134.31 (CH), 135.77 (Cquat), 143.57 (Cquat), 159.23 (=C-O), 
169.68 (O=C-O), 170.65 (O=C-O), 190.61 (C=O). IR (ATR): νmax 3056, 1798, 1688, 1660, 1649, 1597 
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cm-1. MS m/z (%): 361 ([M-H]+, 100). Anal. Calcd for C21H14O6: C 69.61, H 3.89; found: C 69.09, H 3.16. 
HRMS (ESI) for C21H14O6: 361.0790 [M-H]+, found 361.0695. 
4.5.6. Synthesis of methyl 5-hydroxy-2-methylnaphtho[1,2-b]furan-4-carboxylate 178 
To a 10 wt% solution of ammonium acetate (1.0 g) in acetic acid (10 ml) were added 2-
methoxycarbonyl-1,4-naphthoquinone 11 (2.4 mmol, 0.50 g) and ethyl acetoacetate 174a (2.5 mmol, 
0.32 g), and the reaction mixture was subsequently boiled under reflux for 4 h. After cooling to room 
temperature, the reaction mixture was poured in water. The organic phase was separated and the 
aqueous phase was extracted twice with 5 ml of dichloromethane. The combined organic extracts were 
washed with a saturated aqueous solution of sodium bicarbonate and then dried over magnesium(II) 
sulfate. Solvent evaporation in vacuo furnished a mixture of three compounds. Purification by column 
chromatography on silica gel with hexane/ethyl acetate (9/1) gave methyl 5-hydroxy-2-
methylnaphthofuran-4-carboxylate 178 (0.08 g, 13% yield), methyl 1,4-dihydroxynaphthalene-2-
carboxylate 128 (0.03 g, 6% yield) and 3-amino-2-methoxycarbonyl-1,4-naphthoquinone 129a (0.23 g, 
41% yield). 
 
Methyl 5-hydroxy-2-methylnaphthofuran-4-carboxylate 178  
Yield: 13%, white crystals, m.p.:136.0-136.9°C. 1H NMR (CDCl3): δ 2.55 (3H, s, 
CH3), 4.07 (3H, s, OCH3), 6.82 (1H, s, H-3), 7.47 (1H, m, H-7 or H-8), 7.68 (1H, 
m, H-7 or H-8), 8.14 (1H, m, H-6 or H-9), 8.44 (1H, m, H-6 or H-9), 12.21 (1H, s, 
OH). 13C NMR (CDCl3): δ 14.26 (CH3), 52.28 (CH), 99.50 (Cquat), 119.52 (Cquat), 
120.50 (Cquat), 122.20 (Cquat), 124.51 (CH), 124.51 (Cquat), 124.75 (Cquat), 125.59 
(CH), 130.01 (CH), 155.09 (Cquat), 158.96 (Cquat), 175.05 (O=C-O). IR (ATR): νmax 3027, 1638, 1600 cm-
1. MS m/z (%): 257 ([M+H]+, 100). Anal. Calcd for C15H12O4: C 70.31, H 4.72, found: C 71.00, H 5.15. 
4.5.7. Synthesis of methyl 2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-b]furan-4-carboxylate 180 
To a solution of 177a or 177d (0.25 g) in toluene (10 ml) and acetic acid (2 ml) was added 12 
equivalents of ammonium acetate, and the reaction mixture was heated under reflux for 4 hours. After 
cooling to room temperature, the reaction mixture was poured in water. The organic phase was 
separated and the aqueous phase was extracted with 3×8 ml of dichloromethane. The combined 
organic extracts were washed with a saturated solution of sodium bicarbonate, brine and dried over 
magnesium(II) sulfate. Solvent evaporation in vacuo furnished a solid, which was recrystallized from 
ethanol to furnish 180. 
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Yield: 53-91%, brown crystals, m.p.:172.5-173.3°C. 1H NMR (CDCl3): δ 4.03 (3H, 
s, OCH3), 4.07 (2H, s, H-3), 7.60 (1H, dd, J = 7.9, 8.2 Hz, H-7), 7.73 (1H, dd, J = 
7.9, 7.9 Hz, H-8), 7.96 (1H, J = 7.9 Hz, H-9), 8.45 (1H, d, J = 8.2 Hz, H-6), 11.93 
(1H, s, OH). 13C NMR (CDCl3): δ 36.80 (CH2), 52.74 (CH), 101.97 (Cquat), 114.79 
(Cquat), 120.91 (CH), 123.74 (Cquat), 124.75 (CH), 126.78(CH), 130.63 (CH), 142.80 (Cquat), 158.65 
(Cquat), 170.80 (O=C-O), 174.87 (O=C-O). IR (ATR): νmax 3566, 3118, 3028, 2958, 1788, 1670, 1644, 
1599 cm-1. MS m/z (%): 257 ([M-H]+, 100). Anal. Calcd for C15H12O4: C 65.12, H 3.90; found: C 64.70, H 
2.62. HRMS (ESI) for C15H12O4: 257.0528 [M-H]+, found 257.0450. 
4.5.8. Synthesis of 3,4-dialkyl-6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-ones 170 
General procedure: To a solution 2-methoxycarbonyl-1,4-naphthoquinone 19a (2.40 mmol, 0.50 g) in 
toluene (16.7 ml) were added acetic acid (3.3 ml) and 1.05 equivalents of the appropriate enaminoester 
23a-h, respectively. The reaction mixture was subsequently boiled under reflux for 4-48 hours. The 
reaction was followed to completion by TLC and LC-MS. After cooling to room temperature, N-ethyl-3-
methylbenzo[g]furo[4,3,2-de]isoquinoline-1-ones 170a, 170d and 170e precipitated as yellow-orange 
solids from the reaction mixture. After filtration of the crystals, the filtrate was poured in a saturated 
aqueous solution of sodium bicarbonate. The organic phase was separated and the aqueous phase was 
extracted with 3×20 ml of dichloromethane. The combined organic extracts were dried over 
magnesium(II) sulfate. Solvent evaporation in vacuo furnished crude solids, which were mixed with the 
isolated yellow-orange precipitate and were then recrystallized from ethanol.  
4.5.8.1. 6-Hydroxy-3-methyl-4-n-propylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170c 
Yield: 19%, orange crystals, m.p.: 241.7-242.9°C (EtOH). 1H NMR (CDCl3): δ 
1.08 (3H, t, J = 7.1 Hz, NCH2CH2CH3), 1.85-1.75 (2H, m, NCH2CH2CH3), 
2.86 (3H, s, CH3), 4.10 (2H, t, J = 7.2 Hz, NCH2CH2CH3), 7.49 (1H, ddd, J = 
1.4, 7.0, 8.8 Hz, H-7 or H-8), 7.68 (1H, ddd, J = 1.4, 7.0, 8.8 Hz, H-7 or H-8), 
7.98-8.01 (1H, dm, J = 8.8 Hz, H-6 or H-9), 8.42-8.45 (1H, m, H-6 or H-9), 
10.26 (1H, s, OH). 13C NMR (CDCl3): δ 11.43 (CH3), 16.13 (CH3), 22.84 (NCH2CH2CH3), 45.37 (NCH2), 
100.67 (Cquat), 101.94 (Cquat), 120.31 (CH), 120.63 (Cquat), 122.32 (Cquat), 122.86 (Cquat), 124.44 (CH), 
124.67 (CH), 129.82 (CH), 134.13 (Cquat), 150.72 (Cquat), 153.16 (=C-O), 165.36 (O=C-N), 166.51 (O=C-
O). IR (ATR): νmax 3170, 1793, 1754, 1676, 1636, 1610, 1225 cm-1. MS m/z (%): 310 ([M+H]+, 100). 
Anal. Calcd for C18H15NO4: C 69.89, H 4.89, N 4.53; found: C 68.89, H 4.30, N 4.36. HRMS (ESI) for 
C18H15NO4 308.1001 [M-H]+, found 308.0930. 
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4.5.8.2. 4-Ethyl-6-hydroxy-3-methylbenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170d 
Yield: 33%, orange crystals, m.p.: 243.1-244.6°C (EtOH). 1H NMR (CDCl3): δ 
1.40 (3H, t, J = 7.1 Hz, NCH2CH3), 2.86 (3H, s, CH3), 4.23 (2H, q, J = 7.1 Hz, 
NCH2CH3), 7.49 (1H, ddd, J = 1.4, 7.0, 8.8 Hz, H-7 or H-8), 7.68 (1H, ddd, J = 
1.4, 7.0, 8.8 Hz, H-7 or H-8), 7.98-8.02 (1H, dm, J = 8.8 Hz, H-6 or H-9), 8.27-
8.46 (1H, m, H-6 or H-9), 10.23 (1H, s, OH). 13C NMR (CDCl3): δ 14.27 (CH3), 
16.01 (CH3), 38.96 (NCH2), 101.97 (Cquat), 101.97 (Cquat), 120.32 (CH), 120.32 (Cquat), 122.18 (Cquat), 
122.87 (Cquat), 124.46 (CH), 124.69 (CH), 129.84 (CH), 134.48 (Cquat), 150.56 (Cquat), 153.16 (=C-O), 
165.21 (O=C-N), 167.09 (O=C-O). IR (ATR): νmax 3170, 1793, 1754, 1676, 1636, 1610, 1225 cm-1. MS 
m/z (%): 296 ([M+H]+, 100). Anal. Calcd for C17H13NO4: C 69.15, H 4.44, N 4.74; found: C 68.16, H 3.54, 
N 4.49. HRMS (ESI) for C17H13NO4: 294.0845 [M-H]+, found 294.0768. 
4.5.8.3. 3,4-Diethyl-6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-dione 170e 
Yield: 47%, yellow crystals, m.p.: 200.7-201.6°C (EtOH). 1H NMR (CDCl3): δ 
1.41 (3H, t, J = 7.2 Hz, CH2CH3), 1.49 (3H, t, J = 7.2 Hz, NCH2CH3), 3.22 (2H, 
q, J = 7.2 Hz, CH2CH3), 4.22 (2H, q, J = 7.2 Hz, NCH2CH3), 7.46 (1H, ddd, J = 
1.4, 7.0, 8.8 Hz, H-7 or H-8), 7.65 (1H, ddd, J = 1.4, 7.0, 8.8 Hz, H-7 or H-8), 
7.94-7.99 (1H, dm, J = 8.8 Hz, H-6 or H-9), 8.38-8.43 (1H, m, H-6 or H-9), 10.20 
(1H, s, OH). 13C NMR (CDCl3): δ 13.91 (CH3), 14.90 (CH3), 22.84 (CH2CH3), 38.68 (NCH2), 100.70 
(Cquat), 100.90 (Cquat), 120.18 (CH), 120.76 (Cquat), 122.14 (Cquat), 122.72 (Cquat), 124.35 (CH), 124.58 
(CH), 129.73 (CH), 134.37 (Cquat), 153.00 (Cquat), 156.38 (=C-O), 165.34 (O=C-N), 166.57 (O=C-O). IR 
(ATR): νmax 3170, 1793, 1754, 1676, 1636, 1610, 1225 cm-1. MS m/z (%): 310 ([M+H]+, 100). Anal. 
Calcd for C18H15NO4: C 69.89, H 4.89, N 4.53; found: C 69.39, H 4.47, N 4.40. HRMS (ESI) for 
C18H15NO4 308.1001 [M-H]+, found 308.0920. 
4.5.9. Synthesis of 2,3-dialkyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic         
acids 187 
General procedure 100 mg of 3,4-dialkyl-6-hydroxybenzo[g]furo[4,3,2-de]isoquinoline-2,5(4H)-ones 
170d (0.34 mmol) and 170e (0.32 mmol) were added to a solution of 2 ml of 4 M NaOH, 1 ml of THF 
and 1 ml of MeOH. This reaction mixture was stirred for 1.5 hours in an oil bath at 50°C, and which then 
was allowed to cool down to room temperature. The reaction mixture was poured in 8 ml of 1 M HCl and 
extracted with 3×5 ml of chloroform. The combined organic extracts were washed with brine and 
concentrated under reduced pressure to afford compounds 187d and 187e (purity 81-83%). All attempts 
N
O
O
OH O
Me
N
O
O
OH O
 
112 Chapter 4: Experimental section 
to purify the latter compounds by column chromatography and/or recrystallization techniques failed as it 
resulted in degradation of the products. 
4.5.9.1. 2-Ethyl-3-methyl-1,2,5,10-tetrahydro--1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187d 
Crude yield: 40%, brown powder, m.p.: 190.6-191.8°C. 1H NMR (DMSO-d6): δ 
1.24-1.28 (3H, t, J = 7.1 Hz, NCH2CH3 ), 2.51 (3H, s, CH3), 4.12 (2H, q, J = 7.1 
Hz, NCH2CH3), 7.82-7.987 (1H, dd, J = 6.3 and 7.1 Hz, H-7 or H-8), 7.90-7.95 
(1H, dd, J = 6.6 and 7.1 Hz, H-7 or H-8), 8.02 (1H, d, J = 7.1 Hz, H-6 or H-9), 
8.07 (1H, d, J = 7.1 Hz, H-6 or H-9). 13C NMR (DMSO): δ 13.40 (CH3), 18.65 (CH3), 79.74 (NCH2), 
111.89 (Cquat), 116.66 (Cquat), 126.58 (CH), 126.72 (CH), 131.8 (Cquat), 134.00 (2×CH), 135.80 (Cquat), 
141.29 (Cquat), 153.56 (Cquat), 157.56 (Cquat), 168.91 (O=C-N and O=C-O), 180.34 (C=O), 183.76 (C=O). 
IR (ATR): νmax 3352, 3164, 3071, 2922, 2853, 2626, 2360, 2341, 1716, 1682, 1616, 1521, 1285 cm-1. 
MS m/z (%): 312 ([M+H]+, 100). Purity (LC-MS): 83%. 
4.5.9.2. 2,3-Diethyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 187e 
Crude yield: 98%, brown powder, m.p.: 192.1-193.9 °C. 1H NMR (CDCl3): δ 1.43 
(6H, 2×t, J = 7.1 Hz, CH2CH3 and NCH2CH3), 2.94 (2H, q, J = 7.1 Hz, CH2CH3), 
4.28 (2H, q, J = 7.1 Hz, NCH2CH3), 7.71-7.76 (1H, dd, J = 7.1 and 7.1 Hz, H-7 or 
H-8), 7.80-7.85 (1H, dd, J = 7.7 and 7.7 Hz, H-7 or H-8), 8.10 (1H, d, J = 7.7 Hz, 
H-6 or H-9), 8.26 (1H, d, J = 7.7 Hz, H-6 or H-9). 13C NMR (DMSO-d6): δ 14.15 (CH3), 14.39 (CH3), 
25.28 (CH2CH3), 79.94 (NCH2), 111.65 (Cquat), 117.10 (Cquat), 126.60 (CH), 126.72 (CH), 131.79 (Cquat), 
133.97 (Cquat), 134.06 (CH), 135.82 (CH), 141.52 (Cquat), 157.67 (Cquat), 157.76 (CH), 168.75 (O=C-N 
and O=C-O), 180.39 (C=O), 183.78 (C=O). IR (ATR): νmax 3342, 3165, 3073, 3025, 2963, 2700, 1750, 
1678, 1606, 1528 cm-1. MS m/z (%): 326 ([M+H]+, 100). Purity (LC-MS): 81%. 
4.5.10. Synthesis of alkyl 2,3-disubstituted-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-
4-carboxylate 171 
Procedure A: To a solution of 2,3-diethyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzogisoquinoline-4-
carboxylic acid 187e (200 mg, 0.62 mmol) in 2 ml of THF and 8 ml of acetonitrile was added a freshly-
prepared solution of 5 equivalents of diazomethane in dry diethyl ether at room temperature. The 
reaction was run to completion after 2 hours. Then the reaction mixture was poured in 10 ml of water 
and extracted with 3x10 ml of ethyl acetate. The combined organic extracts were washed with brine and 
dried over magnesium sulfate, then filtered. The filtrate was concentrated under in vacuo to form a 
crude solid which was purified by preparative thin layer chromatography using a mixture of hexane/ethyl 
acetate (1/4) as solvent to afford 203 mg (97%) of compound 171e. 
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Procedure B, Oxidative addition: To a mixture of methyl 1,4-dihydroxynaphthalene-2-carboxylate 128 
(0.5 g, 1.15 mmol), manganese oxide (1.34 g, 6.90 mmol) and magnesium(II) sulfate (2.76 g, 11.50 
mmol) was added a solution of enaminoesters 23 (1.05 equivalents in 20 ml of dry dichloromethane). 
The mixture was stirred at room temperature for 3.5 hours. Then the reaction mixture was filtered and 
concentrated in vacuo. The resulting concentrate was dissolved in 15 ml of toluene and 3 ml of acetic 
acid, and this mixture was subsequently heated under reflux for 1-1.5 hours. After cooling to room 
temperature, the reaction mixture was poured in water and extract with ethyl acetate (20 ml×3). The 
organic phase was washed with saturated sodium bicarbonate, brine, filtered and concentrated in 
vacuo. The obtained compounds were recrystallized from methanol for 171c,e and from ethanol for 
171g-j. 
4.5.10.1. Methyl 2-n-propyl-3-methyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-
carboxylate 171c 
Yield: 46%, greenish brown powder, m.p.: not observed-the compound 
decomposes at 256 °C. 1H NMR (CDCl3): δ 1.01 (3H, t, J = 7.4 Hz, 
CH2CH2CH3), 1.36 1.77 (2H, sextet, J = 7.4 Hz, NCH2CH2CH3), 3.19 (3H, 
s,CH3), 4.00 (3H, s, OCH3), 4.11 (2H, br s, NCH2CH2CH3), 7.76 (1H, t, J = 
7.7 Hz, H-7 or H-8), 7.83 (1H, t, J = 7.7 Hz, H-7 or H-8), 8.08 (1H, d, J = 7.7 Hz, H-6 or H-9), 8.25 (1H, 
d, J = 7.7 Hz, H-6 or H-9). 13C NMR (CDCl3): δ 11.17 (NCH2CH2CH3), 22.67 (NCH2CH2CH3), 30.73 
(CH3), 47.07 (NCH2CH2CH3), 53.91 (OCH3), 110.75 (Cquat), 118.86 (Cquat), 126.77 (CH), 127.28 (CH), 
131.39 (Cquat), 133.59 (Cquat), 133.59 (CH), 135.47 (CH), 141.82 (Cquat), 151.41 (Cquat), 159.00 (O=C-N), 
168.40 (O=C-O), 180.20 (C=O), 183.24 (C=O). IR (ATR): νmax 2961, 1717, 1688, 1631, 1592, 1513, 
1437, 1415, 1283, 1254, 1164, 969 cm-1. MS m/z (%): 340 ([M+H]+, 100). Anal. Calcd for C19H17NO5: C 
67.25, H 5.05, N 4.13; found: C 66.39, H 3.78, N 4.93. HRMS (ESI) for C19H17O5: 340.1107 [M+H]+, 
found 340.1181. 
4.5.10.2. Methyl 2-ethyl-3-methyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 
171d 
Yield: 14%, red orange powder, m.p.: not observed-the compound decomposes 
at 280 °C. 1H NMR (CDCl3): δ 1.42 (3H, t, J = 7.4 Hz, CH2CH3), 3.19 (3H, 
s,CH3), 4.09 (3H, s, OCH3), 4.24 (2H, br s, NCH2CH3), 7.74 (1H, t, J = 7.7 Hz, H-
7 or H-8), 7.83 (1H, t, J = 7.7 Hz, H-7 or H-8), 8.09 (1H, d, J = 7.7 Hz, H-6 or H-
9), 8.25 (1H, d, J = 7.7 Hz, H-6 or H-9). 13C NMR (CDCl3): δ 14.27 (NCH2CH3), 30.66 (CH3), 41.32 
(NCH2CH3), 53.79 (OCH3), 110.74 (Cquat), 118.83 (Cquat), 126.61 (CH), 127.20 (CH), 131.28 (Cquat), 
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133.23 (Cquat), 135.43 (CH), 136.91 (CH), 141.78 (Cquat), 151.67 (Cquat), 157.94 (O=C-N), 168.33 (O=C-
O), 180.36 (C=O), 183.32 (C=O). IR (ATR): νmax 1735, 1687, 1508, 1416, 1281, 1259, 994 cm-1. MS 
m/z (%): 326 ([M+H]+, 100). 
4.5.10.3. Methyl 2,3-diethyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 171e 
Yield: 69-97%, red orange crystals, m.p.: 183.1-184.2°C. 1H NMR (CDCl3): δ 
1.37 (3H, t, J = 7.0 Hz, CH2CH3), 1.41 (3H, t, J = 7.0 Hz, NCH2CH3), 2.80 (2H, 
q, J = 7.0 Hz, CH2CH3), 4.00 (3H, s, OCH3), 4.28 (2H, q, J = 7.0 Hz, NCH2CH3), 
7.72 (1H, d, J = 7.7 Hz, H-7 or H-8), 7.82 (1H, d, J = 7.7 Hz, H-7 or H-8), 8.09 
(1H, d, J = 7.7 Hz, H-6 or H-9), 8.25 (1H, d, J = 7.7 Hz, H-6 or H-9). 13C NMR (CDCl3): δ 13.86 
(CH2CH3), 14.13 (NCH2CH3), 25.35 (CH2CH3), 40.88 (NCH2CH3), 53.28 (OCH3), 109.88 (Cquat), 117.60 
(Cquat), 126.67 (CH), 127.22 (CH), 131.47 (Cquat), 133.35 (Cquat), 133.77 (CH), 135.30 (CH), 141.74 
(Cquat), 157.33 (Cquat), 158.28 (O=C-N), 168.29 (O=C-O), 180.40 (C=O), 183.47 (C=O). IR (ATR): νmax 
2946, 1731, 1693, 1632, 1504, 1424, 1283, 1260, 1153, 1087, 994, 749 cm-1. MS m/z (%): 340 ([M+H]+, 
100).  Anal. Calcd for C19H17NO5: C 67.25, H 5.05, N 4.13; found: C 67.04, H 4.47, N 5.53. HRMS (ESI) 
for C19H17NO5 340.1107 [M+H]+, found 340.1201. HRMS (ESI) for C19H17NO5: 340.1107 [M+H]+, found 
340.1201.  
4.5.10.4. Ethyl 2-ethyl-3-phenyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxy-late 
171g 
Yield: 32%, yellow orange crystals, m.p.: 193.4-194.2°C. 1H NMR (CDCl3): δ 
1.00 (3H, t, J = 7.1 Hz,NCH2CH3), 1.21 (3H, t, J = 6.9 Hz, OCH2CH3), 3.97 
(2H, q, J = 7.1 Hz, NCH2CH3), 4.02 (2H, q, J = 6.9 Hz, OCH2CH3), 7.37-7.40 
(2H, m, H-2’ and H-5’), 7.49-7.56 (3H, m, H-3’, H-4’ and H-5’), 7.73 (1H, t, J = 
6.0 Hz, H-7 or H-8), 7.83 (1H, t, J = 6.0 Hz, H-7 or H-8), 8.10 (1H, d, J = 6.0 Hz, H-6 or H-9), 8.28 (1H, 
d, J = 6.0 Hz, H-6 or H-9). 13C NMR (CDCl3): δ 13.66 (NCH2CH3), 13.94 (OCH2CH3), 43.13 (NCH2CH3), 
61.77 (OCH2CH3), 111.88 (Cquat), 119.24 (Cquat), 126.67 (CH), 127.27 (CH), 128.49 (2×CH), 128.75 
(2×CH), 130.46 (CH), 131.44 (Cquat), 131.57 (Cquat), 133.44 (CH), 133.77 (Cquat), 135.29 (CH), 141.42 
(Cquat), 154.69 (Cquat), 157.90 (O=C-N), 166.45 (O=C-O), 180.63 (C=O), 183.21 (C=O). IR (ATR): νmax 
2991, 1735, 1658, 1628, 1591, 1523, 1488, 1444, 1400, 1327, 1223, 1182, 1149, 1047, 977, 916 cm-1. 
MS m/z (%): 401 ([M-H]+, 100). Anal. Calcd for C24H19NO5: C 71.81, H 4.77, N 3.49; found: C 71.39, H 
4.02, N 3.49. HRMS (ESI) for C24H19O5: 402.1263 [M+H]+, found 402.1344. 
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4.5.10.5. Ethyl 3-phenyl-2-n-propyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 
171h 
Yield: 56%, orange crystals, m.p.: 169.0-169.4°C. 1H NMR (CDCl3): δ 0.75 
(3H, t, J = 7.4 Hz, NCH2CH2CH3), 1.00 (3H, t, J = 7.1 Hz, OCH2CH3), 1.66 
(2H, sext, J = 7.4 Hz, NCH2CH2CH3), 3.82 (2H, q, J = 7.4 Hz, NCH2CH2CH3), 
4.02 (2H, q, J = 7.1 Hz, OCH2CH3), 7.36-7.41 (2H, m, H-2’ and H-5’), 7.49-
7.56 (3H, m, H-3’, H-4’ and H-5’), 7.73 (1H, t, J = 6.0 Hz, H-7 or H-8), 7.83 
(1H, t, J = 6.0 Hz, H-7 or H-8), 8.10 (1H, d, J = 6.0 Hz, H-6 or H-9), 8.28 (1H, d, J = 6.0 Hz, H-6 or H-9). 
13C NMR (CDCl3): δ 11.34 (NCH2CH2CH3), 13.66 (OCH2CH3), 22.09 (NCH2CH2CH3), 49.30 
(NCH2CH2CH3), 61.77 (OCH2H3), 111.80 (Cquat), 118.98 (Cquat), 126.67 (CH), 127.28 (CH), 128.57 
(2×CH), 128.67 (2×CH), 130.46 (CH), 131.47 (Cquat), 131.57 (Cquat), 133.42 (CH), 133.79 (Cquat), 135.27 
(CH), 141.39 (Cquat), 158.00 (Cquat), 158.00 (O=C-N), 166.44 (O=C-O), 180.59 (C=O), 183.22 (C=O). IR 
(ATR): νmax 2980, 1688, 1628, 1593, 1524, 1492, 1446, 1406, 1320, 1285, 1177, 1166, 1024, 977, 928 
cm-1. MS m/z (%): 416 ([M+H]+, 100). Anal. Calcd for C25H21NO5: C 72.28, H 5.10, N 3.37; found: C 
71.39, H 4.55, N 8.21. HRMS (ESI) for C25H21NO5: 416.1419 [M+H]+, found 416.1502. 
4.5.10.6. Ethyl 3-methyl-2-n-propyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 
171i 
Yield: 29%, brown crystals, m.p.: 128.0-129.9°C. 1H NMR (CDCl3): δ 1.12 
(3H, t, J = 7.4 Hz, CH2CH2CH3), 1.40 (3H, J = 7.4 Hz,OCH2CH3), 1.77 (2H, 
sextet, J = 7.4 Hz, NCH2CH2CH3), 3.18 (3H, S, CH3), 4.26 (2H, br s, 
NCH2CH2CH3), 4.48 (2H, q, J = 7.4 Hz, OCH2CH3), 7.75 (1H, t, J = 7.7 Hz, 
H-7 or H-8), 7.84 (1H, t, J = 7.7 Hz, H-7 or H-8), 8.09 (1H, d, J = 7.7 Hz, H-6 or H-9), 8.26 (1H, d, J = 
7.7 Hz, H-6 or H-9). 13C NMR (CDCl3): To date, a decent 13C NMR spectrum of this derivative could not 
be recorded even upon prolongation of the relaxation delay and increasing the number of recorded 
scans. IR (ATR): νmax 2968, 1725, 1688, 1629, 1592, 1511, 1440, 1417, 1415, 1327, 1282, 1254, 1210, 
1174, 1058, 1011, 968 cm-1. MS m/z (%): 354 ([M+H]+, 10%), 705 (100%). Anal. Calcd for C20H19NO5: C 
67.98, H 5.42, N 3.96; found: C 67.66, H 4.71, N 6.61. HRMS (ESI) for C20H19NO5: 354.1263 [M+H]+, 
found 354.1326.   
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4.5.10.7. Methyl 3-ethyl-2-n-propyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylate 
171j 
Yield: 71%, orange crystals, m.p.: 128.6-129.0°C. 1H NMR (CDCl3): δ 1.05 
(3H, t, J = 7.4 Hz, CH2CH2CH3), 1.36 (3H, J = 7.4 Hz, CH2CH3), 1.79 (2H, 
sextet, J = 7.4 Hz, NCH2CH2CH3), 2.80 (2H, q, J = 7.4 Hz, CH2CH3), 4.00 
(3H, s, OCH3), 4.11 (2H, q, J = 7.4 Hz, NCH2CH3), 7.72 (1H, t, J = 7.7 Hz, H-
7 or H-8), 7.81 (1H, t, J = 7.7 Hz, H-7 or H-8), 8.09 (1H, d, J = 7.7 Hz, H-6 or H-9), 8.25 (1H, d, J = 7.7 
Hz, H-6 or H-9). 13C NMR (CDCl3): δ 11.52 (CH3), 13.80 (CH3), 22.35 (CH2CH3), 25.35 (NCH2CH2CH3), 
47.16 (NCH2CH2CH3), 53.26 (OCH3), 109.96 (Cquat), 117.57 (Cquat), 126.66 (CH), 127.21 (CH), 131.47 
(Cquat), 133.35 (Cquat), 133.76 (CH), 135.29 (CH), 141.71 (Cquat), 157.41 (Cquat), 158.42 (O=C-N), 168.29 
(O=C-O), 180.43 (C=O), 183.47 (C=O). IR (ATR): νmax 2966, 1728, 1691, 1633, 1593, 1516, 1415, 
1330, 1282, 1255, 1147, 1064, 979 cm-1. MS m/z (%): 354 ([M+H]+, 100). Anal. Calcd for C20H19NO5: C 
67.98, H 5.42, N 3.96; found: C 67.73, H 4.92, N 12.35. HRMS (ESI) for C20H19NO5: 354.1262 [M+H]+, 
found 354.1262.  
4.5.11. Synthesis of methyl 1,2-dihydro-5,10-dihydroxy-2-ethyl-3-methyl-1-
oxobenzo[g]isoquinoline-4-carboxylate 188d 
To a solution of 2-ethyl-1,2,5,10-tetrahydro-3-methyl-1,5,10-trioxobenzo[g]isoquinoline-4-carboxylic acid 
186d (200 mg, 0.64 mmol) in 2 ml of THF and 8 ml of acetonitrile was added a freshly-prepared solution 
of 5 equivalents of diazomethane in dry diethyl ether at room temperature. The reaction was run 
overnigth. Then the reaction mixture was poured in 10 ml of water and extracted with 3x10 ml of ethyl 
acetate. The combined organic extracts were washed with brine, stirred and dried over magnesium 
sulfate for 1 hour in open air, then filtered. The filtrate was concentrated under reduced pressure to form 
a crude solid which was purified by preparative thin layer chromatography using a mixture of hexane/ 
ethyl acetate (1/4) as solvent to afford 46 mg of compound 188d (22%) and 29 mg of compound 171d 
(14%). For spectral data of compound 171d vide supra 
Yield: 22%, green sticky solid, 1H NMR (CDCl3): δ 1.40 (3H, t, J = 7.5 Hz, 
NCH2CH3), 2.90 (3H, s, CH3), 4.18 (3H, s, OCH3), 4.25 (2H, q, J = 7.5 Hz, 
NCH2CH3), 7.53 (1H, t, J = 9.0 Hz, H-7 or H-8), 7.67 (1H, t, J = 9.0 Hz, H-7 or H-
8), 8.08 (1H, d, J = 9.0 Hz, H-6 or H-9), 8.45 (1H, d, J = 9.0 Hz, H-6 or H-9). 13C 
NMR (CDCl3): δ 14.12 (CH3), 16.07 (CH3), 39.63 (NCH2CH3), 63.71 (CH3O), 99.92 (Cquat), 109.13 
(Cquat), 120.57 (CH), 122.00 (Cquat), 122.61 (Cquat), 125.04 (CH), 125.68 (CH), 128.05 (Cquat), 129.25 
(CH), 138.31 (Cquat), 151.68 (Cquat), 153.48 (Cquat), 160.13 (O=C-N), 166.94 (O=C-O). IR (ATR) νmax: 
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3347, 2944, 2358, 1751, 1672, 1638, 1440, 1396, 1366, 1237, 1044 cm-1. MS m/z (%): 328 ([M+H]+, 
100). 
4.6. Efforts towards the first total synthesis of paepalantine 24 
4.6.1. Synthesis of N,N-diethyl-2,4-dimethoxybenzamide 195 and N,N-diethyl-2-formyl-4,6-
dimethoxybenzamide 196140  
4.6.1.1. N,N-Diethyl-2,4-dimethoxybenzamide 195 
A mixture of 2,4-dimethoxybenzoic acid 193 (6.5 g, 34.96 mmol), thionyl chloride (16 ml) and toluene 
(200 ml) was boiled for 2.5 hours. The solvent and the excess of thionyl chloride were removed in 
vacuo. The acid chloride residue was dissolved in toluene (80 ml). A solution of diethylamine (11 ml, 
106.33 mmol) in toluene (30 ml) was added dropwise to the solution of the crude acid chloride in toluene 
at 0°C. After stirring for 2 hours, toluene was removed under reduced pressure. The residue was diluted 
with dichloromethane (100 ml), washed with saturated sodium bicarbonate (3×100 ml) and brine (3×100 
ml). The organic layer was dried over magnesium sulfate and concentrated in vacuo. The residue 
underwent column chromatography using diethyl ether/hexane (3/1) to give N,N-diethyl-2,4-
dimethoxybenzamide 195 (7.05 g, 80%) as a viscous yellow oil. Spectra data were in accordance with 
the literature.140 
1H NMR (CDCl3): δ 0.98 (3H, t, J = 7.1 Hz, CH2CH3), 1.16 (3H, t, J = 7.1 Hz, 
CH2CH3), 3.08 (2H, q, J = 7.1 Hz, CH2CH3), 3.47 (2H, q, J = 7.1 Hz, CH2CH3), 
3.70 (3H, s, OCH3), 3.72 (3H, s, OCH3), 6.37 (1H, d, J = 2.1 Hz, H-3), 6.40 (1H, 
dd, J = 8. 0, 2.1 Hz, H-5), 7.03 (1H, d, J = 8.0 Hz, H-6). 
4.6.1.2. N,N-Diethyl-2-formyl-4,6-dimethoxybenzamide 196 
To a stirred solution of N,N-diethyl-2,4-dimethoxybenzamide 195 (7.0 g, 29.50 mmol) in tetrahydrofuran 
(193 ml) at -78°C was added dropwise tert-butyllithium (20.3 ml of a 1.5 M solution in hexanes, 30.42 
mmol). After stirring for 20 minutes, N,N-dimethylformamide (8.5 ml, 117.2 mmol) was added dropwise. 
The reaction mixture was warmed to room temperature, stirred for 12 hours and the solvent removed in 
vacuo. The residue was dissolved in dichloromethane (60 ml), washed with brine (3×50 ml) and the 
organic layer was dried over magnesium sulfate. Removal of the solvent in vacuo followed by column 
chromatography using diethyl ether as eluent gave N,N-diethyl-2-formyl-4,6-dimethoxybenzamide 196 
(7.03 g, 90%) as a viscous yellow oil. Spectra data were in agreement with the literature.139 
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1H NMR (CDCl3): δ 0.94 (3H, t, J = 7.1 Hz, NCH2CH3), 1.20 (3H, t, J = 7.1 Hz, 
NCH2CH3), 3.05 (2H, q, J = 7.1 Hz, NCH2CH3), 3.40-3.54 (1H, m, 
NCHaHbCH3), 3.56-3.68 (1H, m, NCHaHbCH3), 3.75 (3H, s, OCH3), 3.79 (3H, s, 
OCH3), 6.64 (1H, d, J = 2.3 Hz, H-5), 6.96 (1H, d, J = 2.3 Hz, H-6), 9.89 (1H, s, CHO). 
 
4.6.2. Synthesis of 3-cyano-5,7-dimethoxy-3H-isobenzofuran-1-one 25141 
A solution of N,N-diethyl-2,4-dimethoxy-6-formylbenzamide 196 (860 mg, 3.20 mmol) in acetic acid (40 
ml) and 10% hydrochloric acid (40 ml) was boiled for 24 hours. After cooling to room temperature, the 
reaction mixture was concentrated in vacuo and ethyl acetate (150 ml) was added to the reaction 
mixture which was washed with saturated sodium bicarbonate (3×100 ml). The combined aqueous 
layers were carefully acidified to pH 2 with concentrated hydrochloric acid. The acidified solution was 
extracted with ethyl acetate (2×250 ml). The combined organic layers were washed with brine and dried 
over magnesium sulfate. The solvent was removed in vacuo give crude 3-hydroxy-5,7-dimethoxy-3H-
isobenzofuran-1-one 197 as a colourless solid which added to a solution of potassium cyanide (2.3 g, 
35.3 mmol) (480 mg, 2.3 mmol) in water (8 ml) and cooled to 0 °C. Ice (8 g) and concentrated 
hydrochloric acid (10.7 ml, 0.12 mol) were added to the mixture and stirred for 3 hours to room 
temperature (Caution: formation of HCN). The reaction mixture was extracted with ethyl acetate (20 ml), 
the organic layer was washed with saturated sodium bicarbonate (15 ml), water (15 ml) and brine (15 
ml), dried over magnesium sulfate and the solvent was removed in vacuo to give a brown solid. 
Purification by flash column chromatography eluting with dichloromethane gave 3-cyano-5,7-dimethoxy-
3H-isobenzofuran-1-one 25 (479 mg, 68% yield) as a colourless solid. All spectral data were in 
accordance with the literature.141 
1H NMR (CDCl3): δ 3.94 (3H, s, OCH3), 3.98 (3H, s, OCH3), 5.91 (1H, s, H-3), 6.54 
(1H, d, J = 1.7 Hz, H-6), 6.66 (1H, d, J = 1.7 Hz, 4-H).  
 
4.6.3. Synthesis of 1-(2-furyl)ethanol 199 
Magnesium turnings (6.51 g, 0.28 mol) were placed in a 500 ml 3-neck round-bottom flask and a 
condenser along with a side arm addition funnel were attached. The apparatus was flame dried and 
flushed with nitrogen, then anhydrous Et2O (50 ml) and an iodide crystal were added to the magnesium 
turnings. A solution of methyl iodide (38 g, 0.27 mol) in anhydrous Et2O (150 ml) were added dropwise 
to the magnesium solution. After the addition was completed, the solution was stirred at room 
temperature for 1 hour after which a solution of freshly distilled furfural 198 (9.6 g, 0.10 mol) in 
anhydrous Et2O (150 ml) were added slowly to the Grignard reagent at 0°C, and the solution was stirred 
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for 3 hours at 0°C and 1 hour at room temperature. The reaction was quenched with a saturated 
solution of aqueous ammonium chloride and extracted (3×100 ml) with Et2O. The organic phase was 
washed with saturated solution of sodium bicarbonate, brine, dried (MgSO4) and concentrated in vacuo 
to give 1-(2-furyl)ethanol 199 (11.0 g, 98% yield) as a yellow oil. All the spectral data were in 
accordance with the literature.142 
1H NMR (CDCl3): δ 1.53 (3H, d, J = 6.6 Hz, CHCH3), 2.17 (1H, br s, OH), 4.92 (1H, q, J = 
6.6 Hz, CHCH3), 6.23 (1H, d, J = 3.6 Hz, H-2), 6.33 (1H, dd, J = 3.6 and 1.7 Hz, H-3), 
7.33 (1H, d, J =1.7 Hz, H-5).   
4.6.4. Synthesis of 6-hydroxy-2-methyl-6H-pyran-3-one 200 
To a solution of 1-(2-furyl)ethanol 199 (4.3 g, 38.36 mmol) in water (8 ml) and THF (32 ml) cooled to -
4°C were added portionwise under temperature control, a mixture of NBS (7.51 g, 42,91 mmol), 
NaHCO3 (7.1 g, 84.52 mmol) and NaOAc (3.46 g, 38.36 mmol). The mixture was stirred for 1 hour at 
room temperature. The reaction was quenched with saturated solution of sodium bicarbonate and 
extracted with Et2O (3×50 mL), dried over magnesium sulfate, concentrated in vacuo and purified by 
column chromatography eluting with EtOAc/hexane (1/4) to give 6-hydroxy-2-methyl-6H-pyran-3-one 
200 (4.48 g, 91% yield) as a greenish yellow oil.  
1H NMR (CDCl3, 300 MHz): δ 1.30 (3H, d, J = 7.0 Hz, CH3), 2.20 (1H, br, OH), 4.42 (1H, d, 
J = 7.0 Hz, H-2), 5.05 (1H, d, J = 3.1 Hz, H-6), 5.85 (1H, J = 10.0 Hz, H-4), 6.60 (1H, dd, J = 
10.0 Hz, 3.10 Hz, H-5). 
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4. Summary 
Azaanthraquinones and naphthonaphthyridines represent two important related classes of bioactive 
compounds. The synthesis of these compounds represents an attractive target for both organic and 
medicinal chemists. Morever, it is known that 2-azaanthraquinones are more active than the 
corresponding 1-azaanthraquinones and that the presence of a hydroxyl group at the C-1 peri-carbonyl 
position of 2-azaanthraquinones enhances their biological activity. Another important feature which 
improves the biological activity of tricyclic azaaromatic compounds is the presence of a covalent bond 
between the tricyclic aromatic system and another aromatic ring called the biaryl axis. Therefore, the 
chemistry of 2-azaanthraquinones and their corresponding naphthonaphthyridine analogues was 
explored during the present research work. 
In a first part of the present thesis, the synthesis of 2-azacleistopholine iv was achieved by two routes. 
The first route utilized a ligand-free Heck reaction as the key step. Different attempts to obtain aza ring 
closure of N-methanesulfonyl-2-(allylaminomethyl)-3-bromo-1,4-dimethoxynaphthalene i failed to afford 
2-azacleistopholine iv. This latter compound iv was synthesized upon refluxing 2-(allylaminomethyl)-3-
bromo-1,4-naphthoquinone iii, obtained by oxidation of 1,4-dimethoxynaphthalene i with CAN, in the 
presence of 50 mol% of Pd(OAc)2 in 30% yield.  
OMe
OMe
Br
N
O
O
Br
N
Mes
Mes
3 equiv. 
CAN
CH3CN/H2O
 (2/1)
0°C, 30 min
i (60%)
N
OMe
OMe Me
50 mol%
Pd(OAc)2
5 equiv.
K2CO3
X
CH3CN, ∆,
 3 h
N
O
O Me
ii
iii (45%) iv (30%)
50 mol%
Pd(OAc)2
5 equiv.
K2CO3
CH3CN, ∆,
 3 h
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The second route utilized an acid-promoted intramolecular Pomeranz-Fritsch reaction as the key step. 
Condensation of 2-formyl-1,4-dimethoxynaphthalene v and 2-aminomethyl-2-methyl-1,3-dioxolane vi 
yielded intermediate imine vii, which was reduced quantitatively to the corresponding 
aminomethylnaphthalene viii. Different reaction conditions were screened to induce the intramolecular 
cyclization of the aminomethylnaphthalene viii using different Brønsted acids. In the presence of 
gaseous hydrochloric acid, amine viii was protonated to the corresponding ammonium chloride x. 
Reaction of the aminomethylnaphthalene viii with sulfuric acid in a biphase system with 
dichloromethane gave 2-azacleistopholine iv in a 50% yield. 
OMe
OMe
CHO
OMe
OMe
N
H
N
O
O Me
v viii (quant)
iv
 2.0 equiv. 
MgSO4
2.0 equiv. 
NaBH4
OMe
OMe
N
vii
MeOH, rt,
16 h
CH2Cl2, rt, 2 h
HCl(g)
Me
O O
OMe
OMe
N
H
Me
O O
x
H
Me
OO
H2N
vi
Et2O, rt, 1 h
H2SO4/CH2Cl2
(2/1)
rt, 48 h
Cl
Me
O O
 
Having 2-azacleistopholine iv in hand, (E)-4-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione xi 
was synthesized in a 86% yield upon reaction with DMF-DMA. Subsequent reaction of (E)-4-[2-
(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-dione xi with an excess of ammonium chloride in acetic 
acid in order to form 2-azasampangine xii only resulted in intractable complex reaction mixtures. 
Therefore, the synthesis of 2-azasampangine xii still remains a challenge.  
N
O
O Me
N
O
N
N
O
O
NMe Me
iv
xi (86%)
xii
5 equiv.
 DMF-DMA
DMF, 125 °C, 
2.5 h
10 equiv. 
NH4Cl
AcOH, ∆,
 1 h
X
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In the second part of this thesis, the synthesis of 2-azaanthraquinones substituted at the C-1 peri-
carbonyl position and linked to aryl groups at C-3, more specifically 3-aryl-2-aza-1-
hydroxyanthraquinones xv, 3-aryl-2-aza-1-methylanthraquinones xxiii and 3-aryl-2-aza-1-hydroxy-4-
methoxycarbonylanthraquinones xxvii, was investigated. An additional plan was to synthesize 3-aryl-2-
aza-1-(2-dimethylaminovinyl)anthraquinones xxiv in order to convert them to the corresponding 2-
azasampangine analogues xxv. 
In continuation of preceding studies in our research group, the reaction of 2-methoxycarbonyl-1,4-
naphthoquinone xiii with pyridinium salts xiv under Krönhke conditions afforded 3-aryl-1-
hydroxybenzo[g]isoquinoline-5,10-diones xv in 40-75% yield and 3-amino-2-methoxycarbonyl-1,4-
naphthoquinone xi in 15-20% yield as a side product. The formation of the target products xv is 
favoured by the presence of electron-withdrawing groups while their absence favoured the formation of 
the side product xvi.  
R N
O
N
R
OHO
O
Br
1.05 equiv.
10%(w/v) NH4OAc
in HOAc, ∆, 1-4 h
+
OMe
NH2
O
O
O
xvia (15-20%)xv (40-75%)
xiv
O
O
OMe
O
xiii R = C6H5, 4-ClC6H4, t-Bu, OEt, NH2  
3-Alkylamino- or 3-arylamino-2-methoxycarbonyl-1,4-naphthoquinones xvi were prepared by refluxing 
quinone xiii and alkyl- or arylammonium acetates xvii in 69-87% with minor presence of methyl 1,4-
dihydroxynaphthalene-2-carboxylate  xviii (0-12%) resulting from the autooxidation-reduction of the 
starting material xiii and the hydroquinone  form of alkylaminonaphthoquinones xvib-c.  
O
O
OMe
O O
O
OMe
O
N
H
R
RNH3OAc
xvii
PhMe/AcOH (5/1)
 ∆, 4 h
xiii xvib-c (69-87%)
+
OMe
OH
OH
O
xviii (0-12%)R = n-Pr, n-Bu, C6H5
2-12 equiv.
 
Due to the vinylogous character of the amino group and the intramolecular hydrogen bonds of 3-amino-
2-methoxycarbonyl-1,4-naphthoquinone xvia, it was found impossible to react it under mild acid, neutral 
and basic conditions with common electrophiles xix such as ethyl acetoacetate xixa and benzaldehyde 
xixb to form imines xx or to acetylate it using acetic anhydride and acetyl chloride xixd.   
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xvia xix
xxa R1 = Me, R2 = COOEt
xxb R1 = Ph, R2 = H
NH
MeO
OMe
O O
O
xxi
X
X
xixa R1 = Me, R2 = CH2COOEt
xixb R1 = C6H5, R2 = H
xixc R1 = Me, R2 = OAc
xixb R1 = Me, Cl
 
The formation of the side product xvia could be avoided when the synthesis of 3-aryl-1-
hydroxybenzo[g]isoquinoline-5,10-diones xv was run under microwave conditions. These conditions 
were previously optimized in our group. 
O
N
Cl
O
O
OH
N
Br
5% (w/v) NH4OAc in
MeOH, µW, 5 min
1.05 equiv.
xiii xvb (35%)
Cl
O
O
OMe
O
xivb
 
2-Acetyl-1,4-naphthoquinone xxii was treated with pyridinium salts xiv under the abovementioned 
microwave assisted Kröhnke conditions to afford   3-aryl-1-methylbenz[g]isoquinoline-5,10-diones xxiii 
in 47-67% yield. Subsequently, 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones xxiii were reacted with 
an excess of DMF-DMA to give 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isoquinoline-5,10-diones xxiv 
in a 23-77% yield. The reaction of 3-aryl-1-methylbenzo[g]isoquinoline-5,10-diones xxiv with DMF-DMA 
was strongly influenced by the electronic effects of the aryl substituent at position C-3 in substrate xxiv. 
Differents attempts to synthetize the corresponding naphthonaphthyridines xxv using literature 
procedures failed. However, boiling 3-aryl-1-(dimethylaminovinyl)benzo[g]isoquinoline-5,10-dione xxiva 
in a 5% (w/v) solution of NH4OAc in methanol afforded  5-phenyl-7H-naphtho[3,2,1-de]naphthyridine-7-
one xxva in a 89% yield. 
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DMF, 125°C,
 4-20 h
5-10 equiv.
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xxiv (23-77%)
N
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Me
R
Br
5% (w/v) NH4OAc in MeOH,
 µW, 6 min, 90°C
 xxiii (47-67%)
1.05 equiv.
O
O
Me
O
xxii
N
O
R xiv
25-33% (w/v) NH4Cl in AcOH
125°C or ∆, 1 h
X
5% (w/v) NH4OAc in MeOH
∆, 4 h
R = H (89%)
R = H, Cl, F,OMe, Me
R = H,Cl, OMe, Me
 
The synthesis of 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylanthraquinones xxxix was envisaged 
starting from 3-methoxycarbonyl-1,4-naphthoquinone xxii and enaminoesters xxvi. In order to find 
optimized conditions for this synthesis, the reaction of 3-methoxycarbonyl-1,4-napthoquinone xxiii with 
methyl 3-aminocrotonate xxvia was screened. This reaction gave the 5-hydroxyindole xxix when the 
starting material was boiled in a mixture of toluene and acetic acid (5/1) and the indole xxx was 
obtained in boiling toluene in the presence of a catalytic amount of sulfuric acid. Compound xxx could 
also be obtained by treatment of indole xxix with a catalytic amount of sulfuric acid in toluene under 
reflux. When the reaction was conducted at 80°C, only the Michael adduct xxvii could be isolated in 
25% yield. Attemps to cyclize this Michael adduct xxvii to the corresponding methyl 1-hydroxy-3-
phenylbenzo[g]isoquinoline-5,10-dione-4-carboxylate xxviii using heat or ZnCl2 failed. 
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In order to arrange for a more suitable action of the amino group of enaminoesters xxvi, methyl N-
isopropyl-3-aminocrotonate xxvib was reacted with the activated quinone xiii in a mixture of toluene 
and acetic acid (5/1) under reflux. After 36 hours, only the enaminolactone xxxib was retrieved. 
Therefore, it was considered that N-isopropyl-3-alkylbenzo[g]furo[4,3,2-de]isoquinoline-1-one xxxiib 
could be obtained upon prolonged heating of enaminolactone xxxib as a key intermediate towards the 
synthesis of benzo[g]isoquinoline-1,5,10(2H)-trione xxxixb. Unfortunely, the prolongation of heating to 
12 hours did not give the desired benzofuroisoquinoline derivative xxxiib. 
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Me
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Me
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Therefore, three other routes have been explored towards the synthesis of 3-aryl-2-aza-1-hydroxy-4-
methoxycarbonylanthraquinones xxxix. Two routes rely on the synthesis of N-substituted 3-
alkylbenzo[g]furo[4,3,2-de]isoquinoline-1-ones xxxii as key intermediates, which were prepared by 
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treating 2-methoxycarbonyl-1,4-naphthoquinone xiii with either β-ketoesters xxxiii and primary amines 
xxxv (Route A) or N-alkyl enaminoesters xxvi (Route B). A third route consisted of the oxidative 
addition of N-alkyl enaminoesters xxvi onto methyl 1,4-dihydroxynaphthalene-2-carboxylate xviii (Route 
C). 
R OEt
O O
R OEt
OH O
+
OMe
O
O
O
xiii
∆, 3-4 h
xxxiii
xxxiii 
R = Me, Et, i-Bu, C6H5
O
O
R
OMe
OOH
O
xxxiv (17-54 %)
1.05 equiv.
PhMe/AcOH (5/1)
 
The first route commenced with the reaction of 2-methoxy-1,4-naphthoquinone xiii with 3-oxoesters xxx 
under acidic conditions leading to the formation of methyl acyl-2,3-dihydro-5-hydroxy-2-oxonaphtho[1,2-
b]furan-4-carboxylates xxxiv. Subsequent treatment with primary amines xxxv in the presence of acetic 
acid failed to provide N-substituted 3-alkylbenzo[g]furo[4,3,2-de]isoquinoline-1-ones xxxii but 
unexpectedly gave lactone xxxvi.  
N
O
R1
R2
O
OH O
R1NH2.HOAc xxxv 
(R1 = H, n-Pr )
xxxvi
PhMe/AcOH (5/1), 
∆, 3-4 h
(53-91%)
O
O
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OMe
O
O
O
R2
OMe
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O
xxxiv R2 = Me, Ph
xxxii
X
2-12 equiv.
Route A
 
The second route utilized a Nenitzescu reaction of 2-acetyl-1,4-naphthoquinone xiii with enaminoesters 
xxvi to form N-substituted 3-alkylbenzo[g]furo[4,3,2-de]isoquinoline-1-ones xxxii which were hydrolized 
giving the carboxylic acids xxxviii which were converted to the corresponding methyl esters xxxix in 14-
97% yield by treatment with diazomethane.   
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THF/CH3CN (1/4),
 rt, overnight
xxxix (14-97%)
5 equiv. CH2N2/Et2O
Route B
R1 = Et, n-Pr, 
R2 = Me, Et, C6H5
R3 = Me, Et
 
For the third route, the reaction of methyl 1,4-dihydroxynaphthalene-2-carboxylate xviii with 
enaminoester xxvi in the presence of manganese(IV) oxide was screened in order to optimize the 
reaction conditions. A two-step procedure was found to be the best way and N-substituted-
benzo[g]isoquinoline-1,5,10-2H-triones xxxix were synthesized in 29-71% yield. 
N
R2
OO
O COOR3
R1
OH
OH
OMe
O
R2 OR3
ONHR
1
+
(1) 6.0 equiv. MnO2, 10 equiv. MgSO4
CH2Cl2, rt, 3.5 h
(2) PhMe/AcOH (5/1), ∆, 1-1.5 h
xviii xxvi xxxix (29-71%)
Route C
R1 = Et, n-Pr 
R2 = Me, Et, C6H5
R3 = Me, Et  
During this PhD research work, also the first total synthesis of paepalantine xlii by a phthalide 
annulation strategy. Accordingly, 3-cyano-5,7-dimethoxy-(3H)-isobenzofuran-1-one xl would be reacted 
with 6-hydroxy-2-methyl-6H-pyran-3-one xli. However, the synthesis of 3-cyano-5,7-dimethoxy-3H-
isobenzofuran-1-one xl was successful while the synthesis of 6-hydroxy-2-methyl-6H-pyran-3-one xli 
did not work. Therefore, the first total synthesis of paepalantine xlii still remains a challenge.  
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5. Samenvatting 
Azaantrachinonen en naftonaftyridines vertegenwoordigen twee belangrijke verwante klassen van 
bioactieve verbindingen. De synthese van deze verbindingen is een aantrekkelijk doelwit voor zowel 
organische als medicinale chemici. Bovendien blijkt uit de literatuur dat 2-azaantrachinonen actiever zijn 
dan de overeenkomstige 1-azaantrachinonen en dat de aanwezigheid van een hydroxylgroep op de C-1 
peri-carbonylplaats van 2-azaantrachinonen hun biologische activiteit versterkt. Een andere belangrijke 
eigenschap die de biologische activiteit van tricyclische azaaromatische verbindingen bevordert, is de 
aanwezigheid van een covalente binding tussen het tricyclische aromatische systeem en een andere 
aromatische ring die de biarylas wordt genoemd. Bijgevolg is de chemie van 2-azaantrachinonen en 
hun overeenkomstige naftonaftyridine analogen het onderwerp van deze onderzoeksverhandeling. 
In een eerste deel van het doctoraat werd de synthese van 2-azacleistopholine iv voltooid via twee 
routes. De eerste route gebruikte een ligandvrije Heckreactie in de sleutelstap. Verscheidene pogingen 
tot aza-ringsluiting van N-methaansulfonyl-2-(allylaminomethyl)-3-broom-1,4-dimethoxynaftaleen i 
faalden. Uiteindelijk werd 2-azacleistopholine iv gesynthetiseerd door 2-(allylaminomethyl)-3-broom-1,4-
naftochinon iii, bekomen door oxidatie van 1,4-dimethoxynaftaleen i met CAN, te koken onder 
terugvloei in de aanwezigheid van 50 mol% Pd(OAc)2 in een rendement van 30%.  
OMe
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Br
N
O
O
Br
N
Mes
Mes
3 equiv. CAN CH3CN/H2O (2/1)
0°C, 30 min
i (60%)
N
OMe
OMe Me
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5 equiv. K2CO3
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N
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O Me
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iii (45%) iv (30%)
50 mol% Pd(OAc)2
5 equiv. K2CO3
CH3CN, ∆, 3 h
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De tweede route gebruikte een Pomeranz-Fritschreactie in de sleutelstap. Condensatie van 2-formyl-
1,4-dimethoxynaftaleen v en 2-aminomethyl-2-methyl-1,3-dioxolaan vi gaf intermediair imine vii, dat 
kwantitatief gereduceerd werd tot het overeenkomstige aminonaftaleen viii. Verscheidene 
reactieomstandigheden werden getest om de intramoleculaire cyclisatie van dioxolanylmethylamine viii 
uit te voeren gebruik makende van verschillende Brønsted zuren. In de aanwezigheid van gasvormig 
zoutzuur werd amine viii geprotoneerd tot het overeenkomstige ammoniumchloride x. 2-
Azacleistopholine iv werd in een rendement van 50% bekomen door reactie van dioxolanylmethylamine 
viii met zwavelzuur in een tweefasesysteem met dichloormethaan. 
OMe
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v viii (kwant)
iv
 2.0 equiv. 
MgSO4
2.0 equiv. 
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(2/1)
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Startende van 2-azacleistopholine iv werd (E)-4-[2-(dimethylamino)vinyl]benzo[g]isochinoline-5,10-dion 
xi gesynthetiseerd in een rendement van 86% door middel van reactie met DMF-DMA. De 
vervolgreactie van (E)-4-[2-(dimethylamino)vinyl]benzo[g]isochinoline-5,10-dion xi met een overmaat 
ammoniumchloride in azijnzuur met als doel 2-azasampangine xii te vormen resulteerde enkel in niet 
identificeerbare complexe reactiemengsels. Bijgevolg blijft de synthese van 2-azasampangine xii nog 
steeds een uitdaging.  
N
O
O Me
N
O
N
N
O
O
NMe Me
iv
xi (86%)
xii
5 equiv.
 DMF-DMA
DMF, 125 °C, 
2.5 h
10 equiv. 
NH4Cl
AcOH, ∆,
 1 h
X
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In het tweede deel van de doctoraatsverhandeling werd de synthese van 2-azaantrachinonen 
uitgewerkt, die gesubstitueerd zijn op de C-1 peri-carbonylplaats en gelinkt zijn aan een arylgroep op C-
3. Meer specifiek werd hier de synthese 3-aryl-2-aza-1-hydroxyantrachinonen xv, 3-aryl-2-aza-1-
methylanthrachinonen xxiii en 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylantrachinonen xxvii 
onderzocht. 3-Aryl-2-aza-1-(2-dimethylaminovinyl)antrachinonen xxiv werden gesynthetiseerd met als 
doel deze verder om te zetten in de overeenkomstige 2-azasampangine analogen xxv. 
In voortzetting van eerder onderzoek aan de Vakgroep Duurzame Organische Chemie en Technologie, 
leverde de reactie van 2-methoxycarbonyl-1,4-naftochinon xiii met pyridiniumzouten xiv onder Krönhke 
omstandigheden 3-aryl-1-hydroxybenzo[g]isochinoline-5,10-dionen xv op in een rendement van 40-75% 
en 3-amino-2-methoxycarbonyl-1,4-naftochinon xi als nevenproduct in een rendement van 15-20%. 
Hierbij werd de vorming van de doelverbindingen xv door de aanwezigheid van elektronenzuigende 
groepen, terwijl de afwezigheid van elektronenzuigende groepen de vorming van nevenproduct xvi 
bevorderde.  
R N
O
N
R
OHO
O
Br
1.05 equiv.
10%(m/v) NH4OAc
in HOAc, ∆, 1-4 h
+
OMe
NH2
O
O
O
xvia (15-20%)xv (40-75%)
xiv
O
O
OMe
O
xiii
R = C6H5, 4-ClC6H4, t-Bu, OEt, NH2  
3-Alkylamino- en 3-arylamino-2-methoxycarbonyl-1,4-naftochinonen xvi werden bereid door geactiveerd 
naftochinon xiii en alkyl- of arylammoniumacetaten xvii te verhitten onder terugvloei in een rendement 
van 69-87% in de aanwezigheid van kleine hoeveelheden methyl-1,4-dihydroxynaftaleen-2-carboxylaat 
xviii (0-12%). Deze laatste verbinding xviii werd gevormd door autooxidatie-reductie van startmateriaal 
xiii en het hydrochinon gevormd na additie de aminogroep aan geactiveerd naftochinon xiii.  
O
O
OMe
O O
O
OMe
O
N
H
R
4 equiv. RNH3OAc xvii
HOAc/PhMe (1/4), ∆, 4 h
R = n-Pr, n-Bu, C6H5
xiii xvib-c (69-87%)
+
OMe
OH
OH
O
xviii (0-12%)
 
Het was onmogelijk om de aminogroep van 3-amino-2-methoxycarbonyl-1,4-naftochinon xvia te 
imineren of te acetyleren onder zure, neutrale of basische omstandigheden. Dit werd toegeschreven 
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aan het vinyloge karakter van de aminogroep en de mogelijkheid om intramoleculaire 
waterstofbindingen te vormen. 
OMe
NH2
O
O
O
+ R1 R2
O
O
O
OMe
N
R2R1
O
xvia xix
xxa R1 = Me, R2 = COOEt
xxb R1 = Ph, R2 = H
NH
MeO
OMe
O O
O
xxi
X
X
xixa R1 = Me, R2 = CH2COOEt
xixb R1 = C6H5, R2 = H
xixc R1 = Me, R2 = OAc
xixb R1 = Me, Cl
 
De vorming van het nevenproduct xvia kon vermeden worden door de synthese van 3-aryl-1-
hydroxybenzo[g]isochinoline-5,10-dionen xv uit te voeren in een microgolfreactor onder 
omstandigheden die eerder werden geoptimaliseerd aan de Vakgroep Duurzame Organische Chemie 
en Technologie. 
O
N
Cl
O
O
OH
N
Br
5% (m/v) NH4OAc in
MeOH, µW, 5 min
1.05 equiv.
xiii xvb (35%)
Cl
O
O
OMe
O
xivb
 
2-Acetyl-1,4-naftochinon xxii en pyridinium zouten xiv werden onder de hierboven vermelde microgolf 
geassisteerde Krönkhe omstandigheden behandeld met vorming van 3-aryl-1-
methylbenzo[g]isochinoline-5,10-dionen xxiii in een rendement van 47-67%. Vervolgens werden 3-aryl-
1-methylbenzo[g]isochinoline-5,10-dionen xxiii in reactie gebracht met een overmaat DMF-DMA, 
resulterend in 3-aryl-1-[2-(dimethylamino)vinyl]benzo[g]isochinoline-5,10-dionen xxiv in een rendement 
van 23-77%. Verscheidene pogingen om de overeenkomstige naftonaftyridinen xxv te bereiden volgens 
literatuurprocedures faalden. Desalniettemin leverde koken onder terugvloei van 3-aryl-1-
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(dimethylaminovinyl)benzo[g]isochinoline-5,10-dion xxiva in methanol in de aanwezigheid van NH4OAc 
het overeenkomstige 5-fenyl-7H-nafto[3,2,1-de]naftyridine-7-on xxva in een rendement van 89%. 
N
O
O R
NMe Me
DMF, 125°C,
 4-20 h
5-10 equiv.
DMF-DMA
xxiv (23-77%)
N
N
O R
xxv
N
O
O
Me
R
Br
5% (m/v) NH4OAc in MeOH,
 µW, 6 min, 90°C
 xxiii (47-67%)
1.05 equiv.
O
O
Me
O
xxii
N
O
R xiv
25-33% (m/v) NH4Cl in AcOH
125°C of ∆, 1 h
X
5% (m/v) NH4OAc in MeOH
∆, 4 h
R = H (89%)
R = H, Cl, F,OMe, Me
R = H,Cl, OMe, Me
 
De synthese van 3-aryl-2-aza-1-hydroxy-4-methoxycarbonylantrachinon xxxix ging uit van 3-
methoxycarbonyl-1,4-naftochinon xxii and enaminoesters xxvi. Om optimale reactieomstandigheden te 
vinden voor deze synthese werd de reactie van 3-methoxycarbonyl-1,4-naftochinon xxiii met methyl 3-
aminocrotonaat xxvia gescreend. Deze reactie gaf 5-hydroxyindool xxix wanneer de verbindingen 
werden verhit onder terugvloei in een mengsel van tolueen en azijnzuur. Indool xxx werd bekomen in 
kokende tolueen in de aanwezigheid van een katalytische hoeveelheid zwavelzuur. Indool xxx kon 
eveneens bekomen worden door 5-hydroxyindool xxix te behandelen met een katalytische hoeveelheid 
zwavelzuur in kokende tolueen. Alleen Michaeladduct xxvii werd geïsoleerd in een rendement van 25% 
wanneer de reactie uitgevoerd werd bij 80°C. Pogingen om dit Michaeladduct xxvii te cycliseren tot het 
corresponderende methyl-1-hydroxy-3-fenylbenzo[g]isochinoline-5,10-dion-4-carboxylaat xxviii door 
middel van verhitting of ZnCl2 faalden. 
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O
O
OMe
O Me
NH2
OMe
O
OMe
O
COOEt
H2N Me
O
O
xiii
N
O
O
COOMe
Me
OH
xxix
xxviii
xxvia
H2SO4 (kat.)
PhMe, ∆, 4 h 
85%
PhMe/AcOH (5/1),
∆, 4 h, 48% xxvii
X
H2SO4 (kat.)
68%
PhMe, ∆,
4 h
xxx
3 equiv. Ag2O
PhMe/AcOH (5/1)
80°C, 1 h (25%)
1.05 equiv.
HN
OH
OMe
O
COOMe
Me
HN
OH
OMe
O
Me
∆ of
ZnCl2
 
Teneinde de nucleofiliciteit van de aminogroep van enaminoesters xxvi beter te benutten, werd methyl-
N-isopropyl-3-aminocrotonaat xxvib in reactie gebracht met geactiveerd naftochinon xiii in een mengsel 
van tolueen en azijnzuur. Na 36 uur werd alleen enaminolacton xxxib geïsoleerd. Daarom werd 
vooropgesteld dat N-isopropyl-3-methylbenzo[g]furo[4,3,2-de]isochinoline-1-on xxxiib bekomen kon 
worden door verhitting van enaminolacton xxxib als een sleutelintermediair in de synthese van 
benzo[g]isochinoline-1,5,10-(2H)-trionen xxxix. Helaas leverde langdurig verhitten niet het gewenste 
benzofuroisochinolinederivaat xxxiib op. 
O
O
OMe
O
xiii
Me
NH
i-Pr
OMe
O
xxvib
PhMe/AcOH (5/1)
∆, 36 h O
O
OH
N
Me
i-Pr
OOH
∆, 12 h
xxxiibxxxib (31%)
X
Me
N
H
i-Pr
COOMe
O
O
PhMe
 
Daarom werden drie andere routes onderzocht om de beoogde 3-aryl-2-aza-1-hydroxy-4-
methoxycarbonylantrachinonen xxxix te synthetiseren. Twee routes steunden op de synthese van N-
gesubstitueerde 3-alkylbenzo[g]furo[4,3,2-de]isochinoline-1-onen xxxii als intermediairen. Deze werden 
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bereid door 2-methoxycarbonyl-1,4-naftochinon te behandelen xiii met ofwel β-ketoesters xxxiii en 
primaire amines xxxv (Route A) ofwel N-alkylenaminoesters xxvi (Route B). Een derde route bestond 
uit de oxidatieve additie van N-alkylenaminoesters xxvi aan methyl-1,4-dihydroxynaftaleen-2-
carboxylaat xviii (Route C). 
R OEt
O O
R OEt
OH O
+
OMe
O
O
O
xiii
∆, 3-4 h
xxxiii
xxxiii 
R = Me, Et, i-Bu, C6H5
O
O
R
OMe
OOH
O
xxxiv (17-54 %)
1.05 equiv.
PhMe/AcOH (5/1)
 
De eerste route vertrok van de reactie van 2-methoxycarbonyl-1,4-naftochinon xiii met 3-oxoesters xxx 
in zuur midden met vorming van naftofuranon xxxiv. Behandeling van dit naftofuran xxxiv met primaire 
amines xxxv in de aanwezigheid van azijnzuur faalde om benzo[g]furo[4,3,2-de]isochinoline-2,5(4H)-
dionen xxxii te leveren maar gaf onverwacht methyl-2,3-dihydro-5-hydroxy-2-oxonafto[1,2-b]-furan-4-
carboxylaat xxxvi.  
N
O
R1
R2
O
OH O
R1NH2.HOAc xxxv 
(R1 = H, n-Pr )
xxxvi
PhMe/AcOH (5/1), 
∆, 3-4 h
(53-91%)
O
O
OH
OMe
O
O
O
R2
OMe
OOH
O
xxxiv R2 = Me, Ph
xxxii
X
2-12 equiv.
Route A
 
De tweede route steunde op de Nenitzescureactie van 2-acetyl-1,4-naftochinon xiii met enaminoesters 
xxvi om benzo[g]furo[4,3,2-de]isochinoline-2,5(4H)-dionen xxxii te vormen. Deze laatste werden 
gehydrolyseerd tot de overeenkomstige carbonzuren xxxviii. Methylering met diazomethaan leverde 
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2,3-digesubstitueerde methyl-1,2,5,10-tetrahydro-1,5,10-trioxobenzo[g]isochinole-4-carboxylaten xxxix 
in een rendement van 14-97%.  
O
O
OMe
O
R2 OR3
NH OR
1
N
O
O
OH O
R1
R2
N
O
O COOH
R1
R2
O
xiii xxxii (19-47%)
xxxviii (40-98%)
4 M NaOH/THF/ MeOH
 (2/1/1), 1.5 h, 50°C O2 (lucht)
+
1.05 equiv.
PhMe/AcOH (5/1)
∆, 4-48 h
xxxvi
N
O
COOMe
R2
R1
O
O
THF/CH3CN (1/4),
 kt, overnacht
xxxix (14-97%)
5 equiv. CH2N2/Et2O
Route B
R1 = Et, n-Pr, 
R2 = Me, Et, C6H5
R3 = Me, Et
 
Voor de derde route werd de reactie van methyl-1,4-dihydroxynaftaleen-2-carboxylaat xviii met 
enaminoester xxvi in de aanwezigheid van mangaan(IV)oxide bestudeerd om de 
reactieomstandigheden te optimaliseren. Een tweestapsprocedure bleek de beste manier te zijn waarbij 
N-gesubstitueerde benzo[g]isochinoline-1,5,10(2H)-trionen xxxix werden gesynthetiseerd in een 
rendement van 29-71%. 
N
R2
OO
O COOR3
R1
OH
OH
OMe
O
R2 OR3
ONHR
1
+
(1) 6.0 equiv. MnO2
     10 equiv. MgSO4
     CH2Cl2, kt, 3.5 h
(2) PhMe/AcOH (5/1), ∆, 1-1.5 h
xviii xxvi xxxix (29-71%)
Route C
R1 = Et, n-Pr 
R2 = Me, Et, C6H5
R3 = Me, Et  
In het huidige doctoraatsonderzoek was ook de eerste totaalsynthese van paepalantine xlii gepland aan 
de hand van een ftalide anneleringsreactie. Meer specifiek zou 3-cyaan-5,7-dimethoxy-3H-
isobenzofuran-1-on xl in reactie gebracht worden met 6-hydroxy-2-methyl-6H-pyran-3-on xli. Alhoewel 
de synthese van 3-cyaan-5,7-dimethoxy-3H-isobenzofuran-1-on xl succesvol uitgevoerd werd, bleek de 
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in de literatuur gerapporteerde synthese van 6-hydroxy-2-methyl-6H-pyran-3-on xli niet te 
reproduceren. Bijgevolg blijft de eerste totaalsynthese van paepalantine xlii nog steeds een uitdaging.  
O
OMe
MeO
O
CN
O
O
OMe
Me
+
xl xli
O
OH
MeO
OH
OMe
O
Me
xlii
LiOtBu
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